UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the quarterly period ended June 30, 2024
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the transition period from _____ to _____
Commission
File No. 000-53029
![](https://www.sec.gov/Archives/edgar/data/1421636/000121390024070724/image_001.jpg)
C-BOND
SYSTEMS, INC.
(Exact
name of Registrant as Specified in its Charter)
Colorado | | 26-1315585 |
(State or Other Jurisdiction of Incorporation or Organization) | | (IRS Employer Identification No.) |
| | |
2029 Pat Booker Rd. | | |
San Antonio, Texas | | 78148 |
(Address of Principal Executive Offices) | | (Zip Code) |
210-490-3977
(Registrant’s
telephone number, including area code)
N/A
(Former
Name, Former Address and Former Fiscal Year, if Changed Since Last Report)
Securities
registered pursuant to Section 12(b) of the Exchange Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
N/A | | N/A | | N/A |
Indicate
by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was
required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”,
“smaller reporting company “, and “emerging growth company”, in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| | Emerging growth company | ☐ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒
There
were 550,503,623 shares of the registrant’s common stock, par value $0.001 per share, issued and outstanding as of August
14, 2024.
C-BOND
SYSTEMS, INC.
FORM
10-Q
JUNE
30, 2024
TABLE
OF CONTENTS
PART
I - FINANCIAL INFORMATION
ITEM
1. FINANCIAL STATEMENTS
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
| |
June 30, | | |
December 31, | |
| |
2024 | | |
2023 | |
| |
(Unaudited) | | |
| |
ASSETS | |
| | |
| |
CURRENT ASSETS: | |
| | |
| |
Cash | |
$ | 196,315 | | |
$ | 736,461 | |
Accounts receivable, net | |
| 243,369 | | |
| 424,091 | |
Inventory | |
| 162,052 | | |
| 181,663 | |
Prepaid expenses and other current assets | |
| 107,807 | | |
| 28,503 | |
Due from related party | |
| 71,961 | | |
| - | |
Contract assets | |
| 59,856 | | |
| 2,400 | |
Total Current Assets | |
| 841,360 | | |
| 1,373,118 | |
| |
| | | |
| | |
OTHER ASSETS: | |
| | | |
| | |
Property and equipment, net | |
| 147,842 | | |
| 171,606 | |
Right of use asset, net | |
| 128,722 | | |
| 158,484 | |
Intangible asset, net | |
| 204,163 | | |
| 229,414 | |
Goodwill | |
| 350,491 | | |
| 350,491 | |
Total Other Assets | |
| 831,218 | | |
| 909,995 | |
TOTAL ASSETS | |
$ | 1,672,578 | | |
$ | 2,283,113 | |
| |
| | | |
| | |
LIABILITIES AND SHAREHOLDERS’ DEFICIT | |
| | | |
| | |
CURRENT LIABILITIES: | |
| | | |
| | |
Convertible note payable - current portion | |
$ | 180,000 | | |
$ | 180,000 | |
Notes payable, net of discount - current portion | |
| 474,014 | | |
| 81,908 | |
Accounts payable | |
| 798,827 | | |
| 710,222 | |
Accrued expenses | |
| 390,258 | | |
| 474,515 | |
Accrued compensation | |
| 54,462 | | |
| 717,204 | |
Contract liabilities | |
| 148,784 | | |
| 500,720 | |
Lease liabilities, current portion | |
| 60,773 | | |
| 60,503 | |
Total Current Liabilities | |
| 2,107,118 | | |
| 2,725,072 | |
| |
| | | |
| | |
LONG-TERM LIABILITIES: | |
| | | |
| | |
Convertible notes payable, net of current portion | |
| 828,091 | | |
| 918,091 | |
Notes payable, net of current portion and discount | |
| 33,477 | | |
| 42,109 | |
Lease liabilities, net of current portion | |
| 67,949 | | |
| 97,249 | |
Total Long-term Liabilities | |
| 929,517 | | |
| 1,057,449 | |
Total Liabilities | |
| 3,036,635 | | |
| 3,782,521 | |
| |
| | | |
| | |
Commitments and Contingencies (See Note 10) | |
| | | |
| | |
| |
| | | |
| | |
Series B convertible preferred stock: $0.10 par value, 100,000 shares designated; 1,189 and 1,144 shares issued and outstanding on June 30, 2024 and December 31, 2023, respectively ($1,245,313 redemption and liquidation value on June 30, 2024) | |
| 1,245,313 | | |
| 1,203,967 | |
| |
| | | |
| | |
Series C convertible preferred stock: $0.10 par value, 100,000 shares designated; 14,750 and 15,150 shares issued and outstanding on June 30, 2024 and December 31, 2023, respectively ($2,363,855 redemption and liquidation value at June 30, 2024) | |
| 1,575,903 | | |
| 1,621,160 | |
| |
| | | |
| | |
SHAREHOLDERS’ DEFICIT: | |
| | | |
| | |
Preferred stock: $0.10 par value, 2,000,000 shares authorized; 100,000 Series B and 100,000 Series C designated, no shares issued and outstanding | |
| - | | |
| - | |
Common stock: $0.001 par value, 4,998,000,000 shares authorized; 545,253,623 and 532,818,051 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively | |
| 545,254 | | |
| 532,818 | |
Additional paid-in capital | |
| 56,561,018 | | |
| 55,852,477 | |
Accumulated deficit | |
| (61,447,146 | ) | |
| (60,851,714 | ) |
Total C-Bond Systems, Inc. shareholders’ deficit | |
| (4,340,874 | ) | |
| (4,466,419 | ) |
Noncontrolling interest | |
| 155,601 | | |
| 141,884 | |
Total Shareholders’ Deficit | |
| (4,185,273 | ) | |
| (4,324,535 | ) |
Total Liabilities and Shareholders’ Deficit | |
$ | 1,672,578 | | |
$ | 2,283,113 | |
See accompanying notes to
the unaudited consolidated financial statements.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
| |
For the Three Months Ended | | |
For the Six Months Ended | |
| |
June 30, | | |
June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
SALES | |
$ | 863,533 | | |
$ | 414,055 | | |
$ | 1,800,337 | | |
$ | 929,275 | |
| |
| | | |
| | | |
| | | |
| | |
COST OF SALES (excluding depreciation expense) | |
| 424,959 | | |
| 209,071 | | |
| 886,888 | | |
| 454,431 | |
| |
| | | |
| | | |
| | | |
| | |
GROSS PROFIT | |
| 438,574 | | |
| 204,984 | | |
| 913,449 | | |
| 474,844 | |
| |
| | | |
| | | |
| | | |
| | |
OPERATING EXPENSES: | |
| | | |
| | | |
| | | |
| | |
Compensation and related benefits (including stock-based compensation of $0 and $30,046 for the three months ended June 30, 2024 and 2023, and $376,968 and $42,183 for the six months ended June 30, 2024 and 2023, respectively) | |
| (373,548 | ) | |
| (441,181 | ) | |
| (1,152,667 | ) | |
| (868,053 | ) |
Professional fees | |
| (88,030 | ) | |
| (193,263 | ) | |
| (229,614 | ) | |
| (380,953 | ) |
General and administrative expenses | |
| (169,357 | ) | |
| (142,404 | ) | |
| (365,048 | ) | |
| (321,304 | ) |
| |
| | | |
| | | |
| | | |
| | |
Total Operating Expenses | |
| (630,935 | ) | |
| (776,848 | ) | |
| (1,747,329 | ) | |
| (1,570,310 | ) |
| |
| | | |
| | | |
| | | |
| | |
OTHER OPERATING INCOME: | |
| | | |
| | | |
| | | |
| | |
Gain on sale of product line | |
| - | | |
| 4,051,709 | | |
| - | | |
| 4,051,709 | |
| |
| | | |
| | | |
| | | |
| | |
(LOSS) INCOME FROM OPERATIONS | |
| (192,361 | ) | |
| 3,479,845 | | |
| (833,880 | ) | |
| 2,956,243 | |
| |
| | | |
| | | |
| | | |
| | |
OTHER INCOME (EXPENSES): | |
| | | |
| | | |
| | | |
| | |
Gain on debt extinguishment, net | |
| - | | |
| 462,581 | | |
| 347,990 | | |
| 462,581 | |
Interest expense | |
| (53,608 | ) | |
| (166,189 | ) | |
| (67,727 | ) | |
| (361,975 | ) |
Interest expense - related party | |
| - | | |
| (1,964 | ) | |
| - | | |
| (5,663 | ) |
| |
| | | |
| | | |
| | | |
| | |
Total Other Income (Expenses), net | |
| (53,608 | ) | |
| 294,428 | | |
| 280,263 | | |
| 94,943 | |
| |
| | | |
| | | |
| | | |
| | |
NET (LOSS) INCOME BEFORE NONCONTROLLING INTEREST | |
| (245,969 | ) | |
| 3,774,273 | | |
| (553,617 | ) | |
| 3,051,186 | |
| |
| | | |
| | | |
| | | |
| | |
Net (income) loss of subsidiary attributable to noncontrolling interest | |
| (4,207 | ) | |
| 18,640 | | |
| (13,717 | ) | |
| 35,362 | |
Preferred stock dividend | |
| (13,749 | ) | |
| (13,618 | ) | |
| (28,098 | ) | |
| (27,305 | ) |
| |
| | | |
| | | |
| | | |
| | |
NET (LOSS) INCOME ATTRIBUTABLE TO COMMON SHAREHOLDERS | |
$ | (263,925 | ) | |
$ | 3,779,295 | | |
$ | (595,432 | ) | |
$ | 3,059,243 | |
| |
| | | |
| | | |
| | | |
| | |
NET (LOSS) INCOME PER COMMON SHARE: | |
| | | |
| | | |
| | | |
| | |
Basic | |
$ | (0.00 | ) | |
$ | 0.01 | | |
$ | (0.00 | ) | |
$ | 0.01 | |
Diluted | |
$ | (0.00 | ) | |
$ | 0.00 | | |
$ | (0.00 | ) | |
$ | 0.00 | |
| |
| | | |
| | | |
| | | |
| | |
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: | |
| | | |
| | | |
| | | |
| | |
Basic | |
| 543,165,027 | | |
| 493,056,689 | | |
| 539,431,386 | | |
| 458,283,435 | |
Diluted | |
| 543,165,027 | | |
| 2,349,380,186 | | |
| 539,431,386 | | |
| 2,314,606,932 | |
See accompanying notes to the unaudited consolidated
financial statements.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES
IN SHAREHOLDERS' DEFICIT
FOR THE THREE AND SIX MONTHS ENDED
JUNE 30, 2024 AND 2023
(Unaudited)
| |
Common Stock | | |
Additional
Paid-in | | |
Accumulated | | |
Noncontrolling | | |
Total
Shareholders’ | |
| |
# of Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Interest | | |
Deficit | |
Balance, December 31, 2023 | |
| 532,818,051 | | |
$ | 532,818 | | |
$ | 55,852,477 | | |
$ | (60,851,714 | ) | |
$ | 141,884 | | |
$ | (4,324,535 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Common stock issued for conversion of Series C preferred stock | |
| 11,554,535 | | |
| 11,555 | | |
| 28,445 | | |
| - | | |
| - | | |
| 40,000 | |
Cancellation of common stock and Series B preferred shares | |
| (5,250,000 | ) | |
| (5,250 | ) | |
| 132,890 | | |
| - | | |
| - | | |
| 127,640 | |
Preferred stock dividends and deemed dividend | |
| - | | |
| - | | |
| - | | |
| (14,349 | ) | |
| - | | |
| (14,349 | ) |
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation | |
| - | | |
| - | | |
| 326,968 | | |
| - | | |
| - | | |
| 326,968 | |
Net loss | |
| - | | |
| - | | |
| - | | |
| (317,158 | ) | |
| 9,510 | | |
| (307,648 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance, March 31, 2024 | |
| 539,122,586 | | |
| 539,123 | | |
| 56,340,780 | | |
| (61,183,221 | ) | |
| 151,394 | | |
| (4,151,924 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Common stock issued for conversion of Series C preferred stock | |
| 6,131,037 | | |
| 6,131 | | |
| 13,869 | | |
| - | | |
| - | | |
| 20,000 | |
Cancellation of Series B preferred shares | |
| - | | |
| - | | |
| 206,369 | | |
| - | | |
| - | | |
| 206,369 | |
Preferred stock dividends and deemed dividend | |
| - | | |
| - | | |
| - | | |
| (13,749 | ) | |
| - | | |
| (13,749 | ) |
Net loss | |
| - | | |
| - | | |
| - | | |
| (250,176 | ) | |
| 4,207 | | |
| (245,969 | ) |
Balance, June 30, 2024 | |
| 545,253,623 | | |
$ | 545,254 | | |
$ | 56,561,018 | | |
$ | (61,447,146 | ) | |
$ | 155,601 | | |
$ | (4,185,273 | ) |
| |
Common Stock | | |
Additional
Paid-in | | |
Accumulated | | |
Noncontrolling | | |
Total
Shareholders’ | |
| |
# of Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Interest | | |
Deficit | |
Balance, December 31, 2022 | |
| 350,270,172 | | |
$ | 350,270 | | |
$ | 55,141,503 | | |
$ | (62,693,184 | ) | |
$ | 150,742 | | |
$ | (7,050,669 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Common stock issued for cash and accrued compensation | |
| 54,545,455 | | |
| 54,545 | | |
| 245,455 | | |
| - | | |
| - | | |
| 300,000 | |
Common stock issued for professional fees | |
| 6,666,667 | | |
| 6,667 | | |
| 33,333 | | |
| - | | |
| - | | |
| 40,000 | |
Common stock issued for accrued compensation | |
| 9,636,364 | | |
| 9,636 | | |
| 43,364 | | |
| - | | |
| - | | |
| 53,000 | |
Common stock issued for conversion of Series C preferred stock | |
| 26,585,614 | | |
| 26,586 | | |
| 74,814 | | |
| - | | |
| - | | |
| 101,400 | |
Preferred stock dividends | |
| - | | |
| - | | |
| - | | |
| (13,687 | ) | |
| - | | |
| (13,687 | ) |
Accretion of stock-based compensation | |
| - | | |
| - | | |
| 12,137 | | |
| - | | |
| - | | |
| 12,137 | |
Net loss | |
| - | | |
| - | | |
| - | | |
| (706,365 | ) | |
| (16,722 | ) | |
| (723,087 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Balance, March 31, 2023 | |
| 447,704,272 | | |
| 447,704 | | |
| 55,550,606 | | |
| (63,413,236 | ) | |
| 134,020 | | |
| (7,280,906 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Common stock issued for professional fees | |
| 6,500,000 | | |
| 6,500 | | |
| 32,950 | | |
| - | | |
| - | | |
| 39,450 | |
Common stock issued for compensation | |
| 2,500,000 | | |
| 2,500 | | |
| 23,500 | | |
| - | | |
| - | | |
| 26,000 | |
Common stock issued for conversion of Series C preferred stock | |
| 23,157,922 | | |
| 23,158 | | |
| 59,442 | | |
| - | | |
| - | | |
| 82,600 | |
Common stock issued for conversion of debt, accrued interest and fees | |
| 43,371,481 | | |
| 43,372 | | |
| 157,017 | | |
| - | | |
| - | | |
| 200,389 | |
Preferred stock dividends | |
| - | | |
| - | | |
| - | | |
| (13,618 | ) | |
| - | | |
| (13,618 | ) |
Accretion of stock-based compensation | |
| - | | |
| - | | |
| 4,046 | | |
| - | | |
| - | | |
| 4,046 | |
Net income | |
| - | | |
| - | | |
| - | | |
| 3,792,913 | | |
| (18,640 | ) | |
| 3,774,273 | |
Balance, June 30, 2023 | |
| 523,233,675 | | |
$ | 523,234 | | |
$ | 55,827,561 | | |
$ | (59,633,941 | ) | |
$ | 115,380 | | |
$ | (3,167,766 | ) |
See
accompanying notes to the unaudited consolidated financial statements.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| |
For the Six Months Ended | |
| |
June 30, | |
| |
2024 | | |
2023 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | |
| | |
| |
Net (loss) income | |
$ | (553,617 | ) | |
$ | 3,051,186 | |
Adjustments to reconcile net (loss) income to net cash used in operating activities: | |
| | | |
| | |
Depreciation and amortization expense | |
| 49,015 | | |
| 41,395 | |
Amortization of debt discount to interest expense | |
| 22,459 | | |
| 95,922 | |
Interest expense for put premium on convertible notes | |
| - | | |
| 29,212 | |
Non-cash interest expense from fees on debt conversion | |
| - | | |
| 2,250 | |
Stock-based compensation | |
| 376,968 | | |
| 42,183 | |
Stock-based professional fees | |
| - | | |
| 97,817 | |
Non-cash gain on debt extinguishment | |
| (347,990 | ) | |
| (462,581 | ) |
Gain from sale of nanoShield product line | |
| - | | |
| (4,051,709 | ) |
Lease costs | |
| 732 | | |
| 660 | |
Non-cash compensation claw back | |
| (21,961 | ) | |
| - | |
Bad debt expense | |
| 25,833 | | |
| - | |
Change in operating assets and liabilities: | |
| | | |
| | |
Accounts receivable | |
| 154,889 | | |
| 188,934 | |
Inventory | |
| 19,611 | | |
| (51,196 | ) |
Prepaid expenses and other assets | |
| (79,304 | ) | |
| (15,434 | ) |
Contract assets | |
| (57,456 | ) | |
| (52,487 | ) |
Due from related party | |
| (50,000 | ) | |
| - | |
Accounts payable | |
| 88,605 | | |
| (50,027 | ) |
Accrued expenses | |
| (84,257 | ) | |
| 8,040 | |
Accrued interest - related party | |
| - | | |
| 5,663 | |
Accrued compensation | |
| (3,645 | ) | |
| 49,812 | |
Contract liabilities | |
| (351,936 | ) | |
| 157,363 | |
| |
| | | |
| | |
NET CASH USED IN OPERATING ACTIVITIES | |
| (812,054 | ) | |
| (912,997 | ) |
| |
| | | |
| | |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
| | | |
| | |
Proceeds from sale of nanoShield product line | |
| - | | |
| 4,042,631 | |
| |
| | | |
| | |
NET CASH PROVIDED BY INVESTING ACTIVITIES | |
| - | | |
| 4,042,631 | |
| |
| | | |
| | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
| | | |
| | |
Proceeds from sale of common stock | |
| - | | |
| 275,000 | |
Proceeds from notes payable | |
| 405,550 | | |
| 175,000 | |
Repayment of notes payable | |
| (43,642 | ) | |
| (1,792,448 | ) |
Repayment of note payable - related party | |
| - | | |
| (200,000 | ) |
Proceeds from convertible notes payable | |
| - | | |
| 50,000 | |
Repayment of convertible notes payable | |
| (90,000 | ) | |
| (222,750 | ) |
| |
| | | |
| | |
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES | |
| 271,908 | | |
| (1,715,198 | ) |
| |
| | | |
| | |
NET (DECREASE) INCREASE IN CASH | |
| (540,146 | ) | |
| 1,414,436 | |
| |
| | | |
| | |
CASH, beginning of period | |
| 736,461 | | |
| 97,091 | |
| |
| | | |
| | |
CASH, end of period | |
$ | 196,315 | | |
$ | 1,511,527 | |
| |
| | | |
| | |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | |
| | | |
| | |
Cash paid for: | |
| | | |
| | |
Interest | |
$ | 26,561 | | |
$ | 199,122 | |
Income taxes | |
$ | - | | |
$ | - | |
| |
| | | |
| | |
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | |
| | | |
| | |
Common stock issued as prepaid for services | |
$ | - | | |
$ | 79,450 | |
Common stock issued for accrued compensation | |
$ | - | | |
$ | 78,000 | |
Series B preferred stock issued for accrued compensation | |
$ | 312,000 | | |
$ | 144,000 | |
Preferred stock dividend accrued | |
$ | 28,098 | | |
$ | 27,305 | |
Conversion of Series C preferred stock to common stock | |
$ | 60,000 | | |
$ | 184,000 | |
Conversion of notes payable to common stock | |
$ | - | | |
$ | 194,000 | |
Reclassification of Series B preferred stock to additional paid-in capital | |
$ | 334,009 | | |
$ | - | |
See
accompanying notes to the unaudited consolidated financial statements.
C-BOND
SYSTEMS, INC. AND SUBSIDIARIES
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE
30, 2024
(UNAUDITED)
NOTE
1 – NATURE OF ORGANIZATION
Nature
of Organization
C-Bond
Systems, Inc., together with its subsidiaries (the “Company”), is a materials development company and owner and developer
of the patented C-Bond technology. The Company is engaged in the implementation of proprietary nanotechnology applications and processes
to enhance properties of strength, functionality, and sustainability of brittle material systems. The Company’s primary focus is
in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. Prior to May
8, 2023, the Company operated in two segments: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions
sold a windshield strengthening, water repellent solution called C-Bond nanoShield™. Since May 8, 2023, the date that the nanoShieldTM
product line and related technologies were sold (see Note 16), the Company has operated in one segment. Patriot Glass Solutions
sells multi-purpose glass strengthening primer and window film mounting solutions, including C-Bond BRS, a ballistic-resistant film system,
and C-Bond Secure, a forced entry-resistant system.
On June 30, 2021, the Company entered into a Share
Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Patriot Glass Solutions, LLC (formerly Mobile
Tint LLC), a Texas limited liability company doing business as A1 Glass Coating (“Patriot Glass”), (ii) the sole member of
Patriot Glass (the “Patriot Glass Shareholder”), and (iii) Michael Wanke as the Representative of the Patriot Glass Shareholder.
Pursuant to the Exchange Agreement, on July 22, 2021, the Company acquired 80% of Patriot Glass’s units (the “Patriot Glass
Shares”). The Patriot Glass Shares were exchanged for 28,021,016 restricted shares of the Company’s common stock in an amount
equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately
prior to the closing. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into amendment #2 to the Exchange Agreement
(the Exchange Agreement as amended, or the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the
Company shall have the option (the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending at
5:00 P.M. EST on the date that is 30 calendar days after the Option Start Date (the “Option Period”), to acquire the remaining
20% of Patriot Glass Units (the “Additional Units”), representing 20% of Patriot Glass’s issued and outstanding membership
interests, collectively (the “Additional Closing”) (See Note 10). Patriot Glass provides quality window tint solutions for
auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window
film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills.
Patriot Glass also carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types
of vandalism, and even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Patriot Glass’s owner-operator,
Mr. Wanke, joined the Company as President of Patriot Glass. On November 29, 2023, the name of Mobile Tint LLC was changed to Patriot
Glass Solutions, LLC.
On
May 8, 2023, the Company entered into an Asset Purchase Agreement (“APA”) with Apex Protect GPS, LLC (the “Buyer”),
whereby the Company sold its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process,
furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShieldTM division (the
“Assets”) to the Buyer. Accordingly, the Company assigned, transferred and delivered to the Buyer, free and clear of all
liens, all of the Assets. Following the Closing, the Parties entered into an Assignment and Agreement to Re-Execute (“Assignment”)
on June 15, 2023, by and among the Company (“Seller”); Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield,
LLC, (“Assignee”), whereby the Assignor assigned all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and
(iv) and any memorandums, schedules and exhibits related to the foregoing to Assignee. The Seller and Assignee also entered into a Lease
and Assignment and Assumption Agreement on June 15, 2023 (the “Assignment Agreement”), wherein the Seller assigned to Assignee,
and Assignee took assignment from the Seller, of the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the
“Lease”) pursuant to the Assignment Agreement (See Note 16).
NOTE
2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation and Principles of Consolidation
The
Company’s unaudited consolidated financial statements include the financial statements of its wholly owned subsidiary, C-Bond Systems,
LLC, and its 80% owned subsidiary, Patriot Glass. All significant intercompany accounts and transactions have been eliminated in consolidation.
Management
acknowledges its responsibility for the preparation of the accompanying unaudited consolidated financial statements which reflect all
adjustments, consisting of normal recurring adjustments, considered necessary in its opinion for a fair statement of its financial position
and the results of its operations for the periods presented. The accompanying unaudited consolidated financial statements of the Company
have been prepared in accordance with accounting principles generally accepted in the United States of America (the “U.S. GAAP”)
for interim financial information and with the instructions Article 8-03 of Regulation S-X. Operating results for interim periods are
not necessarily indicative of results that may be expected for the fiscal year as a whole.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
Certain
information and note disclosure normally included in consolidated financial statements prepared in accordance with U.S. GAAP has been
condensed or omitted from these statements pursuant to such accounting principles and, accordingly, they do not include all the information
and notes necessary for comprehensive consolidated financial statements. These unaudited consolidated financial statements should be
read in conjunction with the summary of significant accounting policies and notes to the consolidated financial statements for the year
ended December 31, 2023 of the Company which were included in the Company’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2023, as filed with the Securities and Exchange Commission (the “SEC”) on April 1, 2024.
Going
Concern
These unaudited consolidated financial statements
have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments
in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, the Company had a net
loss of $553,617 for the six months ended June 30, 2024. Net cash used in operations was $812,054 and $912,997 for the six months ended
June 30, 2024 and 2023, respectively. Additionally, as of June 30, 2024, the Company had an accumulated deficit, shareholders’
deficit, and working capital deficit of $61,447,146, $4,185,273 and $1,265,758, respectively. On June 30, 2024, the Company had cash of
$196,315. These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve
months from the issuance date of this report. Management cannot provide assurance that the Company will ultimately achieve profitable
operations or become cash flow positive or raise additional debt and/or equity capital. The Company is seeking to raise capital through
additional debt and/or equity financings to fund its operations in the future. Although the Company has historically raised capital from
sales of common shares and preferred shares, and from the issuance of promissory notes and convertible promissory notes, there is no assurance
that it will be able to continue to do so. If the Company is unable to raise additional capital or secure additional lending in the near
future, management expects that the Company will need to curtail its operations. These unaudited consolidated financial statements do
not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities
that might be necessary should the Company be unable to continue as a going concern.
Use
of Estimates
The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited
consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could
differ from those estimates. Estimates during the six months ended June 30, 2024 and 2023 include estimates for allowance for doubtful
accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards
completion on uncompleted jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets,
the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable
preferred stock, the value of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets,
and the fair value of non-cash equity transactions.
Fair
Value of Financial Instruments and Fair Value Measurements
The
carrying amounts reported in the unaudited consolidated balance sheets for cash, accounts receivable, contract assets and liabilities,
notes payable, convertible note payable, accounts payable, accrued expenses, accrued compensation, and lease liabilities approximate
their fair market value based on the short-term maturity of these instruments.
The
Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s
(the “FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified
in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company did not identify
any assets or liabilities that are required to be presented on the balance sheet at fair value in accordance with Accounting Standards
Codification (“ASC”) Topic 820.
ASC
825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities
at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless
a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should
be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding
instruments.
Cash
and Cash Equivalents
For
the purposes of the unaudited consolidated statements of cash flows, the Company considers all highly liquid instruments with a maturity
of three months or less at the purchase date and money market accounts to be cash equivalents. The Company had no cash equivalents as
of June 30, 2024 and December 31, 2023.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
Accounts
Receivable
The
Company recognizes an allowance for losses on accounts receivable and notes receivable in an amount equal to the estimated probable losses
net of recoveries under the current expected credit loss method. The allowance is based on an analysis of historical bad debt experience,
current receivables aging and expected future write-offs, as well as an assessment of specific identifiable customer accounts and notes
receivable considered at risk or uncollectible. On January 1, 2023, the Company adopted ASC 326, “Financial Instruments - Credit
Losses”. In accordance with ASC 326, an allowance is maintained for estimated forward-looking losses resulting from the possible
inability of customers to make the required payments (current expected losses). The amount of the allowance is determined principally
based on past collection experience and known financial factors regarding specific customers. The expense associated with the allowance
for doubtful accounts on accounts receivable is recognized in general and administrative expenses.
Inventory
Inventory,
consisting of raw materials and finished goods, are stated at lower of cost and net realizable value utilizing the first-in, first-out
(FIFO) method. A reserve is established when management determines that certain inventories may not be saleable. If inventory costs exceed
the expected net realizable value due to obsolescence or quantities in excess of expected demand, the Company will record reserves for
the difference between the cost and the net realizable value. These reserves are recorded based on estimates and included in cost of
sales.
Property
and Equipment
Property
and equipment are stated at cost and are depreciated using the straight-line method over their estimated useful lives, which range from
one to seven years. Leasehold improvements are depreciated over the shorter of the useful life or lease term including scheduled renewal
terms. Maintenance and repairs are charged to expense as incurred. When assets are retired or disposed of, the cost and accumulated depreciation
are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. The Company examines
the possibility of decreases in the value of these assets when events or changes in circumstances reflect the fact that their recorded
value may not be recoverable.
Goodwill
and Intangible Assets
Goodwill
represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized.
Any goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with
new customers. Intangible assets may have either an identifiable or indefinite useful life. Intangible assets with identifiable useful
lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable
intangible assets are being amortized over a useful life of 5 years.
Goodwill
is not subject to amortization but is subject to impairment tests at least annually. The Company reviews the carrying amounts of goodwill
by reporting unit at least annually, or when indicators of impairment are present, to determine if goodwill may be impaired. To evaluate
goodwill impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair
value of goodwill is less than its carrying value. The Company would not be required to quantitatively determine the fair value of goodwill
unless it determines, based on the qualitative assessment there are indicators of impairment. Under the quantitative test of goodwill,
the Company compares the fair value of the reporting unit to its carrying value, including goodwill. If the carrying value exceeds the
fair value, then the goodwill is impaired by the excess amount. The Company performs its annual testing for goodwill during the fourth
quarter of each fiscal year or more frequently if an event occurs or circumstances change that would more likely than not reduce the
fair value of a reporting unit.
Intangible
assets determined to have finite lives are amortized over their estimated useful lives of 5 years. The useful life of an intangible asset
is the period over which the asset is expected to contribute directly or indirectly to future cash flows. The Company periodically evaluates
both finite and indefinite lived intangible assets for impairment upon occurrence of events or changes in circumstances that indicate
the carrying amount of intangible assets may not be recoverable.
As
of December 31, 2023, the Company performed its annual goodwill impairment test for its one reporting unit. The results of the Company’s
annual impairment test indicated that the fair value of the reporting unit exceeded its carrying value. Therefore, no impairment of goodwill
or intangibles assets was recorded as of December 31, 2023.
Impairment
of Long-Lived Assets
In
accordance with ASC Topic 360, the Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate
that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss
when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured
as the difference between the asset’s estimated fair value and its book value.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
Warranty
Liability
The
Company provides limited warranties on its products for product defects for periods ranging from 12 months to the life of the product.
Warranty costs may include the cost of product replacement, refunds, labor costs and other costs. Allowances for estimated warranty costs
are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product warranty
claim rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves
based on historical warranty costs for each product line combined with liability estimates based on the prior 12 months’ sales
activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments
to recognize additional cost of sales may be required in future periods. Historically the warranty accrual and the expense amounts have
been immaterial. The warranty liability is included in accrued expenses on the accompanying unaudited consolidated balance sheets and
amounted to $1,000 on June 30, 2024 and December 31, 2023, respectively. During the six months ended June 30, 2024 and 2023, warranty
costs were de minimis.
Revenue
Recognition
The
Company follows ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). This standard establishes a single
comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most of the existing
revenue recognition guidance. ASC 606 requires an entity to recognize revenue to depict the transfer of promised goods or services to
customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services
and requires certain additional disclosures.
The
Company sells its products, which include standard warranties, primarily to distributors and authorized dealers. Product sales are recognized
at a point in time when the product is shipped to the customer and the title is transferred and is recorded net of any discounts or allowances.
The warranty does not represent a separate performance obligation.
Revenues
from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s
estimates of the progress towards completion of contracts using various output or input methods depending on the type of contract terms
including (1) the ratio of number of labor hours spent compared to the number of estimated labor hours to complete a job, (2) using the
milestone method, or (3) using a units completed method. These methods are used because management considers these to be the best available
measure of progress on these contracts. We use the same method for similar types of contracts. The asset, “contract assets”
represents revenues recognized in excess of amounts billed. The liability, “contract liabilities,” represents billings in
excess of revenues recognized.
Cost
of Sales
Cost
of sales includes inventory costs, packaging costs and warranty expenses.
Cost
of revenues from fixed-price contracts for the distribution and installation of window film solutions include all direct material, sub-contractor,
labor and certain other direct costs, as well as those indirect costs related to contract performance, such as indirect labor and fringe
benefits. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes
in job performance, job conditions and estimated profitability may result in revisions to cost and income, which are recognized in the
period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions,
claims, change orders, and settlements, are accounted for as changes in estimates in the current period.
Shipping
and Handling Costs
Shipping
and handling costs incurred for product shipped to customers are included in general and administrative expenses and amounted to $10,272
and $5,577 for the six months ended June 30, 2024 and 2023, respectively. Shipping and handling costs charged to customers are included
in sales.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
Research
and Development
Research
and development costs incurred in the development of the Company’s products are expensed as incurred and includes costs such as
labor, materials, and other allocated costs incurred. For the six months ended June 30, 2024 and 2023, research and development costs
incurred in the development of the Company’s products were $0.
Advertising
Costs
The
Company may participate in various advertising programs. All costs related to advertising of the Company’s products are expensed
in the period incurred. For the six months ended June 30, 2024 and 2023, advertising costs charged to operations were $38,874 and $10,986,
respectively, and are included in general and administrative expenses on the accompanying unaudited consolidated statements of operations.
These advertising expenses do not include cooperative advertising and sales incentives which shall been deducted from sales.
Federal
and State Income Taxes
The
Company accounts for income tax using the liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred
tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities
using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation
allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or
all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or
loss in the period that includes the enactment date.
The
Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740 “Income Taxes”.
Using that guidance, tax positions initially need to be recognized in the financial statements when it is more likely than not the position
will be sustained upon examination by the tax authorities. As of June 30, 2024 and December 31, 2023, the Company had no uncertain tax
positions that qualify for either recognition or disclosure in the financial statements. Tax years that remain subject to examination
are the years ending on and after December 31, 2018. The Company recognizes interest and penalties related to uncertain income tax positions
in other expense. However, no such interest and penalties were recorded as of June 30, 2024 and December 31, 2023.
Stock-Based
Compensation
Stock-based
compensation is accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation”,
which requires recognition in the financial statements of the cost of employee, director, and non-employee services received in exchange
for an award of equity instruments over the period the employee, director, or non-employee is required to perform the services in exchange
for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee, director, and non-employee
services received in exchange for an award based on the grant-date fair value of the award. The Company has elected to recognize forfeitures
as they occur as permitted under the FASB’s Accounting Standards Update (“ASU”) 2016-09 Improvements to Employee
Share-Based Payment.
Leases
The
Company accounts for leases in accordance with ASC 842. The lease standard requires certain leases to be reported on the consolidated
balance sheets as right-of-use assets and lease liabilities. The Company has elected the practical expedients permitted under the transition
guidance of this standard that retained the lease classification and initial direct costs for any leases that existed prior to adoption
of the standard. The Company does not reassess whether any contracts entered into prior to adoption are leases or contain leases.
The
Company categorizes leases with contractual terms longer than twelve months as either operating or finance. Finance leases are generally
those leases that would allow the Company to substantially utilize or pay for the entire asset over its estimated life. Assets acquired
under finance leases are recorded in property and equipment, net. All other leases are categorized as operating leases. The Company does
not have any finance leases as of June 30, 2024 and December 31, 2023. The Company’s leases generally have terms that range from
three to four years for property and equipment and five years for property. The Company elected the accounting policy to include both
the lease and non-lease components of our agreements as a single component and account for them as a lease.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
Lease
liabilities are recognized at the present value of the fixed lease payments using a discount rate based on the Company’s current
borrowing rate. Lease assets are recognized based on the initial present value of the fixed lease payments, reduced by landlord incentives,
plus any direct costs from executing the leases. Leasehold improvements are capitalized at cost and amortized over the lesser of their
expected useful life or the lease term.
When
the Company has the option to extend the lease term, terminate the lease before the contractual expiration date, or purchase the leased
asset, and it is reasonably certain that the Company will exercise the option, the Company considers these options in determining the
classification and measurement of the lease. Costs associated with operating lease assets are recognized on a straight-line basis within
operating expenses over the term of the lease.
Loss
Per Common Share
ASC
260 “Earnings Per Share”, requires dual presentation of basic and diluted earnings per common share (“EPS”) with
a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation.
Basic EPS excludes dilutive securities and non-vested forfeitable shares. Diluted EPS reflects the potential dilution that could occur
if securities or other contracts to issue common shares were exercised or converted into common shares or resulted in the issuance of
common shares that then shared in the earnings of the entity. Basic net loss per common share is computed by dividing net loss available
to members by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed
by dividing net loss by the weighted average number of common shares, common share equivalents and potentially dilutive securities outstanding
during each period. Potentially dilutive common shares consist of stock options and non-vested forfeitable shares (using the treasury
stock method) and shares issuable upon conversion of preferred shares and convertible notes payable (using the as-if converted method).
These common share equivalents may be dilutive in the future.
The
following table presents a reconciliation of basic and diluted net income (loss) per common share:
| |
Three Months Ended June 30, | | |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Net (loss) income per common share - basic: | |
| | | |
| | | |
| | | |
| | |
Net (loss) income attributable to common shareholders | |
$ | (263,925 | ) | |
$ | 3,779,295 | | |
$ | (595,432 | ) | |
$ | 3,059,243 | |
Weighted average common shares outstanding – basic | |
| 543,165,027 | | |
| 493,056,689 | | |
| 539,431,386 | | |
| 458,283,435 | |
Net (loss) income per common share – basic | |
$ | (0.00 | ) | |
$ | 0.01 | | |
$ | (0.00 | ) | |
$ | 0.01 | |
| |
| | | |
| | | |
| | | |
| | |
Net (loss) income per common share - diluted: | |
| | | |
| | | |
| | | |
| | |
Net (loss) income attributable to common shareholders - basic | |
$ | (263,925 | ) | |
$ | 3,779,295 | | |
$ | (595,432 | ) | |
$ | 3,059,243 | |
Add: preferred stock dividends | |
| - | | |
| 13,618 | | |
| - | | |
| 27,305 | |
Add: interest of convertible debt | |
| - | | |
| 52,618 | | |
| - | | |
| 102,639 | |
Numerator for (loss) income per common share – diluted | |
$ | (263,925 | ) | |
$ | 3,845,531 | | |
$ | (595,432 | ) | |
$ | 3,189,187 | |
| |
| | | |
| | | |
| | | |
| | |
Weighted average common shares outstanding – basic | |
| 543,165,027 | | |
| 493,056,689 | | |
| 539,431,386 | | |
| 458,283,435 | |
Add: dilutive shares related to: | |
| | | |
| | | |
| | | |
| | |
Convertible debt | |
| - | | |
| 1,145,833,333 | | |
| - | | |
| 1,145,833,333 | |
Series B preferred | |
| - | | |
| 324,240,164 | | |
| - | | |
| 324,240,164 | |
Series C preferred | |
| - | | |
| 386,250,000 | | |
| - | | |
| 386,250,000 | |
Weighted average common shares outstanding – diluted | |
| 543,165,027 | | |
| 2,349,380,186 | | |
| 539,431,386 | | |
| 2,314,606,932 | |
Net (loss) income per common share – diluted | |
$ | (0.00 | ) | |
$ | 0.00 | | |
$ | (0.00 | ) | |
$ | 0.00 | |
For
the three and six months ended June 30, 2023, stock options and warrants were excluded from the computation of diluted common shares
outstanding as they would have an anti-dilutive impact on the Company’s net income. For the three and six months ended June 30,
2024, all potentially dilutive common shares were excluded from the computation of diluted common shares outstanding as they would have
an anti-dilutive impact on the Company’s net losses. As of June 30, 2024 and 2023, common share equivalents and potentially dilutive
securities consisted of the following:
| |
June 30, | |
| |
2024 | | |
2023 | |
Stock options | |
| 7,345,698 | | |
| 8,445,698 | |
Warrants | |
| 33,400,000 | | |
| 34,000,000 | |
Series B preferred stock | |
| 357,819,360 | | |
| 324,240,164 | |
Series C preferred stock | |
| 450,258,000 | | |
| 386,250,000 | |
Convertible debt | |
| 1,220,101,111 | | |
| 1,145,833,333 | |
| |
| 2,068,924,169 | | |
| 1,898,769,195 | |
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
Segment
Reporting
Prior
to May 8, 2023, the Company operated in two reportable business segments which consisted of (1) the manufacture and sale of a windshield
strengthening water repellent solution as well as disinfection products, and the sale of multi-purpose glass strengthening primer and
window film mounting solutions, including ballistic-resistant film systems and a forced entry system, and (2) the distribution and installation
of window film solutions. The Company’s reportable segments were strategic business units that offered different products and were
managed separately based on the fundamental differences in their operations and locations. On May 8, 2023, the Company sold its C-Bond
nanoShield™ product line and the remaining segment (1) as described above was combined into segment (2) and is now being managed
together (see Note 16).
Noncontrolling
Interest
The
Company accounts for noncontrolling interest in accordance with ASC Topic 810-10-45, which requires the Company to present noncontrolling
interests as a separate component of total shareholders’ deficit on the unaudited consolidated balance sheets and the consolidated
net loss attributable to its noncontrolling interest be clearly identified and presented on the face of the unaudited consolidated statements
of operations.
Risk
and Uncertainties
The
Company operates in an industry that is subject to intense competition and changes in consumer and commercial demand. The Company’s
operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of
business failure.
The
Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected
to contribute to this variability include, among others, (i) the cyclical nature of the business, (ii) general economic conditions in
the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility
of prices in connection with the Company’s products and services. These factors, among others, make it difficult to project the
Company’s operating results on a consistent basis.
Recent
Accounting Pronouncements
In
August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts
in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity.
The ASU simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. Consequently,
more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion
features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception,
which will permit more equity contracts to qualify for the exception. The ASU also simplifies the diluted net income per share calculation
in certain areas. The new guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within
those fiscal years, and early adoption is permitted. The adoption of this standard on January 1, 2024 had no impact on the Company’s
unaudited consolidated financial statements.
Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are
not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.
NOTE
3 – ACCOUNTS RECEIVABLE
On
June 30, 2024 and December 31, 2023, accounts receivable consisted of the following:
| |
June 30, 2024 | | |
December 31, 2023 | |
Accounts receivable | |
$ | 304,525 | | |
$ | 459,414 | |
Less: allowance for doubtful accounts | |
| (61,156 | ) | |
| (35,323 | ) |
Accounts receivable, net | |
$ | 243,369 | | |
$ | 424,091 | |
For
the six months ended June 30, 2024 and 2023, bad debt expense amounted to $23,094 (net of bad debt recovery of $2,739) and $0, respectively.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
NOTE
4 – INVENTORY
On
June 30, 2024 and December 31, 2023, inventory consisted of the following:
| |
June 30, 2024 | | |
December 31, 2023 | |
Finished goods | |
$ | 162,052 | | |
$ | 181,663 | |
Total Inventory | |
$ | 162,052 | | |
$ | 181,663 | |
For
the six months ended June 30, 2024 and 2023, the Company did not record any allowance for slow moving inventory.
NOTE
5 – PROPERTY AND EQUIPMENT
On
June 30, 2024 and December 31, 2023, property and equipment consisted of the following:
| |
Useful Life | |
June 30, 2024 | | |
December 31, 2023 | |
Machinery and equipment | |
5 – 7 years | |
$ | 73,411 | | |
$ | 73,411 | |
Furniture and office equipment | |
3 – 7 years | |
| 2,061 | | |
| 2,061 | |
Vehicles | |
1 – 5 years | |
| 68,050 | | |
| 68,050 | |
Leasehold improvements | |
3 – 5 years | |
| 110,645 | | |
| 110,645 | |
| |
| |
| 254,167 | | |
| 254,167 | |
Less: accumulated depreciation | |
| |
| (106,325 | ) | |
| (82,561 | ) |
Property and equipment, net | |
| |
$ | 147,842 | | |
$ | 171,606 | |
For
the six months ended June 30, 2024 and 2023, depreciation expense was included in general and administrative expenses and amounted to
$23,764 and $16,143, respectively.
NOTE
6 – INTANGIBLE ASSETS AND GOODWILL
On
June 30, 2024 and December 31, 2023, intangible assets and goodwill, which were acquired from Patriot Glass in 2021, consisted of the
following:
| | Useful life | | June 30, 2024 | | | December 31, 2023 | |
Customer relations | | 5 years | | $ | 212,516 | | | $ | 212,516 | |
Non-compete | | 5 years | | | 40,000 | | | | 40,000 | |
Trade name (non-amortizable) | | - | | | 100,000 | | | | 100,000 | |
| | | | | 352,516 | | | | 352,516 | |
Less: accumulated amortization | | | | | (148,353 | ) | | | (123,102 | ) |
Intangible assets, net | | | | $ | 204,163 | | | $ | 229,414 | |
| |
Useful life | |
June 30, 2024 | | |
December 31, 2023 | |
Goodwill | |
- | |
$ | 350,491 | | |
$ | 350,491 | |
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
For
the six months ended June 30, 2024 and 2023, amortization expense of amortizable intangible assets amounted to $25,251 and $25,252, respectively.
On June 30, 2024, accumulated amortization amounted to $124,853 and $23,500 for the customer relations and non-compete, respectively.
On December 31, 2023, accumulated amortization amounted to $103,602 and $19,500 for the customer relations and non-compete, respectively.
Amortization
of intangible assets with identifiable useful lives that is attributable to future periods is as follows:
Twelve months ending June 30: | |
Amount | |
2025 | |
$ | 50,503 | |
2026 | |
| 50,503 | |
2027 | |
| 3,157 | |
Total | |
$ | 104,163 | |
NOTE
7 – CONVERTIBLE NOTES PAYABLE
Mercer
Convertible Debt
On
October 15, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with Mercer Street Global Opportunity
Fund, LLC (the “Investor”), pursuant to which the Company issued and sold to Investor a 10% Original Issue Discount Senior
Convertible Promissory Note in the principal amount of $825,000 (the “Mercer Note”) and five-year warrants to purchase up
to 16,500,000 shares of the Company’s common stock at an initial exercise price of $0.05 per share, an amount equal to 50% of the
conversion shares that were issued (the “Mercer Warrants”). The Company received net proceeds of $680,000, which was net
of original issue discounts of $75,000, placement fees of $60,000, and legal fees of $10,000. The transactions contemplated under the
SPA closed on October 18, 2021.
The
Mercer Note matured 12 months after issuance, bore interest at a rate of 4% per annum through the date of default, and was initially
convertible beginning on the six-month anniversary of the original issue date into the Company’s common stock at a fixed conversion
price of $0.025 per share, subject to adjustment for stock splits, stock combinations, dilutive issuances, and similar events, as described
in the Initial Note.
The
Mercer Note and Mercer Warrants contain conversion limitations providing that a holder thereof may not convert the Notes or exercise
the Warrants to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates
would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect
to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided
that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such
notice.
Upon
the occurrence of an event of default under the Mercer Note, the Investor has the right to be prepaid at 125% of the outstanding principal
balance and accrued interest, and interest accrues at 18% per annum. Events of default included, among other things,
| (i) | any
default in the payment of (A) principal and interest payment under this Note or any other Indebtedness, or (B) Late Fees, liquidated
damages and other amounts owing to the Holder of this Note, as and when the same shall become due and payable (whether on a Conversion
Date, or the Maturity Date, or by acceleration or otherwise), which default, solely in the case of a default under clause (B) above,
is not cured within five Trading Days; |
| (ii) | the
Company or any Subsidiary shall be subject to a Bankruptcy Event; |
| (iii) | the
SEC suspends the Common Stock from trading or the Company’s Common Stock is not listed or quoted for trading on a Trading Market
which failure is not cured, if possible to cure, within the earlier to occur of 10 Trading Days after notice of such failure is sent
by the Holder or by any other Holder to the Company or the transfer of shares of Common Stock through the Depository Trust Company System
is no longer available or is subject to a “chill” by the Depository Trust Company or any successor; |
| (iv) | the
Company shall be a party to any Change of Control Transaction or shall agree to sell or dispose of all or in excess of 50% of its assets
in one transaction or a series of related transactions (whether or not such sale would constitute a Change of Control Transaction); |
| (v) | the
Company incurs any Indebtedness other than Permitted Indebtedness; |
|
(vi) |
the
Company restates any financial statements included in its reports or registration statements filed pursuant to the Securities Act
or the Exchange Act for any date or period from two years prior to the Original Issue Date of this Note and until this Note is or
the Warrants issued to the Holder are no longer outstanding, if following first public announcement or disclosure that a restatement
will occur the VWAP on the next Trading Day is 20% less than the VWAP on the prior Trading Day. For the purposes of this clause the
next Trading Day if an announcement is made before 4:00 pm New York, NY time is either the day of the announcement or the following
Trading Day. The Company filed a Report on Form 8-K announcing the restatement of its financial statements for the year ended December
31, 2020. Following the first public announcement or disclosure that a restatement occurred, the VWAP on the next Trading Day was
not 20% less than the VWAP on the prior Trading Day and accordingly, the default provisions were not triggered. |
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
The
Company has also granted the investor a 12-month (or until the Notes are no longer outstanding) right to participate in specified future
financings, up to a level of 30%.
On
April 20, 2022, the Company and the Investor entered into an Exchange Agreement (the “Exchange Agreement”). The original
SPA remains in effect. Per the terms of the Exchange Agreement, the Parties agreed to exchange (i) the Mercer Note for a new Convertible
Promissory Note (the “New Note”) and (ii) the Mercer Warrant for a new five-year warrant to purchase, in the aggregate, 33,000,000
shares of the Company’s common stock at an exercise price of $0.025 per share (the “New Warrant” and together with
the New Note, the “New Securities”), according to the terms and conditions of the Exchange Agreement. On April 20, 2022,
pursuant to the terms of the Exchange Agreement, the Investor surrendered the Prior Securities in exchange for the New Securities. Other
than the surrender of the Prior Securities, no consideration of any kind whatsoever was given by the Investor to the Company in connection
with the Exchange Agreement. The terms of the New Securities are the same as the Prior Securities except for the pricing of the shares
issuable under the New Note and the shares issuable upon exercise of the New Warrant. The New Securities are composed of the New Note,
which is a 10% Original Issue Discount Senior Convertible Promissory Note in the principal amount of $825,000, and the New Warrant. The
New Note matured on October 15, 2022, bore interest at a rate of 4% per annum through the date of default, and was initially convertible
into the Company’s common stock at a fixed conversion price of $0.0125 per share, subject to adjustment for stock splits, stock
combinations, dilutive issuances, and similar events, as described in the New Note. If the average Closing Price during any 10 consecutive
Trading Day period beginning and ending during the 60 Day Effectiveness Period (the “Average Closing Price”) is below the
Conversion Price than the conversion price will be reduced to such Average Closing Price but in no event less than $0.00875.
On
October 15, 2022, the due date of the New Note, the New Note defaulted due to non-payment. Accordingly, the Company added a default penalty
of $206,250, or 25%, to the principal balance and recorded interest expense of $206,250, and interest shall accrue at 18% per annum.
On
December 4, 2023, the Company entered into a letter agreement (the “Agreement”) with the Investor to eliminate the convertible
features and implement a standstill on the interest due under the Convertible Promissory Note Dated October 15, 2021 (the “Note”).
This Note is the only remaining convertible note on the Company’s balance sheet. Per the terms of the Agreement, provided that
the Company continues making the Payments as outlined in the Agreement and meets its obligations under the Agreement, the Investor shall
not have the right to convert the Note into the Company’s common stock. The Company shall make the Payments on the 15th of every
month. “Payments” shall mean $15,000 per month for 35 months with a balloon payment of $588,091 on the 36th month, for aggregate
payments of $1,113,091.
Additionally,
the Company shall pay Mercer 20% of the gross proceeds from capital raised by the Company through the issuance of securities or incurrence
of any Debt (regardless of whether the incurrence of debt includes of the sale of any securities) (“Capital Raise Payments”).
Capital Raise Payments shall only be required for capital raises resulting in the Company receiving gross proceeds of at least $500,000.
By way example, if the Company receives $600,000 from the issuance of Debt, the Company shall make a Capital Raise Payment of $120,000
to Mercer. Any Capital Raise Payments shall be first be applied to the then outstanding Balloon Payment and thereafter to the last Payments
(35th, 34th and so on). “Debt” means borrowed money including the sale of any existing and future receivables. The Capital
Raise Payments shall be made within two business days of the receipt of the funds under such raise. Any failure to make the Payments
within the cure period or from the Capital Raise Payments by the required date shall make this Agreement null and void.
Additionally,
provided that the Company is in compliance with this Agreement, Mercer agrees to a standstill on the interest due under the Note beginning
with the date that the first $15,000 Payment is made which the Company paid on December 15, 2023 as required by the Note. Further, if
the Company pays off the entire principal and accrued interest by the dates detailed below, the Investor agrees to reduce the total amount
due on the Note (principal and interest) by the percentages as follows: 20% if fully paid by March 31, 2024, 15% if fully paid by June
30, 2024, 10% if fully paid by September 30, 2024, and 5% if fully paid by December 31, 2024. All rights and obligations under the original
Note shall remain the same. Mercer is not waiving any of its rights under the original Note, including but not limited to, rights available
prior to this Agreement.
As
of June 30, 2024 and December 31, 2023, the principal balance of the New Note was $1,008,091 and $1,098,091, respectively. Additionally,
as of June 30, 2024 and December 31, 2023, accrued interest payable amounted to $176,184 and $176,184, respectively, which is reflected
in accrued expenses on the accompanying unaudited consolidated statements of operations. Under the terms of the Agreement, $176,184 of
accrued interest is subject to forgiveness if the Company complies with the terms of the Agreement. As of the date of this report, the
Company has made all required payments.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
At
any time this Note or any amounts accrued and payable thereunder remain outstanding, the Company or any Subsidiary, as applicable, sells
or grants any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale,
grant or any option to purchase or other disposition), any common stock or common stock equivalents entitling any Person to acquire shares
of the Company’s common stock at an effective price per share that is lower than the conversion price then in effect (such lower
price, the “Base Conversion Price” and each such issuance or announcement a “Dilutive Issuance”), then the conversion
price shall be immediately reduced to equal the Base Conversion Price. Such adjustment shall be made whenever such common stock or common
stock equivalents are issued. On September 6, 2022, the Company issued common stock equivalents with an initial conversion price of $0.009
per share and accordingly, the conversion price and warrant down-round provisions were triggered. As a result, the conversion price of
the New April 2022 Note was reduced to $0.009 per share and the exercise price of the New April 2022 Warrant was lowered to $0.009.
Pursuant
to the provisions of ASC 815-40 – Derivatives and Hedging – Contracts in an Entity’s Own Stock, the convertible
note and related warrants issued in connection with the Mercer convertible note was analyzed and it was determined that the terms of
the convertible note and warrants contained terms that were not considered derivatives.
1800
Diagonal Lending Convertible Debt
On
November 9, 2022, the Company closed a Securities Purchase Agreement dated November 4, 2022, with 1800 DIAGONAL LENDING LLC (“Diagonal”),
pursuant to which a Promissory Note (the “November 2022 Diagonal Note”) dated November 4, 2022, was made to Diagonal in the
aggregate principal amount of $104,250 and the Company received net proceeds of $100,000 which was net of fees of $4,250. The November
2022 Diagonal Note bore interest at a rate of 12% per annum and all outstanding principal and accrued and unpaid interest was due on
May 4, 2024. In May 2023, the November 2022 Diagonal Note and any interest due was repaid in full (See Note 16).
On
December 27, 2022, the Company closed a Securities Purchase Agreement dated December 27, 2022, with 1800 Diagonal pursuant to which a
Promissory Note (“December 2022 Diagonal Note”) dated December 27, 2022, was made to Diagonal in the aggregate principal
amount of $64,250 and the Company received net proceeds of $60,000 which was net of fees of $4,250. The December 2022 Diagonal Note bore
interest at a rate of 12% per annum and all outstanding principal and accrued and unpaid interest was due on June 27, 2024. In May 2023,
the December 2022 Diagonal Note and any interest due was repaid in full (See Note 16).
On
March 17, 2023, the Company closed a Securities Purchase Agreement dated November 4, 2022, with Diagonal pursuant to which a Promissory
Note (the “March 2023 Diagonal Note”) dated March 17, 2023, was made to Diagonal in the aggregate principal amount of $54,250
and the Company received net proceeds of $50,000 which was net of fees of $4,250. The March 2023 Diagonal Note bore interest at a rate
of 12% per annum and all outstanding principal and accrued and unpaid interest was due on March 17, 2024. In May 2023, the March 2023
Diagonal Note and any interest due was repaid in full (See Note 16).
The
Company accounted for the November 2022 and December 2022 Diagonal Notes as stock settled debt under ASC 480 and recorded an aggregate
debt premium of $90,731 with a charge to interest expense. The Company has accounted for the March 2023 Diagonal Note as stock settled
debt under ASC 480 and recorded an aggregate debt premium of $29,212 with a charge to interest expense. On May 11, 2023, upon repayment
of the November 2022, December 2022 and March 2023 Diagonal Notes, the Company reversed the debt premium of $119,943 and recorded a gain
on debt extinguishment of $119,943 on the accompanying unaudited consolidated statement of operations.
For
the six months ended June 30, 2024 and 2023, amortization of debt discounts related to the convertible notes payable amounted to $0 and
$2,627, respectively, which has been included in interest expense on the accompanying unaudited consolidated statements of operations.
On
June 30, 2024 and December 31, 2023, accrued interest payable under all outstanding convertible notes discussed above amounted to $176,184
and $176,184, respectively, and was included in accrued expenses on the accompanying unaudited consolidated balance sheets.
On
June 30, 2024 and December 31, 2023, convertible notes payable consisted of the following:
| |
June 30, 2024 | | |
December 31, 2023 | |
Convertible note payable | |
$ | 1,008,091 | | |
$ | 1,098,091 | |
Convertible note payable, net | |
| 1,008,091 | | |
| 1,098,091 | |
Less: current portion of convertible note payable | |
| (180,000 | ) | |
| (180,000 | ) |
Convertible note payable – long-term | |
$ | 828,091 | | |
$ | 918,091 | |
On
June 30, 2024, future annual maturities of convertible note payable are as follows:
June 30, | |
Amount | |
2025 | |
$ | 180,000 | |
2026 | |
| 180,000 | |
2027 | |
| 648,091 | |
Total convertible note payable on June 30, 2024 | |
$ | 1,008,091 | |
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
NOTE
8 – NOTES PAYABLE
On
June 30, 2024 and December 31, 2023, notes payable consisted of the following:
| |
June 30, 2024 | | |
December 31, 2023 | |
Notes payable | |
$ | 553,469 | | |
$ | 105,958 | |
Note payable – PPP note | |
| 13,864 | | |
| 18,823 | |
Total notes payable | |
| 567,333 | | |
| 124,781 | |
Less: unamortized debt discount | |
| (59,842 | ) | |
| (764 | ) |
Note payable, net | |
| 507,491 | | |
| 124,017 | |
Less: current portion of notes payable, net of discount | |
| (474,014 | ) | |
| (81,908 | ) |
Notes payable – long-term | |
$ | 33,477 | | |
$ | 42,109 | |
Notes
Payable
BOCO
Investment Note
On
November 14, 2018, the Company entered into a Revolving Credit Facility Loan and Security Agreement (“Loan Agreement”) and
a Secured Promissory Note (the “Note”) with BOCO Investments, LLC (the “Lender”). Subject to and in accordance
with the terms and conditions of the Loan Agreement and the Note, the Lender agreed to lend to the Company up to $400,000 (the “Maximum
Loan Amount”) against the issuance and delivery by the Company of the Note for use as working capital and to assist in inventory
acquisition. In 2018, the Lender loaned $400,000 to the Company, the Maximum Loan Amount. The outstanding principal advanced to Company
pursuant to the Loan Agreement initially bore interest at the rate of 12% per annum, compounded annually. Upon the occurrence of an Event
of Default under the Loan Agreement and Note, all amounts then outstanding (including principal and interest) bore interest at the rate
of 18% per annum, compounded annually until the Event of Default is cured.
In
May 2023, the Company and the Lender entered into a Debt Exchange and Release Agreement in regard to the $400,000 Note discussed above,
whereby the Company paid the Lender cash of $200,000 and issued the Lender 22,000,000 shares of Common Stock of the Company (see Note
9) in exchange for settlement of the remaining $200,000 of the loan and all accrued interest amounting to $317,293, which were deemed
paid in full (see Note 16). The 22,000,000 shares issued were valued at $132,000, or $0.006 per share, based on the quoted closing price
of the Company’s common stock on the measurement date. In connection with the repayment and settlement of this debt, in May 2023,
the Company recorded a gain from debt extinguishment of $385,293 consisting of a) $68,000 calculated as the difference in the principal
amount settled for shares of $200,000 and the fair value of the shares on the measurement date of $132,000, and b) the forgiveness of
interest due of $317,293.
On
June 30, 2024 and December 31, 2023, the principal amount due and accrued interest payable under this Note amounted to $0.
Mercer
Street Global Opportunity Fund Notes
On
March 14, 2022, the Company entered into an Original Issue Discount Promissory Note and Security Agreement (the “March 2022 Note”)
in the principal amount of $197,500 with Mercer Street Global Opportunity Fund, LLC (the “Investor”). The March 2022 Note
was funded on March 14, 2022 and the Company received net proceeds of $175,000 which is net of an original issue discount and investor
legal fees of $22,500. The original issue discount was recorded as a debt discount to be amortized over the life of the March 2022 note.
On June 30, 2024 and December 31, 2023, the principal balance due and accrued interest payable on the March 2022 Note amounted to $0.
In May 2023, the March 2022 Note and all accrued interest due was paid in full (See Note 16).
On
November 22, 2022, the Company entered into a Promissory Note and Security Agreement (the “November 2022 Note”) with a principal
amount of $65,000 with the Investor. The November 2022 Note was funded on November 22, 2022 and the Company received net proceeds of
$62,500 which is net of Investor legal fees of $2,500. The legal fees were recorded as a debt discount to be amortized over the life
of the November 2022 note. The November 2022 Note was to mature on August 22, 2023 and bore interest at a rate of 8% per annum. On June
30, 2024 and December 31, 2023, the principal balance due and accrued interest payable on the November 2022 Note amounted to $0. In May
2023, the November 2022 Note and all accrued interest due was paid in full and the Company recorded a gain on debt extinguishment of
approximately $18,900 (See Note 16).
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
GS
Capital Debt
On
June 23, 2022, the Company entered into a Securities Purchase Agreement (“Agreement”) with GS Capital Partners, LLC (“GS
Capital”), pursuant to which a Promissory Note (the “GS Capital June 2022 Note”) was made to GS Capital in the aggregate
principal amount of $195,000. The GS Capital June 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000,
and was funded on June 24, 2022 (less legal and other administrative fees). The Company received net proceeds of $148,420. In 2022, the
Company issued GS Capital a total of 1,750,000 commitment shares (“Commitment Shares”) as additional consideration for the
purchase of this Note. Through December 31, 2022, the Company paid $53,512 of principal balance and during the year ended December 31,
2023, paid principal balance of $79,488. During April and May 2023, the Company issued 21,371,481 shares of its common stock upon the
conversion of the remaining principal amount of $62,000, accrued interest of $4,139, and fees of $2,250 (See Note 9). On June 30, 2024
and December 31, 2023, the principal balance due on the GS Capital Note and accrued interest payable amounted to $0 (See Note 16).
On
July 26, 2022, the Company closed a Securities Purchase Agreement (“July 2022 Agreement”) with GS Capital, pursuant to which
a Promissory Note (“GS Capital July 2022 Note”) was made to GS Capital in the aggregate principal amount of $195,000. The
GS Capital July 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000, and was funded on July 28,
2022 (less legal and other administrative fees). The Company received net proceeds of $158,920. In 2022, the Company issued GS Capital
a total of 2,600,000 commitment shares (“July 2022 Commitment Shares”) as additional consideration for the purchase of the
July 2022 Note. In addition, in 2022, the Company issued 998,008 of its common stock to the placement agent as a fee for the capital
raise, respectively. The July Commitment Shares and the placement agent shares were recorded as a debt discount of $34,606 based on the
relative fair value method to be amortized over the life of the Note. Principal and interest payments were payable in 10 installments
of $21,060 each beginning on the 90th-day anniversary following the issue date and continuing thereafter each 30 days for nine months.
The GS Capital July 2022 Note was to mature 12 months after issuance and bore interest at a rate of 8% per annum. On December 15, 2022,
the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital July 2022 note by 60 days. Specifically,
the maturity date of the GS Capital July 2022 note was extended to September 26, 2023 and the next payment due date was extended to February
28, 2023. Through December 31, 2022, the Company paid $34,120 of principal balance and in May 2023, the Company paid the remaining principal
balance of $160,880 and all accrued interest due in full (See Note 16). On June 30, 2024 and December 31, 2023, the principal balance
due on the GS Capital July 2022 Note and accrued interest payable amounted to $0.
On
September 6, 2022, the Company closed a Securities Purchase Agreement (“September 2022 Agreement”) with GS Capital, pursuant
to which a Promissory Note (“September 2022 Note”) was made to GS Capital in the aggregate principal amount of $195,000.
The September 2022 Note was purchased for $176,000, reflecting an original issuance discount of $19,000, and was funded on September
6, 2022 (less legal and other administrative fees). The Company received net proceeds of $158,920. In 2022, the Company issued GS Capital
a total of 3,300,000 commitment shares (“September 2022 Commitment Shares”) as additional consideration for the purchase
of the September 2022 Note. In addition, in 2022, the Company issued 773,626 of its common stock to the placement agent as fee for the
capital raise, respectively. The September Commitment Shares and the placement agent shares were recorded as a debt discount of $30,326
based on the relative fair value method to be amortized over the life of the Note. Principal and interest payments were payable in 9
installments of $23,400 each beginning on the 120th-day anniversary following the issue date and continuing thereafter each 30 days for
eight months. The September 2022 Note was to mature 12 months after issuance and bore interest at a rate of 8% per annum. In the event
that following the Issue Date the closing trading price of the Company’s common stock was then being traded below $0.009 per
share for more than ten consecutive trading days, then the conversion price shall be equal to $0.0032 per share. On December
15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital September 2022 note by
60 days. Specifically, the maturity date of the GS Capital September 2022 note was extended to November 6, 2023 and the next payment
due date was extended to March 6, 2023. In May 2023, the GS Capital September 2022 Note and all accrued interest due was paid in full
(See Note 16). On June 30, 2024 and December 31, 2023, the principal balance due on the GS Capital September 2022 Note and accrued interest
payable amounted to $0.
In
May 2023, the GS Capital June 2022 Note, the GS Capital July 2022 Note, and the September 2022 Note were paid in full without any default
penalty and the Company recorded a gain on debt extinguishment of approximately $25,400 (see Note 16).
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
1800
Diagonal Lending Note Payable - March 2024
On March 1, 2024, the Company executed a Promissory
Note (the “Note”) in favor of Diagonal in the aggregate principal amount of $157,000 (the “Principal”), and an
accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed below, is the Note convertible
into shares of the Company’s common stock. The Note was funded on March 4, 2024, in the amount of $125,000, which is net of an original
issue discount of $13,000 and a one-time interest charge at 12% (the “Interest Rate”) of approximately $19,000 was applied
on the issuance date to the Principal. Under the terms of the Note, the Company is required to make monthly payments as outlined in the
Note, beginning on August 30, 2024 and the Note matures on December 30, 2024. Any amount of principal or interest on this Note which is
not paid when due shall bear interest at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”).
Monthly payments of principal and interest was as follows:
Payment Date: | |
Amount | |
August 30, 2024 | |
$ | 87,920 | |
September 30, 2024 | |
| 21,980 | |
October 30, 2024 | |
| 21,980 | |
November 30, 2024 | |
| 21,980 | |
December 30, 2024 | |
| 21,980 | |
Total | |
$ | 175,840 | |
Among
other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest
when due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the Note shall
become immediately due and payable and the Company shall pay to the Investor, in full satisfaction of its obligations hereunder, an amount
equal to 220% times the sum of the then outstanding principal amount of this Note plus accrued and unpaid interest on the unpaid principal
amount of this Note to the date of payment plus Default Interest, if any. At any time following an Event of Default, the Holder shall
have the right to convert all or any part of the outstanding and unpaid amount of this Note into fully paid and non-assessable shares
of the Company’s Common Stock. The conversion price (the “Conversion Price”) shall be the greater of $0.0025 per share
(the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid price during the 10 trading days prior to the
conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”). At no time may the Note be converted
into shares of our common stock if such conversion would result in the Investor and its affiliates owning an aggregate of in excess of
4.99% of the then outstanding shares of our common stock.
On
June 30, 2024 and December 31, 2023, the principal balance due on the March 2024 Note amounted to $157,000 and $0, respectively.
On August 15, 2024, The Company and Diagonal amended
this Note to change the payment schedule and change the conversion terms (See Note 17).
1800
Diagonal Lending Note Payable – April 2024
On
April 8, 2024, the Company executed a Promissory Note (the “April 2024 Note”) in favor of Diagonal in the aggregate principal
amount of $127,693 (the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the
event of a default, as discussed below, is the April 2024 Note convertible into shares of the Company’s common stock. The Note
was funded on April 10, 2024, in the amount of $100,000. A one-time interest charge of 12% (the “Interest Rate”) shall be
applied on the issuance date to the Principal. Under the terms of the April 2024 Note, the Company is required to make monthly payments
as outlined in the Note, beginning on August 15, 2024. Any amount of principal or interest on the April 2024 Note which is not paid when
due shall bear interest at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”).
Among
other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest
when due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the April 2024
Note shall become immediately due and payable and the Company shall pay to the Investor, in full satisfaction of its obligations hereunder,
an amount equal to 220% times the sum of the then outstanding principal amount of this April 2024 Note plus accrued and unpaid interest
on the unpaid principal amount of this April 2024 Note to the date of payment plus Default Interest, if any.
At
any time following an Event of Default, the Holder shall have the right to convert all or any part of the outstanding and unpaid amount
of this April 2024 Note into fully paid and non-assessable shares of the Company’s common stock. The conversion price (the “Conversion
Price”) shall be the greater of $0.0025 (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid
price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”).
At no time may the April 2024 Note be converted into shares of our common stock if such conversion would result in the Investor and its
affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of the Company’s common stock.
Monthly payments of principal and interest on
the April 2024 Note was as follows:
Payment Date: | |
Amount | |
August 15, 2024 | |
$ | 85,810 | |
September 15, 2024 through February 15, 2025 (6 monthly payments) | |
| 57,206 | |
Total | |
$ | 143,016 | |
On
June 30, 2024 and December 31, 2023, the principal balance due on the April 2024 Note amounted to $127,693 and $0, respectively.
On August 15, 2024, the Company and Diagonal amended
the April 2024 Note to change the payment schedule and change the conversion terms (See Note 17).
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
1800
Diagonal Lending Note Payable – June 2024
On
June 5, 2024, the Company executed a Promissory Note (the “June 2024 Note”) in favor of Diagonal in the aggregate principal
amount of $67,500 (the “Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event
of a default, as discussed below, is the June 2024 Note convertible into shares of the Company’s common stock. The Note was funded
on June 5, 2024, in the amount of $50,000, net of original issue discount and fees of $17,500. Under the terms of the June 2024 Note,
the Company is required to make nine monthly payments of principal and interest of $8,775 beginning on July 15, 2024. Any amount of principal
or interest on the April 2024 Note which is not paid when due shall bear interest at the rate of 22% per annum from the due date thereof
until the same is paid (“Default Interest”).
Among
other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest
when due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the June 2024
Note shall become immediately due and payable and the Company shall pay to the Investor, in full satisfaction of its obligations hereunder,
an amount equal to 220% times the sum of the then outstanding principal amount of this June 2024 Note plus accrued and unpaid interest
on the unpaid principal amount of this June 2024 Note to the date of payment plus Default Interest, if any.
At
any time following an Event of Default, the Holder shall have the right, to convert all or any part of the outstanding and unpaid amount
of this June 2024 Note into fully paid and non-assessable shares of the Company’s common stock. The conversion price (the “Conversion
Price”) shall be the greater of $0.0025 (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid
price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”).
At no time may the June 2024 Note be converted into shares of our common stock if such conversion would result in the Investor and its
affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of the Company’s common stock.
On
June 30, 2024 and December 31, 2023, the principal balance due on the June 2024 Note amounted to $67,500 and $0, respectively.
On August 15, 2024, the Company and Diagonal amended
the June 2024 Note to change the conversion terms (See Note 17).
Other
Notes Payable
On
May 10, 2021, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) and a Secured Promissory Note
(the “Promissory Note”) in the amount of $500,000 with a lender. The Promissory Note accrued interest at 8% per annum, compounded
annually, and all outstanding principal and accrued interest was due and payable on May 10, 2023. In May 2023, this Promissory Note and
all accrued interest was paid in full (See Note 16).
On
July 22, 2021, in connection with the acquisition of Patriot Glass, the Company’s subsidiary, Patriot Glass, assumed vehicle and
equipment loans in the amount of $95,013. These loans bear interest at rates ranging from 6.79% to 8.24% and are payable monthly through
April 2025. On June 30, 2024 and December 31, 2023, notes payable related to these vehicle and equipment loans amounted to $5,526 and
$8,250, respectively.
On
November 8, 2022, the Company entered into a Promissory Note (the “November 2022 Note”) with a lender investor (the “Private
Investor”) in the principal amount of $200,000 and received net proceeds of $200,000. The November 2022 Note bore interest at a
rate of 8% per annum and all outstanding principal and accrued and unpaid interest was due on November 8, 2024. In May 2023, the November
2022 Note and all unpaid interest was paid in full (See Note 16).
During
the year ended December 31, 2023, in connection with the acquisition of a vehicle and an air conditioner unit, the Company’s subsidiary,
Patriot Glass, entered into three vehicle and equipment loans in the amount of $117,721. These loans bear interest at rates ranging from
10.0% to 35.1% and are payable monthly through September 2028. On June 30, 2024 and December 31, 2023, notes payable related to the vehicle
and equipment loans amounted to $71,006 and $97,708, respectively. The net book value on June 30, 2024 relating to the collateralized
assets was $98,573.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
On
February 21, 2024, the Company’s subsidiary, Patriot Glass, entered into a Promissory Note (the “February 2024 Note”)
with a lender in the principal amount of $50,000 and received net proceeds of $49,000, net of original issue discount of $1,000, which
was reflected as a debt discount to be amortized into interest expense over the term of the note. The February 2024 Note bears interest
at an effective rate of 33.4% per annum and all outstanding principal and accrued and unpaid interest is due on August 21, 2025. On June
30, 2024, the principal amount due on the February 2024 Note is $40,920.
On
June 17, 2024, the Company’s subsidiary, Patriot Glass, entered into a Merchant Loan (the “June 2024 Merchant
Loan”) with a lender in the principal amount of $85,000 and received net proceeds of $81,550, net of fees of $3,450, which was
reflected as a debt discount to be amortized into interest expense over the term of the note. The June 2024 Merchant Loan requires a
weekly payment of principal and interest of $2,988 through March 19, 2025 for an effective interest rate of 85.9%. On June 30, 2024, the principal amount due on the June
2024 Merchant Loan is $83,824.
For
the six months ended June 30, 2024 and 2023, amortization of debt discounts related to all the above notes payable amounted to $22,459
and $93,295, respectively, which has been included in interest expense on the accompanying unaudited consolidated statements of operations.
PPP
Loan
On
April 28, 2020, the Company entered into a Paycheck Protection Program Promissory Note (the “PPP Note”) with respect to a
loan of $156,200 (the “PPP Loan”) from Comerica Bank. The PPP Loan was obtained pursuant to the Paycheck Protection Program
(the “PPP”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES act”) administered by the U.S.
Small Business Administration (“SBA”). The PPP Loan matured on April 28, 2022 and bears interest at a rate of 1.00% per annum.
The PPP Loan was payable in 18 equal monthly payments of approximately $8,900 commencing November 1, 2020. The PPP Loan may be prepaid
at any time prior to maturity with no prepayment penalties. The Company applied for forgiveness of its PPP Loan, and on November 4, 2021,
the Company was notified that the Small Business Administration forgave $95,000 of the principal loan amount and $1,442 of interest.
On February 29, 2029, the Company entered into a payment plan arrangement with the SBA and agreed to pay the remaining balance of $17,824
by making 17 monthly payments of $990 and a final payment of $994. On June 30, 2024 and December 31, 2023, the principal amount due under
the PPP Loan amounted to $13,864 and $18,823, respectively. As of June 30, 2024 and December 31, 2023, accrued interest payable amounted
to $0 and $358, respectively.
On
June 30, 2024, future annual maturities of notes payable are as follows:
June 30, | |
Amount | |
2025 | |
$ | 533,856 | |
2026 | |
| 16,654 | |
2027 | |
| 7,013 | |
2028 | |
| 7,751 | |
2029 | |
| 2,059 | |
Total notes payable on June 30, 2024 | |
$ | 567,333 | |
NOTE
9 – SHAREHOLDERS’ DEFICIT
Preferred
Stock
Series
B Preferred Stock
On
December 12, 2019, the Company filed an Amendment to its Articles of Incorporation to designate a series of preferred stock, the Series
B Convertible Preferred Stock (the “Series B”), with the Secretary of State of the State of Colorado. The Certificate of
Designations established 100,000 shares of the Series B, par value $0.10, having such designations, preferences, and rights as determined
by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Articles of Incorporation and
Amended and Restated Bylaws. The Certificate of Designations became effective with the State of Colorado upon filing.
The
Series B ranks senior with respect to dividends and right of liquidation with the Company’s common stock and junior to all existing
and future indebtedness of the Company. The Series B has a stated value per share of $1,000, subject to adjustment as provided in the
Certificate of Designations (the “Stated Value”), and a dividend rate of 2% per annum of the Stated Value.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
The
Series B is subject to redemption (at Stated Value, plus any accrued, but unpaid dividends (the “Liquidation Value”) by the
Company no later than three years after a Deemed Liquidation Event and at the Company’s option after one year from the issuance
date of the Series B, subject to a ten-day notice (to allow holder conversion). A “Deemed Liquidation Event” will mean: (a)
a merger or consolidation in which the Company is a constituent party or a subsidiary of the Company is a constituent party and the Company
issues shares of its capital stock pursuant to such merger or consolidation, except any such merger or consolidation involving the Company
or a subsidiary in which the shares of capital stock of the Company outstanding immediately prior to such merger or consolidation continue
to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation,
at least a majority, by voting power, of the capital stock of the surviving or resulting corporation or, if the surviving or resulting
corporation is a wholly-owned subsidiary of another corporation immediately following such merger or consolidation, the parent corporation
of such surviving or resulting corporation; or (b) the sale, lease, transfer, exclusive license or other disposition, in a single transaction
or series of related transactions, by the Company or any subsidiary of the Company of all or substantially all the assets of the Company
and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the
Company if substantially all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries,
except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company.
The
Series B is convertible into common stock at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion
Price for a period of twenty consecutive trading days, at the option of the Company. Conversion Price means a price per share of the
common stock equal to 100% of the lowest daily volume weighted average price of the common stock during the two years preceding or subsequent
two years following the Issuance Date, subject to adjustment as otherwise provided in the Certificate of Designations (the “Conversion
Price”).
In
the event of a conversion of any Series B, the Company shall issue to the holder a number of shares of common stock equal to the sum
of the Stated Value plus accrued but unpaid dividends multiplied by the number of shares of Series B Preferred Stock being converted
divided by the Conversion Price.
Upon
liquidation of the Company after payment or provision for payment of liabilities of the Company and after payment or provision for any
liquidation preference payable to the holders of any preferred stock ranking senior to the Series B but prior to any distribution to
the holders of Common Stock or preferred stock ranking junior upon liquidation to the Series B, the holders of Series B will be entitled
to be paid out of the assets of the Company available for distribution to its stockholders an amount with respect to each share of Series
B equal to the Liquidation Value.
The
Series B has voting rights per Series B Share equal to the Liquidation Value per share, divided by the Conversion Price, multiplied by
fifty (50). Subject to applicable Colorado law, the holders of Series B will have functional voting control in situations requiring shareholder
vote.
These
Series B preferred share issuances with redemption provisions that permit the issuer to settle in either cash or common stock, at the
option of the issuer, were evaluated to determine whether temporary or permanent equity classification on the consolidated balance sheet
was appropriate. As per the terms of the Series B preferred stock agreements, Series B preferred stock is redeemable for cash and other
assets on the occurrence of a deemed liquidation event. A deemed liquidation event includes a change of control which is not in the Company’s
control. As such, since Series B preferred stock is redeemable upon the occurrence of an event that is not within the Company’s
control, the Series B preferred stock is classified as temporary equity.
The
Company concluded that the Series B Preferred Stock represented an equity host and, therefore, the redemption feature of the Series B
Preferred Stock was not considered to be clearly and closely related to the associated equity host instrument. However, the redemption
features did not meet the net settlement criteria of a derivative and, therefore, were not considered embedded derivatives that required
bifurcation. The Company also concluded that the conversion rights under the Series B Preferred Stock were clearly and closely related
to the equity host instrument. Accordingly, the conversion rights feature on the Series B Preferred Stock were not considered an embedded
derivative that required bifurcation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to
be beneficial on the commitment date.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
On
January 17, 2023, the Board of Directors of the Company agreed to satisfy $144,000 of accrued compensation owed to its executive officers
(collectively, the “Management”) which, as of December 31, 2022 was included in accrued compensation on the accompanying
unaudited consolidated balance sheet. Management agreed to accept 144 shares of the Company’s Series B convertible preferred stock
in settlement of this accrued compensation. The beneficial conversion feature of the Series B Preferred Stock at the time of issuance
was determined to be deminimis on the commitment date.
On
January 2, 2024, the Board of Directors of the Company agreed to satisfy $312,000 of accrued compensation owed to its executive officers
(collectively, the “Management”) as of December 31, 2023, which was included in accrued compensation on the accompanying
unaudited consolidated balance sheet. Management agreed to accept 312 shares of the Company’s Series B convertible preferred stock
in settlement of this accrued compensation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined
to be beneficial on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions
could occur any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $281,807 related
to the beneficial conversion feature arising from the issuance of Series B Preferred Stock. The beneficial conversion feature amount
of $281,807 was determined by calculating the number of excess common shares to be received upon conversion of the accrued compensation
of $312,000 on the grant date based on (i) the quoted closing price of the Company’s common stock on the grant date of $0.059 and
(ii) the initial conversion of the Series B Preferred Stock of $0.0031, multiplied by the quoted closing price of the Company’s
common stock on the grant date of $0.059.
On
January 2, 2024, the Board of Directors of the Company agreed to issue 50 shares of the Company’s Series B convertible preferred
stock to a director for services rendered. The conversion feature of the Series B Preferred Stock at the time of issuance was determined
to be beneficial on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions
could occur any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $95,161, which
consisted of (i) $50,000 of Series B stated value and (ii) $45,161 related to the beneficial conversion feature arising from the issuance
of Series B Preferred Stock. The beneficial conversion feature amount of $45,161 was determined by calculating the number of excess common
shares to be received upon conversion of the $50,000 of Series B stated value on the grant date based on (i) the quoted closing price
of the Company’s common stock on the grant date of $0.059 and (ii) the initial conversion of the Series B Preferred Stock of $0.0031,
multiplied by the quoted closing price of the Company’s common stock on the grant date of $0.059.
On
February 8, 2024, 120 shares of Series B Preferred Stock were forfeited. In connection with this forfeiture, the Company reclassified
an aggregate amount of $127,640 from Series B convertible preferred stock to additional paid-in capital, which consisted of (i) stated
value of $120,000, and (ii) $7,640 of accrued dividends.
On
May 20, 2024, the Company’s chief executive officer returned 197 shares of Series B Preferred Stock to the Company granted to
him in January 2022, per the terms of the Securities and Exchange Commissions’ Order issued to the Company on May 8, 2024 (See Note 10). In
connection with this forfeiture, the Company reclassified an aggregate amount of $206,369 from Series B convertible preferred stock
to additional paid-in capital, which consisted of (i) stated value of $197,000, and (ii) $9,369 of accrued dividends.
During
the six months ended June 30, 2024 and 2023, the Company accrued dividends of $13,355 and $11,226, respectively, which was included in
Series B convertible preferred stock on the accompanying unaudited consolidated balance sheets.
As
of June 30, 2024, the net Series B Preferred Stock balance was $1,245,313, which includes stated value of $1,189,623 and accrued dividends
payable of $55,690 As of December 31, 2023, the net Series B Preferred Stock balance was $1,203,967, which includes stated value of $1,144,624
and accrued dividends payable of $59,343. The net Series B Preferred Stock balance is included on the accompanying unaudited consolidated
balance sheets.
During
the six months ended June 30, 2024 and 2023, Series B preferred stock activity is as follows:
| |
For the Six Months Ended June 30, 2024 | | |
For the Six Months Ended June 30, 2023 | |
| |
Number of Shares | | |
Amount | | |
Number of Shares | | |
Amount | |
Balance at beginning of period | |
| 1,144 | | |
$ | 1,203,967 | | |
| 1,000 | | |
$ | 1,037,201 | |
Shares issued for accrued compensation | |
| 312 | | |
| 312,000 | | |
| 144 | | |
| 144,000 | |
Shares issued for compensation | |
| 50 | | |
| 50,000 | | |
| - | | |
| - | |
Shares and accrued dividends forfeited | |
| (317 | ) | |
| (334,009 | ) | |
| - | | |
| - | |
Dividends accrued | |
| - | | |
| 13,355 | | |
| - | | |
| 11,226 | |
Balance at end of period | |
| 1,189 | | |
$ | 1,245,313 | | |
| 1,144 | | |
$ | 1,192,427 | |
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
Series
C Preferred Stock
On
August 20, 2020, the Company filed an Amendment to its Articles of Incorporation to designate a series of preferred stock, the Series
C Convertible Preferred Stock (the “Series C”), with the Secretary of State of the State of Colorado. The Certificate of
Designations established 100,000 shares of the Series C, par value $0.10, having such designations, preferences, and rights as determined
by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Articles of Incorporation and
Amended and Restated Bylaws. The Certificate of Designations became effective with the State of Colorado upon filing.
The
Series C ranks senior with respect to dividends and right of liquidation with the Company’s common stock and junior to all existing
and future indebtedness of the Company. The Series C has a stated value per share of $100, subject to adjustment as provided in the Certificate
of Designations (the “Stated Value”), and a dividend rate of 2% per annum of the Stated Value.
The
Company has no option to redeem the Series C Preferred Stock. If the Company determines to liquidate, dissolve or wind-up its business
and affairs, or effect any Deemed Liquidation Event as defined below, each of which has been approved by the holders of a majority of
the shares of Series C Preferred Stock then outstanding, the Company will redeem all of the shares of Series C Preferred Stock outstanding
immediately prior to such mandatory redemption event at a price per share of Series C Preferred Stock equal to the aggregate Series C
Liquidation Value, which is 150% of the sum of the Stated Value plus accrued and unpaid dividends, for the shares of Series C Preferred
Stock being redeemed.
The
Company will deliver ten-day advance written notice prior to the consummation of any mandatory redemption event via email or overnight
courier (“Notice of Mandatory Redemption”) to each Holder whose shares are to be redeemed. The Series C is subject to redemption
at liquidation Value noted above by the Company. Upon receipt by any Holder of a Notice of Mandatory Redemption, if Holder does not choose
to convert, such Holder will promptly submit to the Company such Holder’s Series C Preferred Stock certificates on the Redemption
Payment Date. Upon receipt of such Holder’s Series C Preferred Stock certificates, the Company will pay the applicable redemption
price to such Holder in cash. A “Deemed Liquidation Event” will mean: (a) a merger or consolidation in which the Company
is a constituent party or a subsidiary of the Company is a constituent party and the Company issues shares of its capital stock pursuant
to such merger or consolidation, except any such merger or consolidation involving the Company or a subsidiary in which the shares of
capital stock of the Company outstanding immediately prior to such merger or consolidation continue to represent, or are converted into
or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by
voting power, of the capital stock of the surviving or resulting corporation or, if the surviving or resulting corporation is a wholly-owned
subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting
corporation; or (b) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions,
by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a
whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of
the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale,
lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company. Since the Company has determined
that a deemed liquidation event is not probable, the Series C is stated at the Stated Value plus accrued and unpaid dividends rather
than redemption value, which is liquidation value.
The
Series C is convertible at the option of a holder at any time following the issuance date. In the event of a conversion of any Series
C Preferred Stock, the Company shall issue to such Holder a number of Conversion Shares equal to (x) the sum of (1) the Stated Value
per share of Series C Preferred Stock plus (2) any accrued but unpaid dividends thereon multiplied by (y) the number of shares of Series
C Preferred Stock held by such Holder and subject to the Holder Conversion Notice, divided by (z) the Conversion Price with respect to
such Series C Preferred Stock. Conversion Price means a price per share of the common stock equal to the lowest daily volume weighted
average price of the common stock for any trading day during the two years preceding the date of delivery of the conversion notice, subject
to adjustment as otherwise provided in the Series C Certificate of Designation.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
Upon
liquidation of the Company after payment or provision for payment of liabilities of the Company and after payment or provision for any
liquidation preference payable to the holders of any preferred stock ranking senior to the Series C but prior to any distribution to
the holders of Common Stock or preferred stock ranking junior upon liquidation to the Series C, the holders of Series C will be entitled
to be paid out of the assets of the Company available for distribution to its stockholders an amount with respect to each share of Series
C equal to the Liquidation Value.
On
April 28, 2021, the Company filed an Amended and Restated Certificate of Designations of Preferences, Rights, and Limitations of Series
C Convertible Preferred Stock (the “Amended Certificate”). The Amended Certificate changed the voting rights of the Series
C Preferred Stock on any matters requiring shareholder approval or any matters on which the common shareholders are permitted to vote.
Series C Preferred Stock shall have no right to vote on any matters requiring shareholder approval or any matters on which the common
shareholders (or other preferred stock of the Company which may vote with the common shareholders) are permitted to vote. With respect
to any voting rights of the Series C Preferred Stock set forth herein, the Series C Preferred Stock shall vote as a class, each share
of Series C Preferred Stock shall have one vote on any such matter, and any such approval may be given via a written consent in lieu
of a meeting of the Holders of the Series C Preferred Stock. Any reference herein to a determination, decision or election being made
by the “Majority Holders” shall mean the determination, decision or election as made by Holders holding a majority of the
issued and outstanding shares of Series C Preferred Stock at such time. It also adjusts the conversion feature of the Series C Preferred
Stock so that any Holder of Series C Preferred Stock cannot convert any portion of the Series C in excess of that number of Series C
Preferred Stock that upon conversion would result in beneficial ownership by the Holder of more than 4.99% of the outstanding shares
of common stock of the Company.
These
Series C preferred stock issuances with redemption provisions that permit the issuer to settle in either cash or common stock, at the
option of the holder, were evaluated to determine whether temporary or permanent equity classification on the consolidated balance sheet
was appropriate. As per the terms of the Series C preferred stock agreements, Series C preferred stock is redeemable for cash and other
assets on the occurrence of a deemed liquidation event. A deemed liquidation event includes a change of control which is not in the Company’s
control. As such, since Series C preferred stock is redeemable upon the occurrence of an event that is not within the Company’s
control, the Series C preferred stock is classified as temporary equity.
The
Company concluded that the Series C Preferred Stock represented an equity host and, therefore, the redemption feature of the Series C
Preferred Stock was not considered to be clearly and closely related to the associated equity host instrument. However, the redemption
features did not meet the net settlement criteria of a derivative and, therefore, were not considered embedded derivatives that required
bifurcation. The Company also concluded that the conversion rights under the Series C Preferred Stock were clearly and closely related
to the equity host instrument. Accordingly, the conversion rights feature on the Series C Preferred Stock were not considered an embedded
derivative that required bifurcation. The conversion feature of the Series C Preferred Stock at the time of issuance was determined to
be beneficial on the commitment date.
During
the three months ended March 31, 2023, the Company issued 26,585,614 shares of its common stock upon the conversion of 1,014 shares of
Series C preferred with a stated redemption value of $101,400. The conversion price was based on contractual terms of the related Series
C preferred shares.
During
the three months ended June 30, 2023, the Company issued 23,157,922 shares of its common stock upon the conversion of 826 shares of Series
C preferred with a stated redemption value of $82,600. The conversion price was based on contractual terms of the related Series C preferred
shares.
During
the three months ended September 30, 2023, the Company issued 8,584,376 shares of its common stock upon the conversion of 300 shares
of Series C preferred with a stated redemption value of $30,000. The conversion price was based on contractual terms of the related Series
C preferred shares.
On
February 1, 2024, the Company issued 5,772,973 shares of its common stock upon the conversion of 200 shares of Series C preferred with
a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.
On
March 1, 2024, the Company issued 5,781,562 shares of its common stock upon the conversion of 200 shares of Series C preferred with a
stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.
On
May 1, 2024, the Company issued 6,131,037 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated
redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.
During
the six months ended June 30, 2024 and 2023, the Company accrued dividends of $14,743 and $16,079, respectively, which was included in
Series C convertible preferred stock on the accompanying unaudited consolidated balance sheets.
As
of June 30, 2024, the net Series C Preferred Stock balance was $1,575,903, which includes stated liquidation value of $1,455,000 and
accrued dividends payable of $120,903. As of December 31, 2023, the net Series C Preferred Stock balance was $1,621,160, which includes
stated liquidation value of $1,515,000 and accrued dividends payable of $106,160. The net Series C Preferred Stock balance is included
on the accompanying unaudited consolidated balance sheets.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
During
the six months ended June 30, 2024 and 2023, Series C preferred stock activity is as follows:
| |
For the Six Months Ended June 30, 2024 | | |
For the Six Months Ended June 30, 2023 | |
| |
Number of Shares | | |
Amount | | |
Number of Shares | | |
Amount | |
Balance at beginning of period | |
| 15,150 | | |
$ | 1,621,160 | | |
| 17,290 | | |
$ | 1,803,731 | |
Conversion of Series C shares to common shares | |
| (600 | ) | |
| (60,000 | ) | |
| (1,840 | ) | |
| (184,000 | ) |
Dividends accrued | |
| - | | |
| 14,743 | | |
| - | | |
| 16,079 | |
Balance at end of period | |
| 14,550 | | |
$ | 1,575,903 | | |
| 15,450 | | |
$ | 1,635,810 | |
Common
Stock
Common
Stock Issued for Cash and Accrued Compensation
On
January 17, 2023, the Company entered into a Subscription Agreement with its Chairman and Chief Executive Officer, Scott R. Silverman
(the “Subscription Agreement”), whereby Mr. Silverman purchased 54,545,455 shares (the “Subscription Shares”)
of the Company’s common stock for $300,000, or $0.0055 per share, based on the quoted closing price of the Company’s common
stock on the measurement date (the “Consideration”). The Consideration consisted of a cash payment of $275,000 the conversion
of $25,000 of accrued compensation owed to Mr. Silverman.
On
January 17, 2023, Barry Edelstein, a member of the Company’s Board of Directors, elected to convert $53,000 of accrued compensation
into 9,636,364 shares of unregistered common stock of the Company. The shares were valued at $53,000, or $0.0055, based on the quoted
closing price of the Company’s common stock on the measurement date.
Issuance
of Common Stock for Services
Issuance
of Common Stock for Professional Fees
2023
On
February 6, 2023, the Company issued 6,666,667 shares of its common stock for public relations services to be rendered. These shares
were valued at $40,000, or $0.006 per common share, based on the quoted closing price of the Company’s common stock on the measurement
date. In connection with these shares, during the six months ended June 30, 2023, the Company recorded stock-based professional fees
of $11,667 and prepaid expense of $28,333, which was amortized into professional fees over the remaining term of the agreement.
On
April 3, 2023, the Company issued 5,000,000 shares of its common stock for investor relations services to be rendered. These shares were
valued at $22,500, or $0.0045 per common share, based on the quoted closing price of the Company’s common stock on the measurement
date. In connection with these shares, the Company recorded stock-based professional fees of $22,500, which was amortized into professional
fees over the term of the agreement.
On
June 3, 2023, the Company issued 1,500,000 shares of its common stock for investor relations services to be rendered. These shares were
valued at $16,950, or $0.0011 per common share, based on the quoted closing price of the Company’s common stock on the measurement
date. In connection with these shares, the Company recorded stock-based professional fees of $5,650 and prepaid expenses of $11,300,
which will be amortized into professional fees over the remaining term of the agreement.
During
the six months ended June 30, 2024 and 2023, the Company recorded stock-based professional fees of $0 and $38,000 in connection with
the amortization to prepaid expenses related to common shares previously issued, respectively.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
Issuance
of Common Stock for Stock-Based Compensation
On
June 7, 2023, the Company issued 2,500,000 shares of its common stock to employees for services for services rendered. These shares were
valued at $26,000, or $0.0104 per common share, based on the quoted closing price of the Company’s common stock on the measurement
date.
During the six months ended June 30, 2024 and
2023, aggregate accretion of stock-based compensation expense on granted common shares amounted to $0 and $42,183, respectively. Total
unrecognized compensation expense related to these unvested common shares on June 30, 2024 and December 31, 2023 amounted to $0. By mutual
agreement between the parties, the vesting date of previously granted shares was extended through May 2025.
The
following table summarizes activity related to non-vested shares:
| |
Number of Non-Vested Shares | | |
Weighted Average Grant Date Fair Value | |
Non-vested, December 31, 2023 | |
| 14,970,120 | | |
$ | 0.132 | |
Shares vested | |
| - | | |
| - | |
Non-vested, June 30, 2024 | |
| 14,970,120 | | |
$ | 0.132 | |
Common
Stock Forfeited
On
February 8, 2024, 5,250,000 shares of the Company’s common stock were forfeited. In connection with this forfeiture, the Company
reclassified the amount of $5,250 from common stock, par value to additional paid-in capital.
Common
Stock Issued in Connection with Notes Payable
During
April and May 2023, the Company issued 21,371,481 shares of its common stock upon the conversion of principal of $62,000, accrued interest
of $4,139, and fees of $2,250.
In
May 2023, the Company issued the Lender 22,000,000 shares of common stock of the Company in exchange for settlement of the remaining
$200,000 of the loan and all accrued interest amounting to $317,293, which were deemed paid in full (see Note 8 - BOCO Investment
Note). The 22,000,000 shares issued were valued at $132,000, or $0.006 per share, based on the quoted closing price of the Company’s
common stock on the measurement date. In connection with the issuance of these shares, the Company recorded a gain from debt extinguishment
of $68,000 calculated as the different in the principal amount settled for shares of $200,000 and the fair value of the shares on the
measurement date of $132,000.
Common
Stock Issued for Conversion of Series C Preferred Stock
2023
During
the three months ended March 31, 2023, the Company issued 26,585,614 shares of its common stock upon the conversion of 1,014 shares of
Series C preferred with a stated redemption value of $101,400. The conversion price was based on contractual terms of the related Series
C preferred shares.
During
the three months ended June 30, 2023, the Company issued 23,157,922 shares of its common stock upon the conversion of 826 shares of Series
C preferred with a stated redemption value of $82,600. The conversion price was based on contractual terms of the related Series C preferred
shares.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
2024
On
February 1, 2024, the Company issued 5,772,973 shares of its common stock upon the conversion of 200 shares of Series C preferred with
a stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.
On
March 1, 2024, the Company issued 5,781,562 shares of its common stock upon the conversion of 200 shares of Series C preferred with a
stated redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.
On
May 1, 2024, the Company issued 6,131,037 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated
redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares.
Stock
Options
For
the six months ended June 30, 2024 and 2023, the Company recorded no compensation expense related to stock options. Total unrecognized
compensation expense related to unvested stock options on June 30, 2024 and December 31, 2023 amounted to $0.
Stock
option activities for the six months ended June 30, 2024 are summarized as follows:
| | Number of Options | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Term (Years) | | | Aggregate Intrinsic Value | |
Balance Outstanding, December 31, 2023 | | | 8,445,698 | | | $ | 0.40 | | | | 2.43 | | | | - | |
Expired | | | (1,100,000 | ) | | | - | | | | - | | | | - | |
Balance Outstanding, June 30, 2024 | | | 7,345,698 | | | $ | 0.44 | | | | 2.25 | | | $ | - | |
Exercisable, June 30, 2024 | | | 7,345,698 | | | $ | 0.44 | | | | 2.25 | | | $ | - | |
Warrants
Warrant
activities for the six months ended June 30, 2024 are summarized as follows:
| | Number of Warrants | | | Weighted Average Exercise Price | | | Weighted Average Remaining Contractual Term (Years) | | | Aggregate Intrinsic Value | |
Balance Outstanding December 31, 2023 | | | 34,000,000 | | | $ | 0.011 | | | | 2.73 | | | $ | - | |
Expired | | | (600,000 | ) | | | - | | | | - | | | | - | |
Balance Outstanding June 30, 2024 | | | 33,400,000 | | | $ | 0.01 | | | | 2.28 | | | $ | - | |
Exercisable, June 30, 2024 | | | 33,400,000 | | | $ | 0.01 | | | | 2.28 | | | $ | - | |
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
2018
Long-Term Incentive Plan
On
June 7, 2018, a majority of the Company’s shareholders and its board approved the adoption of a 2018 Long-Term Incentive Plan (the
“2018 Plan”). The purpose of the 2018 Plan is to advance the interests of the Company, its affiliates and its stockholders
and promote the long-term growth of the Company by providing employees, non-employee directors and third-party service providers with
incentives to maximize stockholder value and to otherwise contribute to the success of the Company and its affiliates, thereby aligning
the interests of such individuals with the interests of the Company’s stockholders and providing them additional incentives to
continue in their employment or affiliation with the Company. The Plan was adopted on June 7, 2018 and effective on August 2, 2018. Under
the 2018 Plan, the Plan Administrator may grant:
| ● | options
to acquire the Company’s common stock, both incentive stock options that are intended to satisfy the requirements of Section 422
of the Internal Revenue Code and nonqualified stock options which are not intended to satisfy such requirements. The exercise price of
options granted under our 2018 Plan must at least be equal to the fair market value of the Company’s common stock on the date of
grant and the term of an option may not exceed ten years, except that with respect to an incentive stock option granted to any employee
who owns more than 10% of the voting power of all classes of the Company’s outstanding stock as of the grant date the term must
not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date. |
| ● | stock
appreciation rights, or SARs, which allow the recipient to receive the appreciation in the fair market value of the Company’s common
stock between the date of grant and the exercise date. The amount payable under the stock appreciation right may be paid in cash or with
shares of the Company’s common stock, or a combination thereof, as determined by the Administrator. |
| ● | restricted
stock awards, which are awards of the Company’s shares of common stock that vest in accordance with terms and conditions established
by the Administrator. |
| ● | restricted
stock units, which are awards that are based on the value of the Company’s common stock and may be paid in cash or in shares of
the Company’s common stock. |
| ● | other
types of stock-based or stock-related awards not otherwise described by the terms and provision of the 2018 Plan, including the grant
or offer for sale of unrestricted shares of the Company’s common stock, and which may involve the transfer of actual shares of
the Company’s common stock or payment in cash or otherwise of amounts based on the value of shares of the Company’s common
stock and may be designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States. |
| ● | other
cash-based awards to eligible persons in such amounts and upon such terms as the Administrator shall determine. |
An
award granted under the 2018 Plan must include a minimum vesting period of at least one year, provided, however, that an award may provide
that the award will vest before the completion of such one-year period upon the death or qualifying disability of the grantee of the
award or a change of control of the Company and awards covering, in the aggregate, 25,000,000 shares of our common stock may be issued
without any minimum vesting period.
The
aggregate number of shares of common stock and number of shares of the Company’s common stock that may be subject to incentive
stock options granted under the 2018 Plan is 50,000,000 shares, of which 11,445,698 shares have been issued or granted under incentive
stock options and 29,451,070 shares of restricted stock have been issued as of June 30, 2024. All shares underlying grants are expected
to be issued from the Company’s unissued authorized shares available.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
NOTE 10 – COMMITMENTS AND CONTINGENCIES
Legal
Matters
From
time to time, the Company may be involved in litigation related to claims arising out of its operations in the normal course of business.
As of June 30, 2024, other than discussed below, the Company is not involved in any other pending or threatened legal proceedings that
it believes could reasonably be expected to have a material adverse effect on its financial condition, results of operations, or cash
flows.
On January 20, 2022, we received an Order Directing Examination and
Designating Officers to Take Testimony (a “Formal Order”) from the SEC. The Formal Order authorizes that an examination be
made to determine whether a stop order should be issued under Section 8(d) of the Securities Act of 1933 with respect to the Company’s
Registration Statement on Form S-1, and any supplements and amendments thereto. The Formal Order indicates that the Form S-1 may be deficient
in that it may contain untrue statements of material fact or omit to state material facts necessary in order to make the statements made,
in light of the circumstances under which they were made, not misleading concerning, among other things, the Company’s revenue and
financial condition. On April 15, 2022, the Company filed an amendment to its Annual Report on Form 10-K for the fiscal year ended December
31, 2020. The restatement had the cumulative effect of decreasing the Company’s reported revenue for fiscal year 2020 by $102,569
and decreasing the Company’s bad debt expense for the same period by $102,569. There was no effect on the Company’s reported
net loss for fiscal year 2020 or on the financial condition of the Company on December 31, 2020. The Company received a subpoena from
the SEC on April 25, 2022, requesting all documents and communications concerning the review of C-Bond’s revenue recognition practices
for fiscal year 2020. In response, the Company provided the requested information and its Chief Executive Officer provided his testimony
regarding this Formal Order in October 2022. The Company also filed a request to withdraw its Registration Statement on Form S-1
(“S-1”) (File No. 333-261472) (the “Registration Statement”), filed by the Company with the SEC on December 3,
2021. The S-1 related to shares of common stock underlying certain convertible promissory notes held by selling securityholders. The S-1
was not declared effective and no securities were sold in reliance thereon. The Company and its Chief Executive Officer submitted
offers to settle and close the pending SEC investigation, and on May 8, 2024, the SEC filed an administrative proceeding, File No. 3-21932,
and agreed to accept the settlement offers and institute an Order. Without admitting or denying the SEC’s findings, C-Bond and its
Chief Executive Officer consented to a cease-and-desist order and agreed to pay penalties of $175,000 and $50,000, respectively. The Chief
Executive Officer also agreed, pursuant to Section 304 of the Sarbanes-Oxley Act, to reimburse C-Bond for a bonus of $21,961 in cash and
197 Series B preferred shares of stock, which he had received during the time C-Bond’s financial statements were misstated. In May
2024, the 197 Series B preferred shares were cancelled (See Note 9) and the Chief Executive Officer issued a check to the Company in the
amount of $21,961, which the Company expects to deposit before year end. The amount due of $21,961 is included in due from related party on the accompanying
unaudited balance sheet as of June 30, 2024. As of December 31, 2023,
based on the settlement offers, the Company had accrued $175,000 of settlement expense associated with this matter which was included
in accrued expenses on the accompany unaudited consolidated balance sheet. In connection with the settlement offer, in March 2024, the
Company deposited $225,000 into escrow. Upon acceptance of the settlement offer by the SEC in May 2024, the escrow amount was paid to
the SEC and accordingly, the Company reduced accrued expenses by $175,000 and recorded an amount due from related party of $50,000 on the accompanying unaudited balance sheet as of June 30, 2024, which amount was repaid in August 2024.
On
March 8, 2021, a former officer of the Company resigned. Both parties alleged certain claims against the other, including with respect
to certain compensation claims. Neither party has filed litigation. The Company intends to vigorously defend itself against any possible
claims and assert any relevant claims against the former executive and believes it will prevail. The Board of Directors of the Company
has resolved and taken action in February 2024 to cause the forfeiture of equity and deferred compensation owed/outstanding by said officer.
Accordingly, on February 8, 2024, the Board of Directors of the Company determined that 120 shares of Series B convertible preferred
stock and 5,250,000 shares of the Company’s common stock shall be forfeited (See Note 9). Additionally, on February 8, 2024, the
Company reversed accrued compensation that was outstanding to this former officer as of December 31, 2023 of $347,097 and accordingly,
during the six months ended June 30, 2024, the Company recorded a gain on debt extinguishment of $347,097.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
Employment
Agreements
On
October 18, 2017, the Company entered into an employment agreement with Mr. Scott Silverman, pursuant to which he serves as the Chief
Executive Officer of the Company for an initial term of three years that extends for successive one-year renewal terms unless either
party gives 30-days’ advance notice of non-renewal. As consideration for these services, the employment agreement provides Mr.
Silverman with the following compensation and benefits:
| ● | An annual base salary of $300,000, with a 10% increase on each anniversary date contingent upon achieving certain performance objectives as set by the Board. Until the Company raises $1,000,000 in debt or equity financing after entering into this agreement, Mr. Silverman will receive ½ of the base salary on a monthly basis with the other ½ being deferred. Upon the financing being raised, Mr. Silverman will receive the deferred portion of his compensation and his base salary will be paid in full moving forward. |
| | |
| ● | After the first $500,000 of equity investments is raised by the Company, after entering into this employment agreement, Mr. Silverman will receive a capital raise success bonus of 5% of all equity capital raised from investors/lenders introduced by him to the Company. |
| | |
| ● | Annual cash performance bonus opportunity as determined by the Board. |
| | |
| ● | An option to acquire 3,000,000 common shares of the Company, with a strike price of $0.31 per unit. These options vested pro rata on a monthly basis for the term of the employment agreement. On each anniversary, Mr. Silverman will be eligible to be granted a minimum of 500,000 stock options of the Company at a strike price of $0.85 per common unit contingent upon the achievement of certain performance objectives. |
| | |
| ● | Certain other employee benefits and perquisites, including reimbursement of necessary and reasonable travel and participation in retirement and welfare benefits. |
The
receipt of $1,240,000 in connection with the April 25, 2018 financing triggered the right of the employee to receive the deferred
salary and the 5% bonus provision disclosed above.
Mr.
Silverman’s employment agreement provides that, in the event that his employment is terminated by the Company without “cause”
(as defined in his employment agreement), or if Mr. Silverman resigned for “good reasons” (as defined in his new employment
agreement), subject to a complete release of claims, he will be entitled to (i) retain all stock options previously granted; and (ii)
receive any benefits then owed or accrued along with one year of base salary and any unreimbursed expenses incurred by him. All amounts
shall be paid on the termination date. In the event that Mr. Silverman’s employment is terminated by the Company for “cause”
(as defined in his employment agreement), or if Mr. Silverman resigned without “good reasons” (as defined in his employment
agreement), subject to a complete release of claims, he will be entitled to receive any unpaid base salary and benefits then owed or
accrued and any unreimbursed expenses incurred by him. Additionally, if a change of control (as defined in his employment agreement)
occurs during the term of this agreement, all unvested stock options will vest in full and if the valuation of the Company in the change
of control transaction is greater than $0.85 per common share, then Mr. Silverman shall be paid a bonus equal to two times his minimum
base salary and minimum target bonus. Pursuant to the employment agreement, Mr. Silverman will be subject to a confidentiality covenant,
a two-year post-termination non-competition covenant and a two-year post-termination non-solicitation covenant. On June 30, 2020, the
Company amended the employment agreement of Mr. Silverman to provide for successive one-year extensions until either the executive or
the Board of Directors of the Company gives notice to terminate the employment agreement per its terms. This employment agreement amendment
also includes an allowance of up to $10,000 per year to cover uncovered medical/dental expenses for Mr. Silverman and his family.
On
July 21, 2021, the Company entered into the Employment Agreement with Mr. Wanke, the President of Patriot Glass, to serve as the President
of C-Bond’s Safety Solutions Group. Under the three-year Employment Agreement, Mr. Wanke will receive a base salary of $240,000
per year, which may be increased from time to time with the approval of the board of directors. In addition, Mr. Wanke may receive an
annual bonus as determined by the board of directors. It is understood that although Mr. Wanke’s base salary will be paid by Patriot
Glass, 50% of the base salary will be allocated to the expenses of Patriot Glass, and the other 50% of the base salary will be allocated
to the expenses of the Company. The term of this Agreement (the “Initial Term”) shall begin as of July 21, 2021 (the “Effective
Date”) and shall end on the earlier of (i) the third anniversary of the Effective Date and (ii) the time of the termination of
the Executive’s employment in accordance with the Employment Agreement. This Initial Term and any Renewal Term (as defined below)
shall automatically be extended for one or more additional terms of one (1) year each (each a “Renewal Term” and together
with the Initial Term, the “Term”), unless either the Company or Executive provide notice to the other Party of their desire
to not so renew the Initial Term or Renewal Term (as applicable) at least thirty (30) days prior to the expiration of the then-current
Initial Term or Renewal Term, as applicable. All unvested shares of stock and stock options shall expire upon such termination, if any.
The Executive shall be eligible for an annual bonus payment in an amount to be determined by the Board of Directors of the Company (the
“Bonus”). The Bonus shall be determined and payable based on the achievement of certain performance objectives of the Company
as established by the Board and communicated to and agreed to by the Executive in writing as soon as practicable after commencement of
the year in respect of which the Bonus is paid. The Bonus, if earned, is payable in cash and/or restricted stock at the discretion of
the Board. It is understood between the Parties that the target bonus for each year shall be up to 50% of the Base Salary.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
On
December 7, 2023, the Company’s board of directors approved a bonus to two officers in the aggregate amount of $480,000. For the
bonus approved for Mr. Silverman, which amounted to $300,000, this bonus was paid 50%, or $150,000, in cash, which was paid in December
2023, and 50% in equity amounting to $150,000 which as of December 31, 2023 has been accrued and as of December 31, 2023, is included
in accrued compensation on the accompanying unaudited consolidated balance sheet. For the bonus approved for Ms. Tomek, which amounted
to $180,000, this bonus is to be paid 10% in cash of $18,000 and 90% in equity amounting to $162,000, which as of December 31, 2023 has
been accrued and as of December 31, 2023, is included in accrued compensation on the accompanying unaudited consolidated balance sheet.
On January 2, 2024, the Board of Directors of the Company agreed to satisfy the aggregate of $312,000 of the bonus owed to these executive
officers (collectively, the “Management”). Management agreed to accept an aggregate of 312 shares of the Company’s
Series B convertible preferred stock in settlement of this accrued compensation (See Note 9).
Anti-dilution
rights related to C-Bond Systems, LLC
Prior
to the Merger, C-Bond Systems, LLC entered into certain contracts, described below, which provided certain anti-dilution protection to
the counterparties to those contracts. The Company believes that these contracts do not apply to any future issuances of equity
by C-Bond Systems, Inc.
In
2013, pursuant to a subscription agreement, the Company’s subsidiary. C-Bond Systems, LLC issued 2,425,300 common shares. To the
extent that during the term of the agreement C-Bond Systems, LLC issues any “down-round” or subsequent investments based
upon an enterprise value of less than $2,000,000 (“Dilutive Transaction”) (other than an issuance pursuant to an option agreement
with an employee or otherwise to compensate an employee, or incident to an acquisition of assets by C-Bond Systems, LLC in which common
units were issued to the seller of such assets) contemporaneously with the Dilutive Transaction, the contract obligated C-Bond Systems,
LLC to issue the investor additional common units in C-Bond Systems, LLC in an amount which would provide them with the ownership percentage
interest which they would have held in C-Bond Systems, LLC represented by the common units purchased by them on this date.
In
2015, pursuant to a subscription agreement, C-Bond Systems, LLC issued 3,880,480 common shares to an entity at $0.77 per common share.
This agreement entitled the subscriber to anti-dilution protection to the extent that C-Bond Systems, LLC issued any equity in a “down-round”
based upon a value of less than $0.77 per common unit of C-Bond Systems, LLC (other than an issuance pursuant to an option agreement
with an employee or consultant or otherwise to compensate an employee or consultant, or incident to an acquisition of assets by C-Bond
Systems, LLC in which common units are issued to the seller of such assets (“Dilutive Transaction”)). Contemporaneously with
the Dilutive Transaction, the contract obligated C-Bond Systems, LLC to issue the Subscriber additional common units in C-Bond Systems,
LLC in an amount which would provide the investor with the ownership percentage interest in C-Bond Systems, LLC on a fully diluted basis
which Subscriber held immediately prior to the Dilutive Transaction.
In
2016, pursuant to a subscription agreement, C-Bond Systems, LLC issued 1,175,902 common shares to an entity at $0.85 per common share.
This agreement entitled this investor to customary broad-based weighted average anti-dilution protection to the extent that after the
date of this subscription agreement C-Bond Systems, LLC issued any equity in a “down round” based upon a value of less than
$0.85 per common share, including the issuance of options with an exercise price per share of less than $0.85 to compensate employees
or consultants (“Dilutive Transaction”), subject to exclusions for issuances of common shares or options in connection with
strategic partnerships, equity kickers to lenders or vendors, mergers or acquisitions. The agreement obligated C-Bond Systems, LLC to
give to this investor written notice (an “Issuance Notice”) of any proposed issuance by C-Bond Systems, LLC of any C-Bond
Systems, LLC common units, or other form of equity interest (excluding issuances of C-Bond Systems, LLC options or other equity to compensate
employees or consultants and the issuance of shares in connection with strategic partnerships, equity kickers to lenders or vendors,
mergers or acquisitions) at least ten business days prior to the proposed issuance date. This contract entitled the investor to purchase
their pro rata portion of such shares or other equity interest of C-Bond Systems, LLC at the price and on the other terms and conditions
specified in the issuance notice.
Option
to purchase 20% of Patriot Glass
In
connection with the Exchange Agreement with Patriot Glass and the Patriot Glass Shareholder (See Note 1), the Company had the option
to acquire the remaining 20% of Patriot Glass’s issued and outstanding membership interests in exchange for a number of shares
of the Company’s common stock equal to 300% of Patriot Glass’s average EBIT value, divided by the price of the Company’s
common stock as defined in the Exchange Agreement. On September 20, 2023, the Company and the Patriot Glass Shareholder entered into
an amendment to the Exchange Agreement (the “Amended Exchange Agreement”). Pursuant to the Amended Exchange Agreement, the
Company shall have the option (the “Option”), beginning on July 1, 2025 (the “Option Start Date”) and ending
on 5:00 P.M. EST on the date that is thirty calendar days after the Option Start Date (the “Option Period”), to acquire the
remaining 20% of Patriot Glass Units (the “Additional Units”), representing 20% of Patriot Glass’s issued and outstanding
membership interests, collectively (the “Additional Closing”).
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
If
the Company exercises the Option, the Company shall acquire the Additional Units in exchange for (i) a number of shares of Company Common
Stock equal to (a) the Share Value (as defined below) divided by (b) the Additional Closing Share Price (as defined below) (the “Additional
Closing Exchange Shares”), and (ii) a cash payment equal to the Net Income (as below). “Total EBIT Value” shall mean
the sum of (i) Patriot Glass’s net income, before income tax expense and interest expense have been deducted, for the period beginning
on July 1, 2023 and ending on June 30, 2025 plus (ii) $240,000. “EBIT Value” shall mean the Total EBIT Value divided by two
(2). “Share Value” shall mean (i) 300% of the EBIT Value (the “Triple EBIT Value”), minus (ii) the Net Income.
“Net Income” shall mean Patriot Glass’s net income, after income tax expense and interest expense have been deducted,
for the period beginning on July 1, 2023 and ending on June 30, 2025. Any salary paid by Patriot Glass, including but not limited to
any salary paid to the Patriot Glass Shareholder, shall not be included in Net Income. If the Company Common Stock is quoted or listed
for trading on a Trading Market on July 1, 2025, then “Additional Closing Share Price” shall mean the average of all of the
closing prices of Company Common Stock on such Trading Market during the calendar month of June 2024.
M&A
advisory agreement
On
October 18, 2023, the Company and Maxim Group LLC (“Maxim”) entered into an engagement letter, whereby Maxim was engaged
as the Company’s exclusive financial advisor to perform merger and acquisition advisory services. Either Maxim or the Company may
terminate this Agreement at any time upon thirty (30) days’ prior written notice to the other party after the six (6) month anniversary
of this Agreement. The Company paid Maxim a one-time non-refundable cash fee of $25,000 due promptly upon execution of the Agreement
(the “Retainer”). The Retainer shall be creditable against the Success Fee. If during the term of this Agreement a Transaction
is consummated or the Company enters into an agreement regarding a Transaction (which is consummated subsequent to the completion of
the Term), a fee (the “Success Fee”) will be payable in U.S. dollars upon the closing of the Transaction to Maxim equal to
6.5% of the Consideration (as defined hereinafter), provided however, that if a Transaction is consummated or the company enters
into an agreement regarding a Transaction with Curtis Stout Inc., such Success Fee shall be reduced to 4.0% of Consideration from Curtis
Stout Inc. In the event that the Company enters into an agreement with respect to a Transaction during the term of this Agreement that
is subsequently terminated, and the Company becomes entitled to a break-up, termination, topping, expense reimbursement or similar fee
or payment (including any judgment for damages or amount in settlement of any dispute as a result of such termination, or any profit
on any stock acquired from, or stock option granted by, any party to such transaction), a fee (the “Break-up Fee”) equal
to 10.0% of all such amounts, payable promptly upon receipt of such amounts by the Company. Upon the closing of a Transaction, for a
period of twelve (12) months from such closing, the Company grants Maxim the right of first refusal to act as sole managing underwriter
and sole book runner, sole placement agent, or sole sales agent, for any and all future public or private equity, equity-linked or debt
(excluding commercial bank debt) offerings for which the Company retains the service of an underwriter, agent, advisor, finder or other
person or entity in connection with such offering period of the Company, or any successor to or any subsidiary of the Company. The Company
shall not offer to retain any entity or person in connection with any such offering on terms more favorable than terms on which it offers
to retain Maxim. Such offer shall be made in writing in order to be effective. Maxim shall notify the Company within ten (10) business
days of its receipt of the written offer contemplated above as to whether or not it agrees to accept such retention. If Maxim should
decline such retention, the Company shall have no further obligations to Maxim with respect to the offering for which it has offered
to retain Maxim, except as otherwise provided for herein. As of the date of this report, no funds have been raised. In connection with
this agreement, during the six months ended June 30, 2024, the Company recorded professional fees of $14,383.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
NOTE
11 – CONCENTRATIONS
Concentrations
Of Credit Risk
Financial
instruments that potentially subject the Company to concentrations of credit risk consist primarily of trade accounts receivable and
cash deposits. The Company places its cash in banks at levels that, at times, may exceed federally insured limits. On June 30, 2024,
the Company had no cash in bank in excess of FDIC insured levels. To reduce its risk associated with the failure of such a financial
institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits. Any material
loss that the Company may experience in the future could have an adverse effect on its ability to pay its operational expenses or make
other payments and may require the Company to move its cash to other high quality financial institutions. The Company reviews
its bank relationships in order to mitigate its risk to ensure that its exposure is limited or reduced to the FDIC protection limits.
The Company has not experienced any losses in such accounts through June 30, 2024.
Geographic
Concentrations of Sales
During
the six months ended June 30, 2024 and 2023, all sales were in the United States.
Customer
Concentrations
For
the six months ended June 30, 2024, two customers accounted for approximately 41.0% of total sales (14.5% and 26.5%, respectively). For
the six months ended June 30, 2023, one customer accounted for approximately 14.8% of total sales. On June 30, 2024, five customers accounted
for 63.2% (11.8%, 11.0%, 13.5%, 12.7% and 14.2%, respectively) of the total accounts receivable balance. On December 31, 2023, two customers
accounted for 41.8% (29.5% and 12.3%, respectively) of the total accounts receivable balance.
Vendor
concentrations
Generally,
the Company purchases substantially all its inventory from four suppliers. The loss of these suppliers may have a material adverse effect
on the Company’s consolidated results of operations and financial condition. However, the Company believes that, if necessary,
alternate vendors could supply similar products in adequate quantities to avoid material disruptions to operations.
NOTE
12 – SEGMENT REPORTING
Through
May 8, 2023, the date that the Company entered into an Asset Purchase Agreement with Apex Protect GPS, LLC agreed to sell its C-Bond
nanoShield™ product line (See Note 16), the Company operated in two reportable business segments - (1) the manufacture and sale
of a windshield strengthening water repellent solution as well as a disinfection product, and the sale of multi-purpose glass strengthening
primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system (the “C-Bond Segment”),
and (2) the distribution and installation of window film solutions (the “Patriot Glass Segment”). The Company’s reportable
segments were strategic business units that offered different products. They were managed separately based on the fundamental differences
in their operations and locations. Upon the sale of the C-Bond nanoShield™ business, the legacy C-Bond business is being conducted
through Patriot Glass in order to combine administrative functions and they are now being managed together.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
Information
with respect to these reportable business segments for the three and six months ended June 30, 2024 and 2023 was as follows:
| |
For the Three Months Ended June 30, | | |
For the Six Months Ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Revenues: | |
| | |
| | |
| | |
| |
C-Bond | |
$ | - | | |
$ | 31,166 | | |
$ | - | | |
$ | 124,372 | |
Patriot Glass | |
| 863,533 | | |
| 382,889 | | |
| 1,800,337 | | |
| 804,903 | |
| |
| 863,533 | | |
| 414,055 | | |
| 1,800,337 | | |
| 929,275 | |
Depreciation and amortization: | |
| | | |
| | | |
| | | |
| | |
C-Bond | |
| - | | |
| 132 | | |
| - | | |
| 569 | |
Patriot Glass | |
| 24,508 | | |
| 20,413 | | |
| 49,015 | | |
| 40,826 | |
| |
| 24,508 | | |
| 20,545 | | |
| 49,015 | | |
| 41,395 | |
Interest expense: | |
| | | |
| | | |
| | | |
| | |
C-Bond | |
| 171 | | |
| 357 | | |
| 171 | | |
| 357 | |
Patriot Glass | |
| 18,140 | | |
| 6,655 | | |
| 27,081 | | |
| 11,798 | |
Other (a) | |
| 35,297 | | |
| 161,141 | | |
| 40,475 | | |
| 355,483 | |
| |
| 53,608 | | |
| 168,153 | | |
| 67,727 | | |
| 367,638 | |
Net income (loss): | |
| | | |
| | | |
| | | |
| | |
C-Bond | |
| (225,255 | ) | |
| 3,759,343 | | |
| (147,411 | ) | |
| 3,483,967 | |
Patriot Glass | |
| 21,033 | | |
| (93,201 | ) | |
| 68,584 | | |
| (176,813 | ) |
Other (a) | |
| (41,747 | ) | |
| 108,131 | | |
| (474,790 | ) | |
| (255,968 | ) |
| |
$ | (245,969 | ) | |
$ | 3,774,273 | | |
$ | (553,617 | ) | |
$ | 3,051,186 | |
| |
June 30, 2024 | | |
December 31, 2023 | |
Identifiable long-lived tangible assets on June 30, 2024 and December 31, 2023 by segment: | |
| | | |
| | |
C-Bond | |
$ | - | | |
$ | - | |
Patriot Glass | |
| 147,842 | | |
| 171,606 | |
| |
$ | 147,842 | | |
$ | 171,606 | |
NOTE
13 – REVENUE RECOGNITION
Prior
to the sale of the Company’s C-Bond segment in May 2023, the revenue that the Company recognized arose from purchase requests the
Company received from its customers. The Company’s performance obligations under purchase orders or by a verbal order correspond
to each shipment of product that the Company makes to its customer under the purchase order or verbal order. As a result, each purchase
order or verbal order generally contains more than one performance obligation based on the number of products ordered, the quantity of
product to be shipped and the mode of shipment requested by the customer. Control of the Company’s products transfers to its customers
when the customer is able to direct the use of, and obtain substantially all of the benefits from, the Company’s products, which
generally occurs at the later of when the customer obtains title to the product or when the customer assumes risk of loss of the product.
The transfer of control generally occurs at the time of shipment from the Company’s warehouse. Once this occurs, the Company has
satisfied its performance obligation and the Company recognizes revenue. In connection with the Company’s C-Bond segment,
when the Company receives a purchase order or verbal order from a customer, the Company is obligated to provide the product during a
mutually agreed upon time period. Depending on the terms of the purchase order or verbal order, either the Company or the customer arranges
delivery of the product to the customer’s intended destination. In situations where the Company has agreed to arrange delivery
of the product to the customer’s intended destination and control of the product transfers upon loading of the Company’s
product onto transportation equipment, the Company has elected to account for any freight income associated with the delivery of these
products as freight revenue, since this activity fulfills the Company’s obligation to transfer the product to the customer.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
In
connection with the Company’s Patriot Glass segment, the revenue that the Company recognizes arises from purchase requests the
Company receives from its customers. The Company’s performance obligations under purchase order or a signed proposal correspond
to each job for the distribution and installation of window film solutions. As a result, each purchase order or signed proposal generally
may contain more than one performance obligation based on the specific job. Control of the Company’s products transfers to its
customers when the customer is able to direct the use of, and obtain substantially all of the benefits from, the Company’s products,
which generally occurs when the job or a specific portion of the job is completed. Once this occurs, the Company has satisfied its performance
obligation and the Company recognizes revenue. Revenues from contracts for the distribution and installation of window film solutions
are recognized over time on the basis of the Company’s estimates of the progress towards completion of contracts using various
output of input methods including (1) the ratio of number of labor hours spent compared to the number of estimated labor hours to complete
a job, (2) using the milestone method, or (3) using a units completed method. These methods are used because management considers these
methods to be the best available measure of progress on these contracts.
Transaction
Price
The
Company agrees with its customers on the selling price of each transaction. This transaction price is generally based on the product,
market conditions, including supply and demand balances, labor costs, and freight. In the Company’s C-Bond contracts with customers,
the Company allocates the entire transaction price to the sale of product to the customer, which is the basis for the determination of
the relative standalone selling price allocated to each performance obligation. Returns of the Company’s product by its customers
are permitted only when the product is not to specification and were not material for the six months ended June 30, 2024 and 2023. Any
sales tax, value added tax, and other tax the Company collects concurrently with its revenue-producing activities are excluded from revenue.
Revenue
Disaggregation
The
Company tracks its revenue by product. The following table summarizes our revenue by product for the six months ended June 30, 2024 and
2023:
| |
For the Six Months Ended June 30, | |
| |
2024 | | |
2023 | |
C-Bond Secure multi-purpose and BRS ballistic resistant glass protection systems | |
$ | 33,537 | | |
$ | 9,709 | |
C-Bond nanoShield solution sales | |
| - | | |
| 112,413 | |
Window tint installation and sales recognized over time | |
| 1,766,800 | | |
| 804,903 | |
Freight and delivery | |
| - | | |
| 2,250 | |
Total | |
$ | 1,800,337 | | |
$ | 929,275 | |
NOTE
14 – OPERATING LEASE RIGHT-OF-USE (“ROU”) ASSETS AND OPERATING LEASE LIABILITIES
In
October 2019, the Company entered into an 18-month lease agreement for the lease of office and warehouse space under a non-cancelable
operating lease through May 31, 2021. From the lease commencement date of December 1, 2019 until November 30, 2020, monthly rent shall
be $4,444 and from December 1, 2020 to May 31, 2021, monthly rent shall be $4,577 per month. On May 12, 2021 and effective June 1, 2021,
the Company entered into an amendment to the lease which extended the lease for one year until May 31, 2022 at a monthly base rent of
$5,283. On May 4, 2022 and effective June 1, 2022, the Company entered into an amendment to the lease which extended the lease for three
years until May 31, 2025. On June 15, 2023, in connection with the sale of the Company’s nanoShield™ product line, the purchaser
assumed the operating lease and the Company vacated the premises.
In
connection with the 2021 Exchange Agreement between in the Company and Patriot Glass, the Company was named as guarantor (“Guarantor”)
of a Commercial Lease Agreement dated July 21, 2021, by and between landlord MDW Management, LLC, a company owned by Mr. Wanke and his
wife and tenant Patriot Glass d/b/a A-1 Glass (the “Lease”). The term of the Lease is 60 months, at a minimum monthly rent
of $5,600 (not including tax), with two five-year options for the tenant to renew. The Company’s obligation as Guarantor of the
Lease will terminate upon the occurrence of earlier of the following: (i) the date of Guarantor’s acquisition of 100% of the ownership
interests of Patriot Glass; (ii) the date that Guarantor beneficially owns less than an eighty percent (80%) ownership interest in Patriot
Glass; or (iii) two (2) years from and after the effective date of the guaranty. During the year ended December 31, 2023, the Company’s
obligation as Guarantor expired.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
In
September 2021, the Company entered into a 48-month lease agreement for the lease of office equipment under a non-cancelable operating
lease through September 2025. The monthly base rent is $365 per month. This lease has been assumed by CB NANOSHIELD LLC as part of its
purchase of the nanoShield Assets (see Note 16).
In
February 2022, the Company entered into a 36-month lease agreement for the lease of a vehicle under a non-cancelable operating lease
through January 2025. The monthly base rent is $788 per month.
In
adopting ASC Topic 842, Leases (Topic 842) on January 1, 2019, the Company had elected the ‘package of practical expedients’,
which permitted it not to reassess under the new standard its prior conclusions about lease identification, lease classification and
initial direct costs (see Note 2). In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12
months or less. Upon signing of new leases for property and equipment, the Company analyzed the new leases and determined it is required
to record a lease liability and a right of use asset on its unaudited consolidated balance sheets, at fair value.
During
the six months ended June 30, 2024 and 2023, in connection with its property operating leases, the Company recorded rent expense of $16,800
and $40,845, respectively, which is expensed during the year and included in general and administrative expenses on the accompanying
unaudited consolidated statements of operations.
On
June 30, 2024 and December 31, 2023, right-of-use asset (“ROU”) is summarized as follows:
| |
June 30, 2024 | | |
December 31, 2023 | |
Office leases and office equipment right of use assets | |
$ | 279,162 | | |
$ | 279,162 | |
Less: accumulated amortization | |
| (150,440 | ) | |
| (120,678 | ) |
Balance of ROU assets | |
$ | 128,722 | | |
$ | 158,484 | |
On
June 30, 2024 and December 31, 2023, operating lease liabilities related to the ROU assets are summarized as follows:
| |
June 30, 2024 | | |
December 31, 2023 | |
Lease liabilities related to office leases right of use assets | |
$ | 128,722 | | |
$ | 157,752 | |
Less: current portion of lease liabilities | |
| (60,773 | ) | |
| (60,503 | ) |
Lease liabilities – long-term | |
$ | 67,949 | | |
$ | 97,249 | |
On
June 30, 2024, future minimum base lease payments due under non-cancelable operating leases are as follows:
Twelve months ending June 30, | |
Amount | |
2025 | |
$ | 72,715 | |
2026 | |
| 67,200 | |
2027 | |
| 5,600 | |
Total minimum non-cancelable operating lease payments | |
| 145,515 | |
Less: discount to fair value | |
| (16,793 | ) |
Total lease liability on June 30, 2024 | |
$ | 128,722 | |
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
NOTE
15 – RELATED PARTY TRANSACTIONS
Due
from Related Party
On May 8, 2024, the SEC filed an administrative
proceeding, File No. 3-21932, and agreed to accept the settlement offers and institute an Order. Without admitting or denying the SEC’s
findings, C-Bond and its Chief Executive Officer consented to a cease-and-desist order and agreed to pay penalties of $175,000 and $50,000,
respectively. The Chief Executive Officer also agreed, pursuant to Section 304 of the Sarbanes-Oxley Act, to reimburse C-Bond for a bonus
of $21,961 in cash and 197 Series B preferred shares of stock, which he had received during the time C-Bond’s financial statements
were misstated. In May 2024, the 197 Series B preferred shares were cancelled. As of December 31, 2023, based on the settlement offers,
the Company had accrued $175,000 of settlement expense association with this matter which is included in accrued expenses on the accompany
unaudited consolidated balance sheet. In connection with the settlement offer, in March 2024, the Company deposited $225,000 into escrow.
Upon acceptance of the settlement offer by the SEC in May 2024, the escrow amount was paid to the SEC and the accordingly, the Company
reduced accrued expenses by $175,000 and recorded an amount due from related party of $50,000 on the accompanying unaudited balance
sheet as of June 30, 2024. On August 16, 2024, the Company received cash of $50,000 and reduced the amount due from related party. The
Chief Executive Officer also agreed, pursuant to Section 304 of the Sarbanes-Oxley Act, to reimburse C-Bond for a bonus of $21,961 in
cash and 197 Series B preferred shares of stock, which he had received during the time C-Bond’s financial statements were misstated.
In May 2024, the 197 Series B preferred shares were cancelled (See Note 9) and the Chief Executive Officer issued a check to the Company
in the amount of $21,961, which the Company expects to deposit before year end. The amount
due of $21,961 is included in due from related party on the accompanying unaudited balance sheet as of June 30, 2024.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
NOTE
16 – SALE OF NANOSHIELD PRODUCT LINE
On
May 8, 2023, the Company entered into an Asset Purchase Agreement (the “APA”) with Apex Protect GPS, LLC (the “Buyer”),
a Texas limited liability company, whereby the Company agreed to sell its C-Bond nanoShield™ product line, including intangible
assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s
C-Bond nanoShield division (the “Assets”) to the Buyer for a purchase price of $4,000,000 in cash (the “Transaction”).
The Transaction closed on May 8, 2023. Following the Closing, the parties entered into an Assignment and Agreement to Re-Execute (“Assignment”)
on June 15, 2023, by and among the Company; Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”),
whereby the Assignor assigned all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules
and exhibits related to the foregoing to Assignee.
The
Assets were sold and transferred to buyer by means of (i) with respect to the physical assets, a Bill of Sale; and (ii) with respect
to intangible assets or intellectual property, a Patent and Trademark Assignment Agreement, a Patent and Know-How License Agreement,
and a Patent License-Back Agreement.
The
APA contains customary representations, warranties, and covenants by each party including, among other things, that no bankruptcy or
similar insolvency proceeding under state or federal law has been filed, or is currently being contemplated, with respect to the Company;
that the Company has provided the Seller a true and accurate list of each of the following items of Intellectual Property which comprises
a part of the Assets, including, among other things, patents and trademarks (the “Sold Intellectual Property”); and that
the Company has good, valid, and legal title to, and is the sole and exclusive owner of all rights, title and interest in and to, the
Sold Intellectual Property, free and clear of all liens.
Under
the terms of the APA, the Parties entered into a Patent and Trademark Assignment Agreement, whereby the Company conveyed, transferred,
and assigned to Buyer, among other assets, the C-Bond nanoShield trademark (the “Trademark”) and U.S. Patent No. 11,155,491
B2 (the “C-Bond nanoShield Patent”), and the Company agreed to execute and deliver an assignment of the Trademark and C-Bond
nanoShield Patent, for recording with governmental authorities including, but not limited to, the U.S. Patent and Trademark Office.
The
Parties also entered into a Patent and Know-How License Agreement whereby the Company granted to the Buyer a non-transferable, non-sub-licensable,
exclusive right and license to four patents owned by the Company and licensed know-how to make, have made, use, offer to sell, sell and
import glass and other products and components used in or in relation to the manufacture and operation of civilian, agricultural or military
vehicles and equipment (the “Licensed Product”) in the United States and its legal territories.
Lastly,
the Parties entered into a Patent License-Back Agreement whereby the Buyer agreed to grant to the Company a perpetual, non-exclusive,
worldwide, royalty-free, non-transferable, non-sublicensable license to the C-Bond nanoShield Patent, for all uses and applications except
for any that involve, market to, sell to, do business with, provide related goods or services to, or are consumed by any uses and applications
of the patented technology within the civilian or military automotive, vehicle and/or transportation industry. The Patent License-Back
Agreement also stipulates that all improvements made by either Party to the technology covered by the C-Bond nanoShield Patent shall
be owned by the Buyer. In the event that the Company desires to utilize such improvements to the C-Bond nanoShield Patent made by either
Party, the Parties hereby agree that they will negotiate in good faith a separate license agreement having pricing and other terms and
conditions that are mutually acceptable to both Parties.
Following
the Closing, the Parties completed a transaction wherein the Company assigned to Buyer, and Buyer took assignment from the Company, the
lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to a lease assignment
and assumption agreement as agreed to by the Parties and the lessor pursuant to the Lease.
C-BOND SYSTEMS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE 30, 2024
(UNAUDITED)
In
connection with the APA, the Company received net proceeds of $1,989,755, after the repayment and settlement of notes payable and convertible
notes payable as follows:
| 1) | The
Company repaid and settled the BOCO Investments, LLC Note (See Note 8) with a principal balance of $400,000 and accrued interest payable
of $317,293 for a cash payment of $200,000 and the issuance of 22,000,000 shares of the Company’s common stock (See Note 8 and
9). |
| 2) | The
Company repaid GS Capital Partners, LLC $419,260 for notes dated June 23, 2022, July 26, 2022, and September 6, 2022 (collectively, the
“GS Notes”), and GS Capital Partners, LLC deemed the GS Notes paid in full (See Note 8). |
| 3) | The
Company repaid Mercer Street Global Opportunity Fund, LLC (“Mercer”) $271,825 for notes dated March 14, 2022 and November
22, 2022 (collectively, the “Secured Mercer Notes”) (See Note 7). |
| 4) | The
Company repaid Jeff Badders $875,000 for notes dated May 5, 2021, November 8, 2022, and April 4, 2023 (See Note 8). |
| 5) | The
Company repaid 1800 Diagonal Lending, LLC $288,035 for notes dated November 4, 2022, December 27, 2022, and March 17, 2023 (collectively,
the “1800 Diagonal Notes”), and 1800 Diagonal Lending, LLC deemed the 1800 Diagonal Notes paid in full (See Note 7). |
| 6) | The
Company repaid its CEO $250,000 for the note dated May 2, 2022, and the CEO deemed the note paid in full. |
In
accordance with ASC 205-20, the sale of the C-Bond nanoShield™ product line was not reported in discontinued operations since the
disposal did not represent a strategic shift that has (or will have) a major effect on the Company’s operations and financial results.
The C-Bond nanoShield™ product line was only a component of the C-Bond segment which comprised of operations and cash flows that
were not clearly distinguished, operationally and for financial reporting purposes, from the rest of the C-Bond segment.
In
connection with the sale of the C-Bond nanoShield™ product line, on May 8, 2023, the Company recorded a gain from the sale of the
product line of $4,051,709.
NOTE
17 – SUBSEQUENT EVENTS
Promissory
Notes
On
July 31, 2024, the Company’s subsidiary, Patriot Glass, entered into a Merchant Loan (the “July 2024 Merchant Loan”)
with a lender in the principal amount of $75,000 and received net proceeds of $73,030, net of fees of $1,970, which was reflected as
a debt discount to be amortized into interest expense over the term of the note. The July 2024 Merchant Loan requires a weekly payment
of principal and interest of $3,022 through April 2025.
On August 9, 2024, the Company entered into a
Promissory Note and Security Agreement (the “August 2024 Note”) with a Private investor (the “Private Investor”)
in the principal amount of $990,000 in connection with the conversion of 8,000 shares Series C Preferred Stock held by the Private Investor
with a stated value of $800,000 plus additional cash proceeds from the Private Investor of $190,000. The August 2024 Note consists of
$800,000 stated value of Series C Preferred stock converted plus additional cash proceeds of $190,000 received from the Private Investor.
The August 2024 Note shall bear interest at 6% per annum. The Company shall pay quarterly interest expense of $14,850 starting on October
1, 2024 and continuing until the maturity date, which is the earlier of August 9, 2027, or a change of control in the Company, as defined
in the August 2024 Note. All outstanding principal and unpaid interest is due on the maturity date. The August 2024 Note is secured all
assets of the Company.
On August 15, 2024, the Company entered into two
amendments to its Promissory Note in favor of Diagonal dated March 1, 2024 (“March Note”) in the principal amount of $157,000
(See Note 8). The amendments to the March Note changed the number and dollar amount of mandatory monthly payments to be paid to 9 payments,
each in the amount of $17,877 (a total payback to the Holder of $160,893). The first payment shall be due August 30, 2024, with 8 subsequent
payments due on the 30th day of each month thereafter. The amendments to the March Note also changed the conversion price to 65% multiplied
by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%). All other
terms in the March Note remain the same.
On August 15, 2024, the Company entered into two
amendments to its April 2024 Note in favor of Diagonal in the principal amount of $127,693 (See Note 8). The amendments to the April 2024
Note changed the number and dollar amount of mandatory monthly payments to be paid to 9 payments, each in the amount of $21,980 (a total
payback to the Holder of $197,820). The first payment shall be due August 13, 2024, with 8 subsequent payments due on the 15th day of
each month thereafter. The amendments to the April 2024 Note also changed the conversion price to 65% multiplied by the lowest closing
bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%). All other terms in the April
Note remain the same.
On August 15, 2024, the Company entered an amendment
to its June 2024 Note in favor of Diagonal in the principal amount of $67,500 (See Note 8). The amendment to the June 2024 Note changed
the conversion price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing
a discount rate of 35%). All other terms in the June Note remain the same.
ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This
Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements that involve substantial risks and uncertainties.
All statements, other than statements of historical facts, contained in this Report, including statements regarding our strategy, future
operations, future financial position, future revenue, projected costs, prospects, plans and objectives of management and expected market
growth, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,”
“could,” “will,” “would,” “should,” “expect,” “plan,”, “anticipate,”
“believe,” “estimate,” “intend,” “predict,” “seek,” “contemplate,”
“project,” “continue,” “potential,” “ongoing” or the negative of these terms or other
comparable terminology. These forward-looking statements include, but are not limited to, statements about:
| ● | our
ability to obtain additional funds for our operations; |
| ● | our
ability to obtain and maintain intellectual property protection for our products and our ability to operate our business without infringing
the intellectual
property rights of others; |
| ● | our
reliance on third party distributors; |
| ● | the
initiation, timing, progress and results of our research and development programs; |
| ● | our
dependence on current and future collaborators for developing new products; |
| ● | the
rate and degree of market acceptance of our commercial products; |
| ● | the
implementation of our business model and strategic plans for our business; |
| ● | our
estimates of our expenses, losses, future revenue and capital requirements, including our needs for additional financing; |
| ● | our
reliance on third party suppliers to supply the materials and components for our products; |
| ● | our
ability to attract and retain qualified key management and technical personnel; |
| ● | our
financial performance; |
| ● | the
impact of government regulation and developments relating to our competitors or our industry; and |
| ● | other
risks and uncertainties, including those listed under the caption “Risk Factors” in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2023, as the same may be updated from time to time, including in this Report. |
These
statements relate to future events or our future operational or financial performance, and involve known and unknown risks, uncertainties
and other factors that may cause our actual results, performance, or achievements to be materially different from any future results,
performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ
materially from current expectations include, among other things, those listed in our SEC filings.
Any
forward-looking statement in this Report reflects our current view with respect to future events and is subject to these and other risks,
uncertainties and assumptions relating to our business, results of operations, industry, and future growth. Given these uncertainties,
you should not place undue reliance on these forward-looking statements. No forward-looking statement is a guarantee of future performance.
You should read this Report completely and with the understanding that our actual future results may be materially different from any
future results expressed or implied by these forward-looking statements. Except as required by law, we assume no obligation to update
or revise these forward-looking statements for any reason, even if new information becomes available in the future.
This
Report also may contain estimates, projections and other information concerning our industry, our business and the markets for certain
glass strengthening solutions, hydrophobic products, and window film mounting solutions, including data regarding the estimated size
of those markets and their projected growth rates. Information that is based on estimates, forecasts, projections, or similar methodologies
is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected
in this information. Unless otherwise expressly stated, we obtained these industry, business, market and other data from reports, research
surveys, studies and similar data prepared by third parties, industry, and general publications, government data and similar sources.
In some cases, we do not expressly refer to the sources from which these data are derived.
You
are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this Report. Except as
required by law, we do not undertake any obligation to update or release any revisions to these forward-looking statements to reflect
any events or circumstances, whether as a result of new information, future events, changes in assumptions or otherwise, after the date
hereof.
Overview
We
are a nanotechnology company and marketer of the patented C-Bond technology. We are engaged in the implementation of proprietary nanotechnology
applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. Our present
primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States. Our PGS subsidiary
sells two main security products: C-Bond BRS, a ballistic-resistant window film solution and C-Bond Secure, a forced entry deterrent
solution, to private enterprises, schools, government agencies, and general contractors. PGS also sells offers other types of window
film for various applications, including solar, decorative, reflective, and more.
On
May 8, 2023, we entered into an APA with Apex Protect GPS, LLC (the “Buyer”), a Texas limited liability company, whereby
we agreed to sell its C-Bond nanoShield™ product line, including intangible assets, intellectual property, work in process, furniture,
fixtures, equipment, inventory and other physical assets of our C-Bond nanoShield product line (the “Assets”) to the Buyer
for a purchase price of $4,000,000 in cash (the “Transaction”). The Transaction closed on May 8, 2023.
The
Assets were sold and transferred to buyer by means of (i) with respect to the physical assets, a bill of sale; and (ii) with respect
to intangible assets or intellectual property, a Patent and Trademark Assignment Agreement, a Patent and Know-How License Agreement,
and a Patent License-Back Agreement.
On
June 15, 2023, an Assignment and Agreement to Re-Execute was entered into by and among the Company (“Seller”); Apex Protect
GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, a Texas limited liability company (“Assignee”), whereby the Assignor
assigned to the Assignee all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules
and exhibits related to the foregoing to Assignee.
The
APA contains customary representations, warranties, and covenants by each party including, among other things, that no bankruptcy or
similar insolvency proceeding under state or federal law has been filed, or is currently being contemplated, with respect to the Company;
that the Company has provided the Seller a true and accurate list of each of the following items of Intellectual Property which comprises
a part of the Assets, including, among other things, patents and trademarks (the “Sold Intellectual Property”); and that
the Company has good, valid, and legal title to, and is the sole and exclusive owner of all rights, title and interest in and to, the
Sold Intellectual Property, free and clear of all liens.
Under
the terms of the APA, the Parties entered into a Patent and Trademark Assignment Agreement, whereby the Company conveyed, transferred,
and assigned to Buyer, among other assets, the C-Bond nanoShield trademark (the “Trademark”) and U.S. Patent No. 11,155,491
B2 (the “C-Bond nanoShield Patent”), and the Company agreed to execute and deliver an assignment of the Trademark and C-Bond
nanoShield Patent, for recording with governmental authorities including, but not limited to, the U.S. Patent and Trademark Office.
The
Parties also entered into a Patent and Know-How License Agreement whereby the Company granted to the Buyer a non-transferable, non-sub-licensable,
exclusive right and license to four patents owned by the Company and licensed know-how to make, have made, use, offer to sell, sell and
import glass and other products and components used in or in relation to the manufacture and operation of civilian, agricultural or military
vehicles and equipment (the “Licensed Product”) in the United States and its legal territories.
Lastly,
the Parties entered into a Patent License-Back Agreement whereby the Buyer agreed to grant to the Company a perpetual, non-exclusive,
worldwide, royalty-free, non-transferable, non-sublicensable license to the C-Bond nanoShield Patent, for all uses and applications except
for any that involve, market to, sell to, do business with, provide related goods or services to, or are consumed by any uses and applications
of the patented technology within the civilian or military automotive, vehicle and/or transportation industry. The Patent License-Back
Agreement also stipulates that all improvements made by either Party to the technology covered by the C-Bond nanoShield Patent shall
be owned by the Buyer. In the event that the Company desires to utilize such improvements to the C-Bond nanoShield Patent made by either
Party, the Parties hereby agree that they will negotiate in good faith a separate license agreement having pricing and other terms and
conditions that are mutually acceptable to both Parties.
Following
the Closing, the Parties completed a transaction wherein the Company assigned to Buyer, and Buyer took assignment from the Company, the
lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to a lease assignment
and assumption agreement as to be reasonably agreed to by the Parties and the lessor pursuant to the Lease.
On
May 8, 2023, in connection with the APA, the Company received net proceeds of $1,989,755, after paying debt and accrued interest of approximately
$2,053,000.
The
following discussion highlights our results of operations and the principal factors that have affected our financial condition as well
as our liquidity and capital resources for the periods described and provides information that management believes is relevant for an
assessment and understanding of the statements of financial condition and results of operations presented herein. The following discussion
and analysis are based on our consolidated financial statements contained in this Report, which have been prepared in accordance with
United States generally accepted accounting principles (“GAAP”). You should read the discussion and analysis together with
such financial statements and the related notes thereto.
Going
Concern
These unaudited consolidated
financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities
and commitments in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, we had
a net loss of $553,617 for the six months ended June 30, 2024. Net cash used in operations was $812,054 and $912,997 for the six months
ended June 30, 2024 and 2023, respectively. Additionally, as of June 30, 2024, we had an accumulated deficit, shareholders’
deficit, and working capital deficit of $61,447,146, $4,185,273 and $1,265,758, respectively. On June 30, 2024, we had cash of $196,315.
These factors raise substantial doubt about our ability to continue as a going concern for a period of twelve months from the issuance
date of this report. Management cannot provide assurance that we will ultimately achieve profitable operations or become cash flow positive
or raise additional debt and/or equity capital. We are seeking to raise capital through additional debt and/or equity financings to fund
our operations in the future. Although we have historically raised capital from sales of common shares and preferred shares, and from
the issuance of promissory notes and convertible promissory notes, there is no assurance that we will be able to continue to do so. If
we are unable to raise additional capital or secure additional lending in the near future, management expects that we will need to curtail
our operations. These unaudited consolidated financial statements do not include any adjustments related to the recoverability and classification
of assets or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.
Critical
Accounting Estimates
The
following discussion and analysis of our consolidated financial condition and consolidated results of operations are based upon our unaudited
consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United
States. The preparation of these unaudited consolidated financial statements require management to make estimates and judgments that
affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.
Management continually evaluates such estimates, including those related to critical estimates for estimates used in the calculation
of percentage of completion on uncompleted jobs, assumptions used in assessing impairment of long-term assets, and the fair value of
non-cash equity transactions. Management bases its estimates on historical experience and on various other assumptions that it believes
to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets
and liabilities that are not readily apparent from other sources. Any future changes to these estimates and assumptions could cause a
material change to our reported amounts of revenues, expenses, assets and liabilities. Actual results may differ from these estimates
under different assumptions or conditions. Management believes the following critical accounting policies affect our more significant
judgments and estimates used in the preparation of the unaudited consolidated financial statements.
Revenue
recognition
We
follow the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Codification (“ASC”)
Topic 606, Revenue from Contracts with Customers (“ASC 606”). This standard establishes a single comprehensive model
for entities to use in accounting for revenue arising from contracts with customers and supersedes most of the existing revenue recognition
guidance. ASC 606 requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount
that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services and requires certain
additional disclosures.
We
sell our products, which include standard warranties primarily to distributors and authorized dealers. Product sales are recognized at
a point in time when the product is shipped to the customer and title is transferred and are recorded net of any discounts or allowances.
The warranty does not represent a separate performance obligation.
Revenues
from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s
estimates of the progress towards completion of contracts using various output or input methods depending on the type of contract terms
including (1) the ratio of number of labor hours spent compared to the number of estimated labor hours to complete a job, (2) using the
milestone method, or (3) using a units completed method. These methods are used because management considers these to be the best available
measure of progress on these contracts. We use the same method for similar types of contracts. The asset, “contract assets”
represents revenues recognized in excess of amounts billed. The liability, “contract liabilities,” represents billings in
excess of revenues recognized.
Stock-based
compensation
Stock-based
compensation is accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation”,
which requires recognition in the financial statements of the cost of employee, director, and non-employee services received in exchange
for an award of equity instruments over the period the employee, director, or non-employee is required to perform the services in exchange
for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee, director, and non-employee
services received in exchange for an award based on the grant-date fair value of the award. The Company has elected to recognize forfeitures
as they occur as permitted under Accounting Standards Update (“ASU”) 2016-09 Improvements to Employee Share-Based Payment.
See
Note 2 to our unaudited consolidated financial statements for a summary of significant accounting policies and recent accounting pronouncements.
Results
of Operations
The
following comparative analysis on results of operations was based primarily on the comparative consolidated financial statements, footnotes
and related information for the periods identified below and should be read in conjunction with the unaudited consolidated financial
statements and the notes to those statements for the three and six months ended June 30, 2024 and 2023, which are included elsewhere
in this quarterly report on Form 10-Q. The results discussed below are for the three and six months ended June 30, 2024 and 2023.
Comparison
of Results of Operations for the Three and Six Months ended June 30, 2024 and 2023
Sales
For
the three months ended June 30, 2024, sales amounted to $863,533 as compared to $414,055 for the three months ended June 30, 2023, an
increase of $449,478, or 108.6%. For the six months ended June 30, 2024, sales amounted to $1,800,337 as compared to $929,275 for the
six months ended June 30, 2023, an increase of $871,062, or 93.7%. These increases were attributable to an increase in sales of window
tint installation and services to school districts in Texas. The Texas Education Agency (TEA) mandated that each school district and
open-enrollment charter school install either entry-resistant film or fencing on ground-floor windows that would allow access, glass
doors, and windows adjacent to glass doors. Additionally, we had an increase in sales from the sales of C-Bond Secure multi-purpose and
BRS ballistic resistant glass protection systems. These increases were offset by a decrease in sales of our recently sold C-Bond nanoShield™
solutions product line of approximately $26,825 and $112,413 during the three and six months ended June 2024 and compared to the three
and six months ended June 30, 2023, respectively, due to product line sale in May 2023, and a decrease in freight and delivery sales.
Cost
of Goods Sold
In
connection with our C-Bond Solutions segment, cost of goods sold was comprised primarily of the cost of raw materials and finished inventory
sold, packaging costs, and warranty costs. In connection with our Patriot Glass segment, cost of goods sold is comprised primarily of
cost of raw materials such as film, labor, subcontractor costs, equipment rental, and supplies.
For
the three months ended June 30, 2024, cost of sales amounted to $424,959 as compared to $209,071 for the three months ended June 30,
2023, an increase of $215,888, or 103.3%. For the six months ended June 30, 2024, cost of sales amounted to $886,888 as compared to $454,431
for the six months ended June 30, 2023, an increase of $432,457, or 95.2%.
Gross
Profit
For the three months ended
June 30, 2024, gross profit amounted to $438,574, or 50.8% of sales, as compared to $204,984, or 49.5% of sales, for the three months
ended June 30, 2023, an increase of $233,590, or 114.0%. For the six months ended June 30, 2024, gross profit amounted to $913,449, or
50.7% of sales, as compared to $474,844, or 51.1% of sales, for the six months ended June 30, 2023, an increase of $438,605, or 92.4%.
Operating
Expenses
For the three months ended
June 30, 2024, operating expenses amounted to $630,935 as compared to $776,848 for the three months ended June 30, 2023, a decrease of
$145,913, or 18.8%. For the six months ended June 30, 2024, operating expenses amounted to $1,747,329 as compared to $1,570,310 for the
six months ended June 30, 2023, an increase of $177,019, or 11.3%. For the three and six months ended June 30, 2024 and 2023, operating
expenses consisted of the following:
| |
Three Months ended June 30, | | |
Six Months ended June 30, | |
| |
2024 | | |
2023 | | |
2024 | | |
2023 | |
Compensation and related benefits, including
stock-based compensation charges | |
$ | 373,548 | | |
$ | 441,181 | | |
$ | 1,152,667 | | |
$ | 868,053 | |
Professional fees | |
| 88,030 | | |
| 193,263 | | |
| 229,614 | | |
| 380,953 | |
General and administrative expenses | |
| 169,357 | | |
| 142,404 | | |
| 365,048 | | |
| 321,304 | |
Total | |
$ | 630,935 | | |
$ | 776,848 | | |
$ | 1,747,329 | | |
$ | 1,570,310 | |
Compensation
and related benefits
For
the three months ended June 30, 2024, compensation and related benefits decreased by $67,633, or 15.3%, as compared to the three months
ended June 30, 2023. This decrease was primarily due to a decrease in stock-based compensation of $30,046 and an overall decrease in
compensation and related benefits of $37,587.
For
the six months ended June 30, 2024, compensation and related benefits increased by $284,614, or 32.8%, as compared to the six months
ended June 30, 2023. This increase was primarily due to an increase in stock-based compensation of $334,785, offset by an overall decrease
in compensation and related benefits of $50,171.
On
January 2, 2024, the Board of Directors of the Company agreed to satisfy $312,000 of accrued compensation owed to its executive officers
(collectively, the “Management”) as of December 31, 2023, which was included in accrued compensation on the accompanying
unaudited consolidated balance sheet. Management agreed to accept 312 shares of the Company’s Series B convertible preferred stock
in settlement of this accrued compensation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined
to be beneficial on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions
could occur any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $281,807 related
to the beneficial conversion feature arising from the issuance of Series B Preferred Stock. Additionally, on January 2, 2024, the
Board of Directors of the Company agreed to issue 50 shares of the Company’s Series B convertible preferred stock to a director
for services rendered. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial
on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur
any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $95,161, which consisted of
(i) $50,000 of Series B stated value and (ii) $45,161 related to the beneficial conversion feature arising from the issuance of Series
B Preferred Stock.
Professional
fees
For
the three months ended June 30, 2024, professional fees decreased by $105,233, or 54.4%, as compared to the three months ended June 30,
2023. This decrease was primarily related to a decrease in consulting fees of $73,487 and a decrease in legal fees of $41,553, offset
by an increase in other professional fees of $9,807.
For
the six months ended June 30, 2024, professional fees decreased by $151,339, or 39.7%, as compared to the six months ended June 30, 2023.
This decrease was primarily related to a decrease in consulting fees of $134,634 and a decrease in legal fees of $37,829, offset by an
increase in accounting fees of $7,175 and a net increase in other professional fees of $13,949.
General
and administrative
For the three months ended
June 30, 2024, general and administrative expenses increased by $26,953, or 18.9%, as compared to the three months ended June 30, 2023.
The increase is primarily attributable to an increase in advertising expense of $20,029, and an increase in other selling, general and
administrative expenses of $21,418, an increase in depreciation and amortization of $16,588, and an increase in shipping and handling
expense of $2,863, offset by a decrease in bad debt expense of $6,889 and a decrease in rent of $27,056 associated with the sale of the
C-Bond nanoShield™ product line in May 2023.
For
the six months ended June 30, 2024, general and administrative expenses increased by $43,744, or 13.6%, as compared to the six months
ended June 30, 2023. The increase is primarily attributable to an increase in bad debt expense of $23,094, an increase in advertising
expense of $27,888, an increase in other selling, general and administrative expenses of $31,548, an increase in depreciation expense
of $7,620, and an increase in shipping and handling expense of $4,695, offset by a decrease in rent of $51,101 associated with the sale
of the C-Bond nanoShield™ product line in May 2023.
Other
Operating Income
During the three and six months
ended June 30, 2023, we reported a gain on sale of our nanoShield™ product line of $4,051,709. We did not record any other operating
income during the 2024 periods.
(Loss)
Income from Operations
For the three months ended
June 30, 2024 and 2023, (loss) income from operations amounted to $(192,361) and $3,479,845, respectively, a negative change of $3,672,206,
or 105.5%. For the six months ended June 30, 2024 and 2023, (loss) income from operations amounted to $(833,880) and $2,956,243, respectively,
a negative change of $3,790,123, or 128.1%.
Other
Income (Expenses), net
For the three months ended
June 30, 2024, other income (expenses), net amounted to $(53,608) as compared to $294,428 for the three months ended June 30, 2023, a
negative change of $348,036, or 118.2%. This change was primarily due to a decrease in gain on debt extinguishment of $462,581 related
to the reversal of previously accrued compensation, offset by a decrease in interest expense of $114,545 related to a decrease in the
amortization of debt discount and a decrease in interest-bearing debt.
For the six months ended
June 30, 2024, other income (expenses), net amounted to $280,263 as compared to $94,943 for the six months ended June 30, 2023, an increase
of $185,320, or 195.2%. This change was primarily due to a decrease in interest expense of $299,911 related to a decrease in the amortization
of debt discount and a decrease in interest-bearing debt, offset by a decrease in gain on debt extinguishment of $114,591 related to the
reversal of previously accrued compensation and settlement of debt.
Net
(Loss) Income
Due to factors discussed
above, for the three months ended June 30, 2024 and 2023, net (loss) income amounted to $(245,969) and $3,774,273, respectively. For the
three months ended June 30, 2024, net loss attributable to common shareholders, which included dividends accrued on Series B and C preferred
stock of $13,749 and the deduction of net income attributable to noncontrolling interests of $4,207, amounted to $(263,925), or $(0.00)
per common share (basic and diluted). For the three months ended June 30, 2023, net income attributable to common shareholders, which
included dividends accrued on Series B and C preferred stock of $13,618 and the addition of net loss attributable to noncontrolling interests
of $18,640, amounted to $3,779,295, or $0.01 per basic common shares and $0.00 per diluted common share.
Due to factors discussed
above, for the six months ended June 30, 2024 and 2023, net (loss) income amounted to $(553,617) and $3,051,186, respectively. For the
six months ended June 30, 2024, net loss attributable to common shareholders, which included dividends accrued on Series B and C preferred
stock of $28,098 and the deduction of net income attributable to noncontrolling interests of $13,717, amounted to $(595,432), or $(0.00)
per common share (basic and diluted). For the six months ended June 30, 2023, net income attributable to common shareholders, which included
dividends accrued on Series B and C preferred stock of $27,305 and the addition of net loss attributable to noncontrolling interests of
$35,362, amounted to $3,059,243, or $0.01 per basic common shares and $0.00 per diluted common share.
Liquidity
and Capital Resources
Liquidity
is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. We had cash of $196,315
and $736,461 as of June 30, 2024 and December 31, 2023, respectively.
Our
primary uses of cash have been for compensation and related benefits, fees paid to third parties for professional services, and general
and administrative expenses. Historically, we have received funds from the sales of products, from various financing activities such
as from the sale of our common shares, from the sale of preferred shares and from debt financings. Additionally, in May 2023, we received
net proceeds from the sale of our nanoShield™ product line and related technologies of $1,989,755, after the repayment and settlement
of notes payable and convertible notes payable. The following trends are reasonably likely to result in changes in our liquidity over
the near to long term:
|
● |
An
increase in working capital requirements to finance our current business, |
|
|
|
|
● |
Addition
of administrative and sales personnel needed for business growth; |
|
|
|
|
● |
The
cost of being a public company; |
|
|
|
|
● |
Marketing
expense for building brand; |
|
|
|
|
● |
Capital
requirements for production capacity. |
|
|
|
|
● |
Working
capital requirements to support acquired companies. |
As
discussed elsewhere, on May 8, 2023, we entered into an Asset Purchase Agreement (the “APA”) with Apex Protect GPS, LLC (the
“Buyer”), a Texas limited liability company, whereby we sold our C-Bond nanoShield™ product line, including intangible
assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s
C-Bond nanoShield division (the “Assets”) to the Buyer for a purchase price of $4,000,000 in cash (the “Transaction”).
The Transaction closed on May 8, 2023.
In
connection with the APA, we received net proceeds of $1,989,755, after the repayment and settlement of notes payable and convertible
notes payable as follows:
|
1) |
The
Company repaid and settled the BOCO Investments, LLC Note with a principal balance of $400,000 and accrued interest payable of $317,293
for a cash payment of $200,000 and the issuance of 22,000,000 shares of the Company’s common stock. |
|
|
|
|
2) |
The
Company repaid GS Capital Partners, LLC $419,260 for notes dated June 23, 2022, July 26, 2022, and September 6, 2022 (collectively,
the “GS Notes”), and GS Capital Partners, LLC deemed the GS Notes paid in full. |
|
|
|
|
3) |
The
Company repaid Mercer Street Global Opportunity Fund, LLC (“Mercer”) $271,825 for notes dated March 14, 2022 and November
22, 2022 (collectively, the “Secured Mercer Notes”). |
|
|
|
|
4) |
The
Company repaid Jeff Badders $875,000 plus $87,868 of interest for notes dated May 5, 2021, November 8, 2022, and April 4, 2023. |
|
|
|
|
5) |
The
Company repaid 1800 Diagonal Lending, LLC $288,035 for notes dated November 4, 2022, December 27, 2022, and March 17, 2023 (collectively,
the “1800 Diagonal Notes”), and 1800 Diagonal Lending, LLC deemed the 1800 Diagonal Notes paid in full. |
|
|
|
|
6) |
The
Company repaid its CEO $250,000 for the note dated May 2, 2022, and the CEO deemed the note paid in full. |
Recent
Fundings
On March 1, 2024, we executed a Promissory Note
(“Note”) in favor of 1800 Diagonal Lending LLC (“Diagonal”) in the aggregate principal amount of $157,000 (the
“Principal”), and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed
below, is the Note convertible into shares of the Company’s common stock. The Note was funded on March 4, 2023, in the amount of
$125,000, which is net of an original issue discount of $13,000 and a one-time interest charge of $19,000. A one-time interest charge
of twelve percent (12%) (the “Interest Rate”) was applied on the issuance date to the Principal. Under the terms of the Note,
the Company is required to make monthly payments as outlined in the Note, beginning on August 30, 2024 and the Note matures on December
30, 2024. Any amount of principal or interest on this Note which is not paid when due shall bear interest at the rate of 22% per annum
from the due date thereof until the same is paid (“Default Interest”). Among other things, an event of default (“Event
of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration
or otherwise. Upon the occurrence of any Event of Default, the Note shall become immediately due and payable and the Company shall pay
to Diagonal, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding principal
amount of this Note plus accrued and unpaid interest on the unpaid principal amount of this Note to the date of payment plus Default Interest,
if any. At any time following an Event of Default, the Holder shall have the right to convert all or any part of the outstanding and unpaid
amount of this Note into fully paid and non-assessable shares of the Company’s Common Stock. The conversion price (the “Conversion
Price”) shall be the greater of $0.0025 per share (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing
bid price during the 10 trading days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion
Price”). At no time may the Note be converted into shares of our common stock if such conversion would result in Diagonal and its
affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares of our common stock. On August 15, 2024, the Company
entered into two amendments to its Promissory Note in favor of Diagonal dated March 1, 2024 (“March Note”) in the principal
amount of $157,000 (See Note 8). The amendments to the March Note changed the number and dollar amount of mandatory monthly payments to
be paid to 9 payments, each in the amount of $17,877 (a total payback to the Holder of $160,893.00). The first payment shall be due August
30, 2024, with 8 subsequent payments due on the 30th day of each month thereafter. The amendments to the March Note also changed the conversion
price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount
rate of 35%). All other terms in the March Note remain the same.
On April 8, 2024, we executed a Promissory Note
(“the April 2024 Note”) in favor of Diagonal in the aggregate principal amount of $127,963 (the “Principal”),
and an accompanying Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed below, is the April
2024 Note convertible into shares of the Company’s common stock. The Note was funded on April 10, 2024, in the amount of $100,000.
A one-time interest charge of 12% (the “Interest Rate”) shall be applied on the issuance date to the Principal. Under the
terms of the April 2024 Note, the Company is required to make monthly payments as outlined in the Note, beginning on August 15, 2024.
Any amount of principal or interest on the April 2024 Note which is not paid when due shall bear interest at the rate of 22% per annum
from the due date thereof until the same is paid (“Default Interest”). Among other things, an event of default (“Event
of Default”) shall occur if the Company fails to pay the principal or interest when due on the Note, whether at maturity, upon acceleration
or otherwise. Upon the occurrence of any Event of Default, the April 2024 Note shall become immediately due and payable and the Company
shall pay to Diagonal, in full satisfaction of its obligations hereunder, an amount equal to 220% times the sum of the then outstanding
principal amount of this April 2024 Note plus accrued and unpaid interest on the unpaid principal amount of this April 2024 Note to the
date of payment plus Default Interest, if any. At any time following an Event of Default, the Holder shall have the right to convert all
or any part of the outstanding and unpaid amount of this April 2024 Note into fully paid and non-assessable shares of the Company’s
common stock. The conversion price (the “Conversion Price”) shall be the greater of $0.0025 (the “Fixed Conversion Price”)
or 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion date (representing a discount rate
of 35%) (the “Variable Conversion Price”). At no time may the April 2024 Note be converted into shares of our common stock
if such conversion would result in Diagonal and its affiliates owning an aggregate of in excess of 4.99% of the then outstanding shares
of the Company’s common stock. On August 15, 2024, the Company entered into two amendments to its April 2024 Note in favor of Diagonal
in the principal amount of $127,693 (See Note 8). The amendments to the April 2024 Note changed the number and dollar amount of mandatory
monthly payments to be paid to 9 payments, each in the amount of $21,980 (a total payback to the Holder of $197,820). The first payment
shall be due August 13, 2024, with 8 subsequent payments due on the 15th day of each month thereafter. The amendments to the April 2024
Note also changed the conversion price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the conversion
date (representing a discount rate of 35%). All other terms in the April Note remain the same.
On June 5, 2024, the Company executed a Promissory Note (the “June
2024 Note”) in favor of Diagonal in the aggregate principal amount of $67,500 (the “Principal”), and an accompanying
Securities Purchase Agreement (“SPA”). Only in the event of a default, as discussed below, is the June 2024 Note convertible
into shares of the Company’s common stock. The Note was funded on June 5, 2024, in the amount of $50,000, net of original issue
discount and fees of $17,500. Under the terms of the June 2024 Note, the Company is required to make nine monthly payments of principal
and interest of $8,775 beginning on July 15, 2024. Any amount of principal or interest on the April 2024 Note which is not paid when due
shall bear interest at the rate of 22% per annum from the due date thereof until the same is paid (“Default Interest”). Among
other things, an event of default (“Event of Default”) shall occur if the Company fails to pay the principal or interest when
due on the Note, whether at maturity, upon acceleration or otherwise. Upon the occurrence of any Event of Default, the June 2024 Note
shall become immediately due and payable and the Company shall pay to Diagonal, in full satisfaction of its obligations hereunder, an
amount equal to 220% times the sum of the then outstanding principal amount of this June 2024 Note plus accrued and unpaid interest on
the unpaid principal amount of this June 2024 Note to the date of payment plus Default Interest, if any. At any time following an Event
of Default, the Holder shall have the right, to convert all or any part of the outstanding and unpaid amount of this June 2024 Note into
fully paid and non-assessable shares of the Company’s common stock. The conversion price (the “Conversion Price”) shall
be the greater of $0.0025 (the “Fixed Conversion Price”) or 65% multiplied by the lowest closing bid price during the 10 trading
days prior to the conversion date (representing a discount rate of 35%) (the “Variable Conversion Price”). At no time may
the June 2024 Note be converted into shares of our common stock if such conversion would result in Diagonal and its affiliates owning
an aggregate of in excess of 4.99% of the then outstanding shares of the Company’s common stock. On August 15, 2024, the Company
entered an amendment to its June 2024 Note in favor of Diagonal in the principal amount of $67,500 (See Note 8). The amendment to the
June 2024 Note changed the conversion price to 65% multiplied by the lowest closing bid price during the 10 trading days prior to the
conversion date (representing a discount rate of 35%). All other terms in the June Note remain the same.
Summary
As of June 30, 2024, we determined
that there was substantial doubt about our ability to maintain operations as a going concern. Our unaudited consolidated financial statements
have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments
in the normal course of business. As reflected in the accompanying unaudited consolidated financial statements, the Company had a net
loss of $553,617 for the six months ended June 30, 2024. Net cash used in operations was $812,054 and $912,997 for the six months ended
June 30, 2024 and 2023, respectively. Additionally, as of June 30, 2024, the Company had an accumulated deficit, shareholders’
deficit, and working capital deficit of $61,447,146, $4,185,273 and $1,265,758, respectively. Management cannot provide assurance that
we will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital. We will
seek to raise capital through additional debt and/or equity financings to fund operations in the future. Although we have historically
raised capital from sales of common and preferred shares, from the issuance of notes payable, and from the issuance of convertible promissory
notes, there is no assurance that it will be able to continue to do so. If we are unable to raise additional capital or secure additional
lending in the near future, management expects that the Company will need to curtail its operations. Our unaudited consolidated financial
statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification
of liabilities that might be necessary should the company be unable to continue as a going concern.
Our
forecast of the period of time through which our financial resources will be adequate to support our operations is a forward-looking
statement that involves risks and uncertainties, and actual results could vary materially because of a number of factors. We have based
this estimate on assumptions that may prove to be wrong and could utilize our available capital resources sooner than we currently expect.
Our capital requirements are difficult to forecast. Please see the section titled “Risk Factors” in our Annual Report on
Form 10-K for the fiscal year ended December 31, 2023, as filed with the SEC, for additional risks associated with our capital requirements.
Until
such time as we generate substantial product revenue to offset operational expenses, we expect to finance our cash needs through a combination
of public and private equity offerings and debt financings. We may be unable to raise capital or enter into such other arrangements when
needed or on favorable terms or at all. Our failure to raise capital or enter into such other arrangements as and when needed would have
a negative impact on our financial condition.
Additional
cash liquidity is generated from product sales. However, to date, we are not profitable, and we cannot provide any assurances that we
will be profitable. We believe that our existing cash and cash equivalents will not be sufficient to fund our current operating plans.
Cash
Flows
For
the six months ended June 30, 2024 and 2023
The
following table shows a summary of our cash flows for the six months ended June 30, 2024 and 2023.
| |
Six Months Ended June 30, | |
| |
2024 | | |
2023 | |
Net cash used in operating activities | |
$ | (812,054 | ) | |
$ | (912,997 | ) |
Net cash provided by investing activities | |
| - | | |
| 4,042,631 | |
Net cash provided by (used in) financing activities | |
| 271,908 | | |
| (1,715,198 | ) |
Net (decrease) increase in cash | |
| (540,146 | ) | |
| 1,414,436 | |
Cash - beginning of the period | |
| 736,461 | | |
| 97,091 | |
Cash - end of the period | |
$ | 196,315 | | |
$ | 1,511,527 | |
Net
Cash Used in Operating Activities:
Net
cash flow used in operating activities was $812,054 for the six months ended June 30, 2024 as compared to net cash flow used in operating
activities of $912,997 for the six months ended June 30, 2023, a decrease of $100,943.
Net cash flow used in operating
activities for the six months ended June 30, 2024 primarily reflected a net loss of $553,617, which was then adjusted for the add-back
(deduction) of non-cash items primarily consisting of depreciation and amortization of $49,015, stock-based compensation expense of $376,968,
amortization of debt discount of $22,459, non-cash gain on debt extinguishment of $(347,990), non-cash compensation claw back of $(21,961),
and bad debt expense of $25,833, and changes in operating assets and liabilities consisting primarily of a decrease in accounts receivable
of $154,889, a decrease in inventory of $19,611, an increase in prepaid expenses of $79,304, an increase in contract liabilities of $57,456,
an increase in amounts due from related party of $50,000, an increase in accounts payable of $88,605, a decrease in contract liabilities
of $351,936, a decrease in accrued compensation of $3,645, and a decrease in accrued expenses of $84,257.
Net
cash flow used in operating activities for the six months ended June 30, 2023 primarily reflected net income of $3,051,186, which was
then adjusted for the add-back (deduction) of non-cash items primarily consisting of depreciation and amortization of $41,395, stock-based
compensation expense of $42,183, stock-based professional fees of $97,817, amortization of debt discount of $95,922, non-cash interest
expense for put premiums of $29,212, non-cash gain on debt extinguishment and inducement expense of $462,581, and gain from sale of nanoShield™
product line of $4,051,709, and changes in operating assets and liabilities consisting primarily of a decrease in accounts receivable
of $188,934, an increase in inventory of $51,196, an increase in prepaid expenses of $15,434, an increase in contract assets of $52,487,
a decrease in accounts payable of $50,027, an increase in accrued expenses of $8,040, an increase in contract liabilities of $157,363,
an increase in accrued compensation of $49,812, and an increase in accrued interest – related party of $5,663.
Net
Cash Provided by Investing Activities:
Net
cash provided by investing activities was $4,042,631 for the six months ended June 30, 2023 as compared to $0 for the six months ended
June 30, 2024.
During
the six months ended June 30, 2023, we received net proceeds of $4,042,631 from the sale of our nanoShield™ product line and related
technologies.
Net
Cash Provided by (Used in) Financing Activities:
Net
cash provided by financing activities was $271,908 for the six months ended June 30, 2024 as compared to net cash used in financing activities
of $(1,715,198) for the six months ended June 30, 2023.
During
the six months ended June 30, 2024, we received net proceeds from notes payable of $405,550. These proceeds were offset by the repayment
of notes payable of $43,642 and the repayment of convertible notes payable of $90,000.
During
the six months ended June 30, 2023, we received net proceeds from the sale of our common stock to our chief executive officer of $275,000,
we received net proceeds from convertible notes payable of $50,000, and we received proceeds from notes payable of $175,000. These proceeds
were offset by the repayment of notes payable of $1,792,448, the repayment of note payable – related party of $200,000, and the
repayment of convertible notes payable of $222,750.
Contractual
Obligations and Off-Balance Sheet Arrangements
Contractual
Obligations
We
have certain fixed contractual obligations and commitments that include future estimated payments. Changes in our business needs, cancellation
provisions, changing interest rates, and other factors may result in actual payments differing from the estimates. We cannot provide
certainty regarding the timing and amounts of payments. We have presented below a summary of the most significant assumptions used in
our determination of amounts presented in the tables, to assist in the review of this information within the context of our consolidated
financial position, results of operations, and cash flows.
The
following tables summarize our contractual obligations as of June 30, 2024, and the effect these obligations are expected to have on
our liquidity and cash flows in future periods.
| |
Payments Due by Period | |
Contractual obligations: | |
Total | | |
Less than 1 year | | |
1-2 years | | |
3-5 years | | |
5 + years | |
Notes payable | |
$ | 567,333 | | |
$ | 533,856 | | |
$ | 23,667 | | |
$ | 9,810 | | |
$ | - | |
Convertible note payable | |
| 1,008,091 | | |
| 180,000 | | |
| 828,091 | | |
| - | | |
| - | |
Interest on notes payable | |
| 176,800 | | |
| 176,800 | | |
| - | | |
| - | | |
| - | |
Operating lease gross base rent | |
| 145,515 | | |
| 72,715 | | |
| 72,800 | | |
| - | | |
| - | |
Total | |
$ | 1,897,739 | | |
$ | 963,371 | | |
$ | 924,558 | | |
$ | 9,810 | | |
$ | - | |
Off-balance
Sheet Arrangements
We
do not have any off-balance sheet arrangements during the period presented as defined in the rules and regulations of the SEC.
ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Not
applicable to smaller reporting companies.
ITEM
4. CONTROLS AND PROCEDURES
Disclosure
Controls and Procedures
We
maintain “disclosure controls and procedures,” as that term is defined in Rule 13a-15(e), promulgated by the SEC pursuant
to the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Disclosure controls and procedures include controls
and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is
accumulated and communicated to our management, including the principal executive officer and principal financial officer, to allow timely
decisions regarding required disclosure. Our management, with the participation of the principal executive officer and principal financial
officer, evaluated our disclosure controls and procedures as of the end of the period covered by this quarterly report on Form 10-Q.
Based on this evaluation, our principal executive officer and principal financial officer concluded that as of June 30, 2024, our disclosure
controls and procedures were not effective.
As
reported in Item 9A of our Annual Report on Form 10-K for the year ended December 31, 2023, our management concluded that our internal
control over financial reporting was not effective as of that date because of a material weakness in our internal control over financial
reporting. The ineffectiveness of our disclosure controls and procedures was due to the following material weaknesses in our internal
control over financial reporting: (1) the lack of multiples levels of management review on complex business, accounting and financial
reporting issues, and (2) a lack of adequate segregation of duties as a result of our limited financial resources to support hiring of
personnel.
Until
such time as we expand our staff to include additional accounting and executive personnel, it is likely we will continue to report material
weaknesses in our internal control over financial reporting.
A
material weakness is a deficiency or a combination of control deficiencies in internal control over financial reporting such that there
is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected
on a timely basis.
Changes
in Internal Control Over Financial Reporting
There
were no changes in our internal control over financial reporting during the quarter ended June 30, 2024 that have materially affected,
or are reasonably likely to materially affect, our internal control over financial reporting.
PART
II - OTHER INFORMATION
ITEM
1. LEGAL PROCEEDINGS
From
time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However,
litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may
harm business.
Except
as set forth below, the Company is not involved in any pending or threatened legal proceedings that it believes could reasonably be expected
to have a material adverse effect on its financial condition, results of operations, or cash flows.
On January 20,
2022, we received an Order Directing Examination and Designating Officers to Take Testimony (a “Formal Order”) from the
SEC. The Formal Order authorizes that an examination be made to determine whether a stop order should be issued under Section 8(d)
of the Securities Act of 1933 with respect to the Company’s Registration Statement on Form S-1, and any supplements and
amendments thereto. The Formal Order indicates that the Form S-1 may be deficient in that it may contain untrue statements of
material fact or omit to state material facts necessary in order to make the statements made, in light of the circumstances under
which they were made, not misleading concerning, among other things, the Company’s revenue and financial condition. On April
15, 2022, we filed an amendment to its Annual Report on Form 10-K for the fiscal year ended December 31, 2020. The restatement had
the cumulative effect of decreasing the Company’s reported revenue for fiscal year 2020 by $102,569 and decreasing the
Company’s bad debt expense for the same period by $102,569. There was no effect on the Company’s reported net loss for
fiscal year 2020 or on the financial condition of the Company on December 31, 2020. The Company received a subpoena from the SEC on
April 25, 2022, requesting all documents and communications concerning the review of C-Bond’s revenue recognition practices
for fiscal year 2020. In response, the Company provided the requested information and its Chief Executive Officer provided his
testimony regarding this Formal Order in October 2022. The Company also filed a request to withdraw its Registration Statement
on Form S-1 (“S-1”) (File No. 333-261472) (the “Registration Statement”), filed by the Company with the
Securities and Exchange Commission on December 3, 2021. The S-1 related to shares of common stock underlying certain convertible
promissory notes held by selling securityholders. The S-1 was not declared effective and no securities were sold in reliance
thereon. The Company and our Chief Executive Officer submitted offers to settle and close the pending SEC investigation, and on
May 8, 2024, the SEC filed an administrative proceeding, File No. 3-21932, and agreed to accept the settlement offers and institute
an Order. Without admitting or denying the SEC’s findings, C-Bond and its Chief Executive Officer consented to a
cease-and-desist order and agreed to pay penalties of $175,000 and $50,000, respectively. The Chief Executive Officer also agreed,
pursuant to Section 304 of the Sarbanes-Oxley Act, to reimburse C-Bond for a bonus of $21,961 in cash and 197 Series B preferred
shares of stock, which he had received during the time C-Bond’s financial statements were misstated. In May 2024, the 197
Series B preferred shares were cancelled and the Chief Executive Officer issued a check to the Company in the amount of $21,961,
which the Company expects to deposit before year end. The amount due of $21,961 is
included in due from related party on the accompanying unaudited balance sheet as of June 30, 2024. As of December 31, 2023,
based on the settlement offers, the Company had accrued $175,000 of settlement expense association with this matter which is
included in accrued expenses on the accompanying unaudited consolidated balance sheet. In connection with the settlement offer, in
March 2024, the Company deposited $225,000 into escrow. Upon acceptance of the settlement offer by the SEC in May 2024, the escrow
amount was paid to the SEC and the accordingly, the Company reduced accrued expenses by $175,000 and recorded an amount due from
related party of $50,000 on the accompanying unaudited balance sheet as of June 30, 2024, which amount was repaid in August
2024.
On
March 8, 2021, a former officer of the Company resigned. Both parties alleged certain claims against the other, including with respect
to certain compensation claims. Neither party has filed litigation. The Company intends to vigorously defend itself against any possible
claims and assert any relevant claims against the former executive and believes it will prevail. The Board of Directors of the Company
have resolved and taken action in February 2024 to cause the forfeiture of equity and deferred compensation owed/outstanding by said
officer. Accordingly, on February 8, 2024, the Board of Directors of the Company determined that 120 shares of Series B convertible preferred
stock and 5,250,000 shares of the Company’s common stock shall be forfeited (See Note 9). Additionally, on February 8, 2024, the
Company reversed accrued compensation that was outstanding to this former officer as of December 31, 2023 of $347,097 and accordingly,
during the six months ended June 30, 2024, the Company recorded a gain on debt extinguishment of $347,097.
ITEM
1A. RISK FACTORS
There
have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December
31, 2023.
ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
| 1. | On
May 1, 2024, the Company issued 6,131,037 shares of its common stock upon the conversion of 200 shares of Series C preferred with a stated
redemption value of $20,000. The conversion price was based on contractual terms of the related Series C preferred shares. |
The
above securities were issued in reliance upon the exemptions provided by Section 4(a)(2) under the Securities Act of 1933, as amended.
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM
4. MINE SAFETY DISCLOSURES
Not
applicable.
ITEM
5. OTHER INFORMATION
(a)
None.
(b)
There have been no material changes to the procedures by which security holders may recommend nominees to the Company’s Board of
Directors since the Company last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K.
(c)
During the quarter ended June 30, 2024, no director or officer of the Company adopted or terminated a contract, instruction or written
plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) and/or
a non-Rule 10b5-1 trading arrangement.
ITEM
6. EXHIBITS
Exhibit No. |
|
Description
of Exhibit |
4.1 |
|
Promissory Note, dated April 8, 2024, in favor of Investor (incorporated by reference to Exhibit 4.1 to Current Report on Form 8-K as filed on April 12, 2024). |
10.1 |
|
Securities Purchase Agreement, dated April 8, 2024, between C-Bond Systems, Inc. and Investor (incorporated by reference to Exhibit 10.1 to Current Report on Form 8-K as filed on April 12, 2024). |
31.1* |
|
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
31.2* |
|
Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
32.1** |
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
101.INS* |
|
Inline
XBRL Instance Document. |
101.SCH* |
|
Inline
XBRL Taxonomy Extension Schema Document. |
101.CAL* |
|
Inline
XBRL Taxonomy Extension Calculation Linkbase Document. |
101.DEF* |
|
Inline
XBRL Taxonomy Extension Definition Linkbase Document. |
101.LAB* |
|
Inline
XBRL Taxonomy Extension Label Linkbase Document. |
101.PRE* |
|
Inline
XBRL Taxonomy Extension Presentation Linkbase Document. |
104* |
|
Cover
Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
C-BOND
SYSTEMS, INC. |
|
|
|
Dated:
August 19, 2024 |
By: |
/s/
Scott R. Silverman |
|
|
Scott
R. Silverman |
|
|
Chief
Executive Officer and
Chief
Financial Officer
(principal
executive officer,
principal financial officer and
principal accounting officer) |
NONE
false
--12-31
Q2
0001421636
0001421636
2024-01-01
2024-06-30
0001421636
2024-08-14
0001421636
2024-06-30
0001421636
2023-12-31
0001421636
cbnt:SeriesBConvertiblePreferredStockMember
2024-06-30
0001421636
cbnt:SeriesBConvertiblePreferredStockMember
2023-12-31
0001421636
cbnt:SeriesCConvertiblePreferredStockMember
2024-06-30
0001421636
cbnt:SeriesCConvertiblePreferredStockMember
2023-12-31
0001421636
2024-04-01
2024-06-30
0001421636
2023-04-01
2023-06-30
0001421636
2023-01-01
2023-06-30
0001421636
us-gaap:CommonStockMember
2023-12-31
0001421636
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001421636
us-gaap:RetainedEarningsMember
2023-12-31
0001421636
us-gaap:NoncontrollingInterestMember
2023-12-31
0001421636
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0001421636
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-03-31
0001421636
us-gaap:RetainedEarningsMember
2024-01-01
2024-03-31
0001421636
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-03-31
0001421636
2024-01-01
2024-03-31
0001421636
us-gaap:CommonStockMember
2024-03-31
0001421636
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
0001421636
us-gaap:RetainedEarningsMember
2024-03-31
0001421636
us-gaap:NoncontrollingInterestMember
2024-03-31
0001421636
2024-03-31
0001421636
us-gaap:CommonStockMember
2024-04-01
2024-06-30
0001421636
us-gaap:AdditionalPaidInCapitalMember
2024-04-01
2024-06-30
0001421636
us-gaap:RetainedEarningsMember
2024-04-01
2024-06-30
0001421636
us-gaap:NoncontrollingInterestMember
2024-04-01
2024-06-30
0001421636
us-gaap:CommonStockMember
2024-06-30
0001421636
us-gaap:AdditionalPaidInCapitalMember
2024-06-30
0001421636
us-gaap:RetainedEarningsMember
2024-06-30
0001421636
us-gaap:NoncontrollingInterestMember
2024-06-30
0001421636
us-gaap:CommonStockMember
2022-12-31
0001421636
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001421636
us-gaap:RetainedEarningsMember
2022-12-31
0001421636
us-gaap:NoncontrollingInterestMember
2022-12-31
0001421636
2022-12-31
0001421636
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001421636
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0001421636
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001421636
us-gaap:NoncontrollingInterestMember
2023-01-01
2023-03-31
0001421636
2023-01-01
2023-03-31
0001421636
us-gaap:CommonStockMember
2023-03-31
0001421636
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0001421636
us-gaap:RetainedEarningsMember
2023-03-31
0001421636
us-gaap:NoncontrollingInterestMember
2023-03-31
0001421636
2023-03-31
0001421636
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001421636
us-gaap:AdditionalPaidInCapitalMember
2023-04-01
2023-06-30
0001421636
us-gaap:RetainedEarningsMember
2023-04-01
2023-06-30
0001421636
us-gaap:NoncontrollingInterestMember
2023-04-01
2023-06-30
0001421636
us-gaap:CommonStockMember
2023-06-30
0001421636
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0001421636
us-gaap:RetainedEarningsMember
2023-06-30
0001421636
us-gaap:NoncontrollingInterestMember
2023-06-30
0001421636
2023-06-30
0001421636
2023-05-08
2023-05-08
0001421636
cbnt:ExchangeAgreementMember
2021-07-22
0001421636
us-gaap:CommonStockMember
2021-07-22
2021-07-22
0001421636
cbnt:OptionPeriodMember
2024-06-30
0001421636
cbnt:AdditionalUnitsMember
2024-06-30
0001421636
cbnt:CBondSystemsLLCMember
2024-06-30
0001421636
srt:MinimumMember
us-gaap:PropertyPlantAndEquipmentMember
us-gaap:LeaseholdImprovementsMember
2024-06-30
0001421636
srt:MaximumMember
us-gaap:PropertyPlantAndEquipmentMember
us-gaap:LeaseholdImprovementsMember
2024-06-30
0001421636
us-gaap:PropertyPlantAndEquipmentMember
2024-06-30
0001421636
us-gaap:FiniteLivedIntangibleAssetsMember
2024-06-30
0001421636
2023-01-01
2023-12-31
0001421636
us-gaap:ShippingAndHandlingMember
2024-01-01
2024-06-30
0001421636
us-gaap:ShippingAndHandlingMember
2023-01-01
2023-06-30
0001421636
us-gaap:GeneralAndAdministrativeExpenseMember
2024-01-01
2024-06-30
0001421636
us-gaap:GeneralAndAdministrativeExpenseMember
2023-01-01
2023-06-30
0001421636
srt:MinimumMember
us-gaap:PropertyPlantAndEquipmentMember
2024-06-30
0001421636
srt:MaximumMember
us-gaap:PropertyPlantAndEquipmentMember
2024-06-30
0001421636
cbnt:PropertyMember
2024-06-30
0001421636
us-gaap:ConvertibleDebtMember
2024-04-01
2024-06-30
0001421636
us-gaap:ConvertibleDebtMember
2023-04-01
2023-06-30
0001421636
us-gaap:ConvertibleDebtMember
2024-01-01
2024-06-30
0001421636
us-gaap:ConvertibleDebtMember
2023-01-01
2023-06-30
0001421636
us-gaap:SeriesBPreferredStockMember
2024-04-01
2024-06-30
0001421636
us-gaap:SeriesBPreferredStockMember
2023-04-01
2023-06-30
0001421636
us-gaap:SeriesBPreferredStockMember
2024-01-01
2024-06-30
0001421636
us-gaap:SeriesBPreferredStockMember
2023-01-01
2023-06-30
0001421636
us-gaap:SeriesCPreferredStockMember
2024-04-01
2024-06-30
0001421636
us-gaap:SeriesCPreferredStockMember
2023-04-01
2023-06-30
0001421636
us-gaap:SeriesCPreferredStockMember
2024-01-01
2024-06-30
0001421636
us-gaap:SeriesCPreferredStockMember
2023-01-01
2023-06-30
0001421636
us-gaap:StockOptionMember
2024-01-01
2024-06-30
0001421636
us-gaap:StockOptionMember
2023-01-01
2023-06-30
0001421636
us-gaap:WarrantMember
2024-01-01
2024-06-30
0001421636
us-gaap:WarrantMember
2023-01-01
2023-06-30
0001421636
us-gaap:ConvertibleDebtMember
2024-01-01
2024-06-30
0001421636
us-gaap:ConvertibleDebtMember
2023-01-01
2023-06-30
0001421636
srt:MinimumMember
us-gaap:MachineryAndEquipmentMember
2024-06-30
0001421636
srt:MaximumMember
us-gaap:MachineryAndEquipmentMember
2024-06-30
0001421636
us-gaap:MachineryAndEquipmentMember
2024-06-30
0001421636
us-gaap:MachineryAndEquipmentMember
2023-12-31
0001421636
srt:MinimumMember
us-gaap:OfficeEquipmentMember
2024-06-30
0001421636
srt:MaximumMember
us-gaap:OfficeEquipmentMember
2024-06-30
0001421636
us-gaap:OfficeEquipmentMember
2024-06-30
0001421636
us-gaap:OfficeEquipmentMember
2023-12-31
0001421636
srt:MinimumMember
us-gaap:VehiclesMember
2024-06-30
0001421636
srt:MaximumMember
us-gaap:VehiclesMember
2024-06-30
0001421636
us-gaap:VehiclesMember
2024-06-30
0001421636
us-gaap:VehiclesMember
2023-12-31
0001421636
srt:MinimumMember
us-gaap:LeaseholdImprovementsMember
2024-06-30
0001421636
srt:MaximumMember
us-gaap:LeaseholdImprovementsMember
2024-06-30
0001421636
us-gaap:LeaseholdImprovementsMember
2024-06-30
0001421636
us-gaap:LeaseholdImprovementsMember
2023-12-31
0001421636
cbnt:CustomerRelationsMember
2024-06-30
0001421636
us-gaap:NoncompeteAgreementsMember
2024-06-30
0001421636
cbnt:CustomerRelationsMember
2023-12-31
0001421636
us-gaap:NoncompeteAgreementsMember
2023-12-31
0001421636
us-gaap:CustomerRelationshipsMember
2024-06-30
0001421636
us-gaap:CustomerRelationshipsMember
2023-12-31
0001421636
us-gaap:TradeNamesMember
2024-06-30
0001421636
us-gaap:TradeNamesMember
2023-12-31
0001421636
cbnt:MercerStreetGlobalOpportunityFundLLCMember
2021-10-15
0001421636
cbnt:SecuritiesPurchaseAgreementMember
2021-10-15
0001421636
us-gaap:WarrantMember
2021-10-15
2021-10-15
0001421636
cbnt:SecuritiesPurchaseAgreementMember
2021-10-15
2021-10-15
0001421636
cbnt:MercerStreetGlobalOpportunityFundLLCMember
2021-10-15
2021-10-15
0001421636
cbnt:MercerConvertibleDebtMember
2021-10-15
2021-10-15
0001421636
cbnt:MercerConvertibleDebtMember
2024-06-30
0001421636
cbnt:MercerConvertibleDebtMember
2024-01-01
2024-06-30
0001421636
cbnt:ExchangeAgreementMember
2022-04-20
2022-04-20
0001421636
cbnt:MercerConvertibleDebtMember
2022-04-20
0001421636
cbnt:ExchangeAgreementMember
2022-04-20
0001421636
cbnt:SecuritiesPurchaseAgreementMember
2022-04-20
0001421636
cbnt:MercerConvertibleDebtMember
2022-04-20
2022-04-20
0001421636
cbnt:OctoberFifteenTwothousandtwentytwoMember
2022-04-20
0001421636
cbnt:ExchangeAgreementMember
2024-06-30
0001421636
2022-04-20
2022-04-20
0001421636
2022-10-15
0001421636
2022-10-15
2022-10-15
0001421636
cbnt:ExchangeAgreementMember
2022-10-15
2022-10-15
0001421636
cbnt:LetterAgreementMember
2023-12-04
2023-12-04
0001421636
cbnt:LetterAgreementMember
2023-12-04
0001421636
2023-12-04
0001421636
cbnt:MercerStreetGlobalOpportunityFundLLCMember
2024-01-01
2024-06-30
0001421636
2023-12-15
2023-12-15
0001421636
srt:ScenarioForecastMember
2024-09-30
0001421636
srt:ScenarioForecastMember
2024-12-31
0001421636
cbnt:MercerConvertibleDebtMember
2023-12-31
0001421636
cbnt:MercerConvertibleDebtMember
2024-01-01
2024-06-30
0001421636
cbnt:MercerConvertibleDebtMember
2023-01-01
2023-12-31
0001421636
2022-09-06
2022-09-06
0001421636
cbnt:MercerConvertibleDebtMember
2022-04-30
0001421636
2022-04-30
0001421636
cbnt:DiagonalLendingConvertiblesDebtMember
2022-11-09
0001421636
cbnt:DiagonalLendingConvertiblesDebtMember
2022-11-09
2022-11-09
0001421636
cbnt:DiagonalLendingConvertiblesDebtMember
2024-05-04
0001421636
cbnt:DiagonalLendingConvertiblesDebtMember
2022-12-27
0001421636
cbnt:DiagonalLendingConvertiblesDebtMember
2022-12-27
2022-12-27
0001421636
cbnt:DiagonalLendingConvertiblesDebtMember
2024-06-27
0001421636
cbnt:DiagonalLendingConvertiblesDebtMember
2023-03-17
0001421636
cbnt:DiagonalLendingConvertiblesDebtMember
2023-03-17
2023-03-17
0001421636
cbnt:DiagonalLendingConvertiblesDebtMember
2024-03-17
0001421636
2022-11-30
0001421636
cbnt:MercerConvertibleDebtMember
2023-03-31
0001421636
2023-05-11
0001421636
2023-05-11
2023-05-11
0001421636
cbnt:MercerConvertibleDebtMember
2023-06-30
0001421636
cbnt:DiagonalLendingConvertiblesDebtMember
2024-01-01
2024-06-30
0001421636
cbnt:DiagonalLendingConvertiblesDebtMember
2023-01-01
2023-12-31
0001421636
us-gaap:ConvertibleNotesPayableMember
2024-06-30
0001421636
cbnt:MaximumLoanAmountMember
2018-11-14
0001421636
cbnt:BOCOInvestmentNoteMember
2018-11-14
0001421636
cbnt:BOCOInvestmentNoteMember
2018-11-14
2018-11-14
0001421636
cbnt:DebtExchangeAndReleaseAgreementMember
cbnt:LenderMember
2023-05-31
0001421636
cbnt:DebtExchangeAndReleaseAgreementMember
2023-05-31
2023-05-31
0001421636
cbnt:DebtExchangeAndReleaseAgreementMember
2023-05-31
0001421636
cbnt:ReleaseAgreementMember
2023-05-31
2023-05-31
0001421636
cbnt:LenderMember
2023-05-31
2023-05-31
0001421636
cbnt:LenderMember
2023-05-31
0001421636
us-gaap:ConvertibleNotesPayableMember
2023-05-31
2023-05-31
0001421636
us-gaap:ConvertibleNotesPayableMember
2023-05-31
0001421636
2023-05-31
0001421636
2023-05-31
2023-05-31
0001421636
cbnt:GSCapitalNoteMember
2024-06-30
0001421636
cbnt:GSCapitalNoteMember
2023-12-31
0001421636
cbnt:March2022NoteMember
2022-03-14
0001421636
cbnt:March2022NoteMember
2022-03-14
2022-03-14
0001421636
cbnt:March2022NoteMember
2024-06-30
0001421636
cbnt:March2022NoteMember
2023-12-31
0001421636
cbnt:November2022NoteMember
2022-11-22
0001421636
cbnt:November2022NoteMember
2022-11-22
2022-11-22
0001421636
cbnt:November2022NoteMember
2024-06-30
0001421636
cbnt:November2022NoteMember
2023-12-31
0001421636
cbnt:November2022NoteMember
2023-05-31
2023-05-31
0001421636
cbnt:SecuritiesPurchaseAgreementMember
cbnt:GSCapitalJuly2022NoteMember
2022-06-23
0001421636
2022-06-23
2022-06-23
0001421636
cbnt:GSCapitalJune2022Member
2022-06-23
0001421636
cbnt:March2022NoteMember
us-gaap:CommonStockMember
2022-01-01
2022-12-31
0001421636
cbnt:GSCapitalJune2022Member
2022-01-01
2022-12-31
0001421636
cbnt:GSCapitalJune2022Member
2023-01-01
2023-12-31
0001421636
us-gaap:CommonStockMember
2023-04-01
2023-04-01
0001421636
us-gaap:CommonStockMember
2023-05-01
2023-05-01
0001421636
cbnt:GSCapitalNoteMember
us-gaap:CommonStockMember
2023-04-01
2023-04-01
0001421636
cbnt:GSCapitalNoteMember
us-gaap:CommonStockMember
2023-05-01
2023-05-01
0001421636
cbnt:GSCapitalDebtMember
2023-04-01
2023-04-01
0001421636
cbnt:GSCapitalDebtMember
2023-05-01
2023-05-01
0001421636
2023-04-01
2023-04-01
0001421636
2023-05-01
2023-05-01
0001421636
cbnt:GSCapitalDebtMember
2024-06-30
0001421636
cbnt:GSCapitalDebtMember
2023-12-31
0001421636
cbnt:GSCapitalDebtMember
2022-07-26
0001421636
2022-07-26
2022-07-26
0001421636
cbnt:SecuritiesPurchaseAgreementMember
2022-07-26
0001421636
cbnt:July2022CommitmentSharesMember
2022-01-01
2022-12-31
0001421636
2022-01-01
2022-12-31
0001421636
cbnt:July2022CommitmentSharesMember
cbnt:GSCapitalJuly2022NoteMember
2022-12-31
0001421636
cbnt:GSCapitalDebtMember
2022-07-26
2022-07-26
0001421636
cbnt:GSCapitalNoteMember
2023-05-31
2023-05-31
0001421636
cbnt:GSCapitalJuly2022NoteMember
2024-06-30
0001421636
cbnt:GSCapitalJuly2022NoteMember
2023-12-31
0001421636
cbnt:September2022NoteMember
2022-09-06
2022-09-06
0001421636
cbnt:September2022AgreementMember
cbnt:September2022CommitmentSharesMember
2022-09-06
0001421636
cbnt:September2022CommitmentSharesMember
2022-01-01
2022-12-31
0001421636
cbnt:PlacementAgentMember
2022-01-01
2022-12-31
0001421636
cbnt:SecuritiesPurchaseAgreementMember
2022-12-31
0001421636
cbnt:GSCapitalDebtMember
2022-09-06
2022-09-06
0001421636
cbnt:GSCapitalSeptemberTwoThousanTwentyTwoMember
2024-01-01
2024-06-30
0001421636
cbnt:GSCapitalSeptemberTwoThousanTwentyTwoMember
2023-01-01
2023-12-31
0001421636
cbnt:GSCapitalDebtMember
2024-01-01
2024-06-30
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member
2024-03-01
2024-03-01
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member
2024-03-01
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member
2024-03-04
0001421636
2024-03-04
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member
2024-03-04
2024-03-04
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member
2024-04-08
2024-04-08
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member
2024-04-10
0001421636
2024-04-10
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member
2024-04-08
0001421636
2024-04-08
2024-04-08
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member
2024-01-01
2024-06-30
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member
2023-01-01
2023-12-31
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableJune2024Member
2024-06-05
2024-06-05
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableJune2024Member
2024-06-05
0001421636
2024-06-05
2024-06-05
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableJune2024Member
2024-01-01
2024-06-30
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableJune2024Member
2023-01-01
2023-12-31
0001421636
cbnt:PromissoryNoteMember
2021-05-10
0001421636
cbnt:VehicleAndEquipmentLoansMember
2021-07-22
0001421636
srt:MinimumMember
cbnt:PatriotGlassMember
2021-07-22
0001421636
srt:MaximumMember
cbnt:PatriotGlassMember
2021-07-22
0001421636
cbnt:VehicleAndEquipmentLoansMember
2024-06-30
0001421636
cbnt:VehicleAndEquipmentLoansMember
2023-12-31
0001421636
cbnt:November2022NoteMember
2022-11-08
0001421636
2022-11-08
2022-11-08
0001421636
cbnt:VehicleAndEquipmentLoansMember
cbnt:OtherNotesPayableMember
2023-12-31
0001421636
srt:MinimumMember
cbnt:VehicleAndEquipmentLoansMember
2023-12-31
0001421636
srt:MaximumMember
cbnt:VehicleAndEquipmentLoansMember
2023-12-31
0001421636
cbnt:VehicleAndEquipmentLoansMember
cbnt:OtherNotesPayableMember
2024-06-30
0001421636
cbnt:OtherNotesPayableMember
2024-06-30
0001421636
cbnt:February2024NoteMember
2024-02-21
0001421636
cbnt:February2024NoteMember
2024-02-21
2024-02-21
0001421636
cbnt:February2024NoteMember
cbnt:PatriotGlassMember
2024-02-21
0001421636
cbnt:February2024NoteMember
2024-01-01
2024-06-30
0001421636
cbnt:June2024MerchantLoanMember
2024-06-17
0001421636
cbnt:June2024MerchantLoanMember
2024-06-17
2024-06-17
0001421636
cbnt:June2024MerchantLoanMember
cbnt:PatriotGlassMember
2024-06-17
0001421636
cbnt:June2024MerchantLoanMember
2024-01-01
2024-06-30
0001421636
cbnt:PPPNoteMember
2020-04-28
0001421636
cbnt:PPPNoteMember
2020-04-28
2020-04-28
0001421636
cbnt:PPPNoteMember
2020-11-01
2020-11-01
0001421636
cbnt:PPPNoteMember
2021-11-04
2021-11-04
0001421636
cbnt:PPPNoteMember
2024-01-01
2024-06-30
0001421636
cbnt:PPPNoteMember
2024-06-30
0001421636
srt:MaximumMember
cbnt:PPPNoteMember
2024-06-30
0001421636
srt:MinimumMember
cbnt:PPPNoteMember
2023-12-31
0001421636
cbnt:PPPNoteMember
2023-12-31
0001421636
us-gaap:NotesPayableOtherPayablesMember
2024-06-30
0001421636
us-gaap:NotesPayableOtherPayablesMember
2023-12-31
0001421636
cbnt:August302024Member
cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member
2024-06-30
0001421636
cbnt:September302024Member
cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member
2024-06-30
0001421636
cbnt:October302024Member
cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member
2024-06-30
0001421636
cbnt:November302024Member
cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member
2024-06-30
0001421636
cbnt:December302024Member
cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member
2024-06-30
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableMarch2024Member
2024-06-30
0001421636
cbnt:August152024Member
cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member
2024-06-30
0001421636
cbnt:September152024ThroughFebruary152025Member
cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member
2024-06-30
0001421636
cbnt:ThousandEightHundredDiagonalLendingNotePayableApril2024Member
2024-06-30
0001421636
cbnt:PPPLoanMember
2024-06-30
0001421636
us-gaap:SeriesBPreferredStockMember
2019-12-12
0001421636
us-gaap:SeriesBPreferredStockMember
2024-06-30
0001421636
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001421636
srt:BoardOfDirectorsChairmanMember
us-gaap:SeriesBPreferredStockMember
2023-01-17
0001421636
us-gaap:SeriesBPreferredStockMember
2023-01-17
0001421636
srt:BoardOfDirectorsChairmanMember
us-gaap:SeriesBPreferredStockMember
2024-01-02
0001421636
us-gaap:SeriesBPreferredStockMember
2024-01-02
0001421636
us-gaap:SeriesBPreferredStockMember
2024-01-02
2024-01-02
0001421636
srt:BoardOfDirectorsChairmanMember
us-gaap:SeriesBPreferredStockMember
2024-01-02
2024-01-02
0001421636
us-gaap:CommonStockMember
2024-01-02
0001421636
us-gaap:SeriesBPreferredStockMember
us-gaap:CommonStockMember
2024-01-02
2024-01-02
0001421636
2024-01-02
0001421636
2024-01-02
2024-01-02
0001421636
us-gaap:CommonStockMember
2024-01-02
2024-01-02
0001421636
us-gaap:SeriesBPreferredStockMember
us-gaap:CommonStockMember
2024-01-02
0001421636
srt:BoardOfDirectorsChairmanMember
us-gaap:SeriesBPreferredStockMember
2024-02-08
2024-02-08
0001421636
cbnt:SeriesBConvertiblePreferredStockMember
2024-02-08
0001421636
us-gaap:SeriesBPreferredStockMember
2024-02-08
0001421636
us-gaap:SeriesBPreferredStockMember
2024-02-08
2024-02-08
0001421636
srt:ChiefExecutiveOfficerMember
us-gaap:SeriesBPreferredStockMember
2024-05-20
2024-05-20
0001421636
us-gaap:SeriesBPreferredStockMember
2024-05-20
0001421636
us-gaap:SeriesBPreferredStockMember
2024-05-20
2024-05-20
0001421636
us-gaap:SeriesBPreferredStockMember
2023-12-31
0001421636
us-gaap:SeriesBPreferredStockMember
2023-01-01
2023-12-31
0001421636
us-gaap:SeriesCPreferredStockMember
2020-08-20
0001421636
us-gaap:SeriesCPreferredStockMember
2024-06-30
0001421636
us-gaap:SeriesCPreferredStockMember
2021-04-28
2021-04-28
0001421636
us-gaap:SeriesCPreferredStockMember
2023-03-31
0001421636
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2023-01-01
2023-03-31
0001421636
us-gaap:SeriesCPreferredStockMember
2023-06-30
0001421636
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2023-04-01
2023-06-30
0001421636
us-gaap:SeriesCPreferredStockMember
2023-09-30
0001421636
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2023-07-01
2023-09-30
0001421636
us-gaap:SeriesCPreferredStockMember
2024-02-01
0001421636
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2024-02-01
2024-02-01
0001421636
us-gaap:SeriesCPreferredStockMember
2024-03-01
0001421636
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2024-03-01
2024-03-01
0001421636
2024-03-01
0001421636
2024-05-01
0001421636
us-gaap:SeriesCPreferredStockMember
us-gaap:PreferredStockMember
2024-05-01
2024-05-01
0001421636
us-gaap:SeriesCPreferredStockMember
2023-12-31
0001421636
us-gaap:SeriesCPreferredStockMember
2023-01-01
2023-12-31
0001421636
cbnt:SubscriptionAgreementsMember
2023-01-17
2023-01-17
0001421636
2023-01-17
0001421636
cbnt:CommonStockIssuedForCashAndAccruedCompensationMember
2023-01-17
0001421636
2023-01-17
2023-01-17
0001421636
cbnt:MrSilvermanMember
2023-01-17
0001421636
cbnt:InvestorRelationsServicesMember
2023-01-17
2023-01-17
0001421636
cbnt:InvestorRelationsServicesMember
2023-01-17
0001421636
2023-02-06
0001421636
2023-02-06
2023-02-06
0001421636
2023-04-03
0001421636
2023-04-03
2023-04-03
0001421636
2023-06-03
0001421636
2023-06-03
2023-06-03
0001421636
cbnt:IssuanceOfCommonStockForServicesMember
2024-06-30
0001421636
cbnt:IssuanceOfCommonStockForServicesMember
2023-06-30
0001421636
us-gaap:CommonStockMember
2023-06-07
2023-06-07
0001421636
us-gaap:CommonStockMember
2023-06-07
0001421636
cbnt:CommonStockForfeitedMember
2024-02-08
2024-02-08
0001421636
cbnt:CommonStockForfeitedMember
2024-02-08
0001421636
cbnt:ReleaseAgreementMember
2023-05-01
2023-05-01
0001421636
cbnt:ReleaseAgreementMember
2023-05-31
0001421636
cbnt:LenderMember
us-gaap:ConvertibleNotesPayableMember
2023-05-31
2023-05-31
0001421636
us-gaap:SeriesCPreferredStockMember
2024-05-01
0001421636
us-gaap:PreferredStockMember
2024-05-01
2024-05-01
0001421636
cbnt:TwoThousandEighteenLongTermIncentivePlanMember
2024-01-01
2024-06-30
0001421636
us-gaap:SeriesBPreferredStockMember
2022-12-31
0001421636
us-gaap:SeriesBPreferredStockMember
2023-06-30
0001421636
us-gaap:SeriesCPreferredStockMember
2022-12-31
0001421636
us-gaap:EmployeeStockOptionMember
2023-12-31
0001421636
us-gaap:EmployeeStockOptionMember
2023-12-31
2023-12-31
0001421636
us-gaap:EmployeeStockOptionMember
2024-01-01
2024-06-30
0001421636
us-gaap:EmployeeStockOptionMember
2024-06-30
0001421636
us-gaap:WarrantMember
2024-01-01
2024-06-30
0001421636
us-gaap:WarrantMember
us-gaap:WarrantMember
2023-12-31
0001421636
us-gaap:WarrantMember
us-gaap:WarrantMember
2023-12-31
2023-12-31
0001421636
us-gaap:WarrantMember
us-gaap:WarrantMember
2023-12-30
0001421636
us-gaap:WarrantMember
us-gaap:WarrantMember
2024-01-01
2024-06-30
0001421636
us-gaap:WarrantMember
us-gaap:WarrantMember
2024-06-30
0001421636
srt:RestatementAdjustmentMember
2020-01-01
2020-12-31
0001421636
srt:MaximumMember
2024-01-01
2024-06-30
0001421636
srt:MinimumMember
2024-01-01
2024-06-30
0001421636
srt:ChiefExecutiveOfficerMember
2024-06-30
0001421636
srt:ChiefExecutiveOfficerMember
us-gaap:SeriesBPreferredStockMember
2024-05-31
0001421636
srt:ChiefExecutiveOfficerMember
2024-05-31
0001421636
2024-05-31
0001421636
2024-05-31
2024-05-31
0001421636
2024-02-08
2024-02-08
0001421636
cbnt:FormerConsultantMember
2023-01-01
2023-12-31
0001421636
2017-10-18
0001421636
cbnt:SilvermanMember
2017-10-18
0001421636
cbnt:SilvermanMember
cbnt:EmploymenAgreementsMember
2018-04-25
2018-04-25
0001421636
cbnt:SilvermanMember
cbnt:EmploymenAgreementsMember
2024-01-01
2024-06-30
0001421636
cbnt:SilvermanMember
cbnt:EmploymenAgreementsMember
2024-06-30
0001421636
2021-07-21
2021-07-21
0001421636
srt:BoardOfDirectorsChairmanMember
2023-12-07
2023-12-07
0001421636
cbnt:SilvermanMember
2023-01-01
2023-12-31
0001421636
cbnt:EquityMethodInvestmentOwnershipMember
2023-12-31
0001421636
cbnt:SilvermanMember
2023-12-31
0001421636
cbnt:EquityMethodInvestmentOwnershipMember
cbnt:EmploymenAgreementsMember
2023-12-31
0001421636
srt:ChiefExecutiveOfficerMember
2023-12-31
0001421636
cbnt:MsTomekMember
2023-12-31
0001421636
us-gaap:PropertyPlantAndEquipmentMember
2023-12-31
0001421636
cbnt:EquityMethodInvestmentOwnershipMember
cbnt:MsTomekMember
2023-12-31
0001421636
cbnt:SubscriptionAgreementsMember
2013-12-31
2013-12-31
0001421636
cbnt:SubscriptionAgreementsMember
2015-12-31
2015-12-31
0001421636
cbnt:CBondSystemsLLCMember
cbnt:SubscriptionAgreementsMember
2015-12-31
0001421636
cbnt:SubscriptionAgreementsMember
2015-12-31
0001421636
cbnt:SubscriptionAgreementsMember
2016-12-31
2016-12-31
0001421636
cbnt:SubscriptionAgreementsMember
2016-12-31
0001421636
srt:MinimumMember
cbnt:SubscriptionAgreementsMember
2016-12-31
0001421636
2016-12-31
2016-12-31
0001421636
cbnt:OptionToPurchaseTwentyPercentageOfMobileTintMember
2024-01-01
2024-06-30
0001421636
cbnt:OptionToPurchaseTwentyPercentageOfPatriotGlassMember
2023-07-01
2023-07-01
0001421636
2023-07-01
0001421636
2023-10-18
2023-10-18
0001421636
cbnt:CurtisStoutIncMember
2023-10-18
2023-10-18
0001421636
cbnt:MAAdvisoryAgreementMember
2024-01-01
2024-06-30
0001421636
cbnt:CustomerMember
us-gaap:SalesMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001421636
cbnt:CustomerOneMember
us-gaap:SalesMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001421636
cbnt:CustomerTwoMember
us-gaap:SalesMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001421636
cbnt:CustomerMember
us-gaap:SalesMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-06-30
0001421636
cbnt:CustomerMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001421636
cbnt:CustomerOneMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001421636
cbnt:CustomerTwoMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001421636
cbnt:CustomerThreeMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001421636
cbnt:CustomerFourMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001421636
cbnt:CustomerFiveMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2024-01-01
2024-06-30
0001421636
cbnt:CustomerMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-12-31
0001421636
cbnt:CustomerOneMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-12-31
0001421636
cbnt:CustomerTwoMember
us-gaap:AccountsReceivableMember
us-gaap:CustomerConcentrationRiskMember
2023-01-01
2023-12-31
0001421636
cbnt:CBondMember
2024-04-01
2024-06-30
0001421636
cbnt:CBondMember
2023-04-01
2023-06-30
0001421636
cbnt:CBondMember
2024-01-01
2024-06-30
0001421636
cbnt:CBondMember
2023-01-01
2023-06-30
0001421636
cbnt:PatriotGlassMember
2024-04-01
2024-06-30
0001421636
cbnt:PatriotGlassMember
2023-04-01
2023-06-30
0001421636
cbnt:PatriotGlassMember
2024-01-01
2024-06-30
0001421636
cbnt:PatriotGlassMember
2023-01-01
2023-06-30
0001421636
us-gaap:AllOtherSegmentsMember
2024-04-01
2024-06-30
0001421636
us-gaap:AllOtherSegmentsMember
2023-04-01
2023-06-30
0001421636
us-gaap:AllOtherSegmentsMember
2024-01-01
2024-06-30
0001421636
us-gaap:AllOtherSegmentsMember
2023-01-01
2023-06-30
0001421636
cbnt:CBondMember
2024-06-30
0001421636
cbnt:CBondMember
2023-12-31
0001421636
cbnt:PatriotGlassMember
2024-06-30
0001421636
cbnt:PatriotGlassMember
2023-12-31
0001421636
cbnt:CBondSecureMultipurposeAndBRSBallisticResistantGlassProtectionSystemsMember
2024-01-01
2024-06-30
0001421636
cbnt:CBondSecureMultipurposeAndBRSBallisticResistantGlassProtectionSystemsMember
2023-01-01
2023-06-30
0001421636
cbnt:CBondNanoshieldSolutionSalesMember
2024-01-01
2024-06-30
0001421636
cbnt:CBondNanoshieldSolutionSalesMember
2023-01-01
2023-06-30
0001421636
cbnt:WindowTintInstallationAndSalesRecognizedOverTimeMember
2024-01-01
2024-06-30
0001421636
cbnt:WindowTintInstallationAndSalesRecognizedOverTimeMember
2023-01-01
2023-06-30
0001421636
cbnt:FreightAndDeliveryMember
2024-01-01
2024-06-30
0001421636
cbnt:FreightAndDeliveryMember
2023-01-01
2023-06-30
0001421636
2019-10-31
0001421636
2019-12-01
2020-11-30
0001421636
2020-12-01
2021-05-31
0001421636
2022-05-31
0001421636
2022-05-31
2022-05-31
0001421636
cbnt:MDWManagementLLCMember
srt:MaximumMember
2024-06-30
0001421636
cbnt:MDWManagementLLCMember
srt:MinimumMember
2024-06-30
0001421636
2021-09-30
2021-09-30
0001421636
2022-02-28
2022-02-28
0001421636
us-gaap:RelatedPartyMember
2024-05-08
2024-05-08
0001421636
srt:ChiefExecutiveOfficerMember
us-gaap:RelatedPartyMember
2024-05-08
2024-05-08
0001421636
us-gaap:RelatedPartyMember
2024-05-08
0001421636
us-gaap:RelatedPartyMember
us-gaap:SeriesBPreferredStockMember
2024-05-08
0001421636
us-gaap:RelatedPartyMember
us-gaap:SeriesBPreferredStockMember
2024-05-31
2024-05-31
0001421636
us-gaap:RelatedPartyMember
2023-01-01
2023-12-31
0001421636
us-gaap:RelatedPartyMember
2023-03-31
0001421636
2022-05-02
2022-05-02
0001421636
us-gaap:RelatedPartyMember
2024-06-30
0001421636
us-gaap:RelatedPartyMember
us-gaap:SeriesBPreferredStockMember
2024-06-30
0001421636
us-gaap:RelatedPartyMember
us-gaap:SeriesBPreferredStockMember
2023-05-31
2023-05-31
0001421636
us-gaap:RelatedPartyMember
2023-05-31
0001421636
2023-03-08
2023-03-08
0001421636
cbnt:BOCOInvestmentsLLCMember
2024-06-30
0001421636
cbnt:BOCOInvestmentsLLCMember
2024-01-01
2024-06-30
0001421636
cbnt:BOCOInvestmentsLLCMember
us-gaap:CommonStockMember
2024-01-01
2024-06-30
0001421636
cbnt:GSCapitalPartnersLLCMember
2022-06-23
2022-06-23
0001421636
cbnt:GSCapitalPartnersLLCMember
2022-07-26
2022-07-26
0001421636
cbnt:GSCapitalPartnersLLCMember
2022-09-06
2022-09-06
0001421636
cbnt:MercerStreetGlobalOpportunityFundLLCMember
2022-03-14
2022-03-14
0001421636
cbnt:MercerStreetGlobalOpportunityFundLLCMember
2022-11-22
2022-11-22
0001421636
cbnt:JeffBaddersMember
2021-05-05
2021-05-05
0001421636
cbnt:JeffBaddersMember
2022-11-08
2022-11-08
0001421636
cbnt:JeffBaddersMember
2023-04-04
2023-04-04
0001421636
cbnt:DiagonalLendingLLCMember
2022-11-04
2022-11-04
0001421636
cbnt:DiagonalLendingLLCMember
2022-12-27
2022-12-27
0001421636
cbnt:DiagonalLendingLLCMember
2023-03-17
2023-03-17
0001421636
cbnt:CEOMember
2022-05-02
2022-05-02
0001421636
us-gaap:SubsequentEventMember
2024-07-31
0001421636
us-gaap:SubsequentEventMember
2024-07-31
2024-07-31
0001421636
srt:ScenarioForecastMember
us-gaap:SeriesCPreferredStockMember
2024-08-31
0001421636
srt:ScenarioForecastMember
us-gaap:SeriesCPreferredStockMember
2024-08-01
2024-08-31
0001421636
srt:ScenarioForecastMember
2024-08-01
2024-08-31
0001421636
srt:ScenarioForecastMember
cbnt:PromissoryNoteMember
2024-08-01
2024-08-31
0001421636
cbnt:PromissoryNoteMember
us-gaap:SubsequentEventMember
2024-08-31
0001421636
us-gaap:SubsequentEventMember
2024-08-01
2024-08-31
0001421636
us-gaap:SubsequentEventMember
2024-08-15
2024-08-15
0001421636
cbnt:PromissoryNoteMember
2024-01-01
2024-06-30
0001421636
cbnt:PromissoryNoteMember
us-gaap:SubsequentEventMember
2024-08-15
0001421636
2024-04-01
2024-04-30
0001421636
us-gaap:SubsequentEventMember
2024-08-15
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
cbnt:segments